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ABSTRACT 
 
An in depth chemical investigation of the major and minor pyrroloiminoquinone metabolites 
produced by four species of endemic South African Latrunculid sponges, collected from Algoa 
Bay and the Tsitsikamma Marine Reserve off the south eastern coast of South Africa, yielded 
eleven new and twelve known pyrroloiminoquinone metabolites. The structures of the new 
metabolites were determined using standard spectroscopic techniques.  
 
Tsitsikamma pedunculata was shown to contain 7,8-dehydro-3-dihydro-discorhabdin C (2.1), 14-
bromo-7,8-dehydro-3-dihydro-discorhabdin C (2.2), discorhabdin S (2.3), 14-bromo-1-hydroxy-
discorhabdin S (2.4), 1-bromo-2-hydroxy-4-debromo-discorhabdin S (2.5), and 2,4-debromo-3-
dihydro-discorhabdin C (2.6), together with the known compounds 14-bromo-discorhabdin C 
(1.51), 14-bromo-3-dihydro-discorhabdin C (1.52) and 3-dihydro-discorhabdin C. The metabolites 
from T. pedunculata were characterised by the presence of a reduced C-3 carbonyl and 
bromination at C-14. 
 
Compounds isolated from a second Latrunculid sponge, Latrunculia lorii, ranged from a 
substituted bicyclic pyrrolecarboxylic acid, makaluvic acid A (1.47), to the simple tricyclic known 
pyrroloiminoquinones makaluvamine C (1.33) and damirone B (1.20) and the more complex 
discorhabdin D type metabolites, discorhabdin M (3.2), 1-amino discorhabdin D (3.3), 1-methoxy 
discorhabdin D (3.4) and 1-alanyl discorhabdin D (3.5). Discorhabdin G* (3.1) was also isolated 
and characterised. This is the first reported occurrence of the known compounds 1.20, 1.33 and 
1.47 in a Latrunculia sponge. 
 
Discorhabdin and bis-pyrroloiminoquinone type compounds predominated in Tsitsikamma favus. 
Three known, tsitsikammamines A (1.71) and B (1.72), 1.52, and five new pyrroloiminoquinones, 
tsitsikammamine N-oxime (4.1), tsitsikammamine B N-oxime (4.2), 2.1, 2.4 and 2.6, were isolated 
from this sponge. A fourth Latrunculid sponge (Strongylodesma sp.) yielded three known 
compounds, discorhabdins A (1.57), D (1.61) and 1.53, and one new pyrroloiminoquinone 3.3.  
 
The dual role of these metabolites as cytotoxic agents and pigments resulted in an attempt to 
relate the photochemical properties of these metabolites to their cytotoxicity. The 
pyrroloiminoquinone metabolites studied exhibited moderate singlet oxygen quantum yields, while 
three compounds (1.57, 4.1 and 4.2) were shown to be capable of producing radicals at a 
wavelength of 532 nm. The possibility of a correlation between the electrochemical properties and 
anti-cancer (HCT-116) activity of selected pyrroloiminoquinones was explored. A study of the 
oesophageal and ovarian cytotoxicities of two pyrroloiminoquinones (1.57 and 1.72), together with 
an investigation into the intercalation and topoisomerase I inhibitory activity of the bis-
pyrroloiminoquinones (1.71, 1.72, 4.1 and 4.2), are presented.  
Chapter 1: Introduction 
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1.1 Marine sponges: a prolific source of potential pharmaceuticals  
 
Natural products, the secondary metabolites produced by many organisms e.g. plants, microbes 
and marine invertebrates, have been utilised by people over the centuries as a source of food, 
medicine, insecticides, poison, dyes, and even cosmetics.1 Terrestrial plants, which have formed 
the basis of many traditional herbal remedies, are still the major source of medicinally important 
natural products. Currently approximately one hundred and twenty products derived from ninety 
plant species can be considered as important drugs, and a 1993 analysis of prescription data 
from the United States revealed that over 50 % of the most frequently prescribed drugs either 
contained a plant natural product or were derived from a plant natural product.2 The increased 
availability of SCUBA in the latter half of the twentieth century has made the marine environment 
far more accessible than before, and this, together with the knowledge that the marine 
environment diversity exceeds that of terrestrial organisms,3 has stimulated research into the vast 
marine natural products reservoir with the objective of discovering new pharmaceutical agents.3,4,5 
 
Marine sponges (Phylum Porifera) are the most prolific producers of biologically active marine 
natural products.3,6-10 Andersen and Williams report that 47 % of the natural products isolated 
from marine organisms in 1997 were sponge metabolites,5 and that sponges contributed 44 % of 
the total number of cytotoxic compounds identified from marine organisms up to 2000.5 Sponges, 
in common with other marine organisms, occupy very different habitats to terrestrial plants and 
are subjected to unique ecological, physiological and predatory challenges. Accordingly, it is not 
surprising that sponges have utilised unique biosynthetic pathways, or have adapted established 
pathways, to produce the plethora of novel marine natural products which abound in the 
literature.5-10 The role of these secondary metabolites in supporting the sponges’ survival in the 
sea includes defence against predation, microbial infection and as chemical mediators in the 
competition for space in competitive marine reef ecosystems. It has been suggested that a 
significant number of sponge metabolites could be of microbial origin because of the large 
number of symbiotic microorganisms (bacteria and fungi) associated with the sponge. However 
this has only been proven in a few cases.11  
 
The ubiquitous Phylum Porifera which evolved more than 500 million years ago is found in a 
variety of habitats from intertidal zones to mid ocean trenches thousands of metres deep.1 
Sponges are the simplest of multicellular animals, sustaining a virtually protozoan independence 
for their constituent cells, which form no tissue layers or organs.1 The location of a particular cell 
is dependent on the specialised functions performed by that cell and the life of a sponge revolves 
around the pumping of a large volume of water through the tissues. The sponge relies on the food 
and oxygen filtered out of the water column for survival. The bodies of sponges therefore consist 
of a system of pores, ostia, canals and chambers, which conduct water from the inhalant ostia on 
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the surface to the oscules, the exhalant apertures also on the surface. Sponges vary widely in 
colour, shape and size, from thin encrusting sponges to branched rope sponges and giant barrel 
sponges that are more than two metres in height.1  
 
The search for sponge marine natural products with pharmaceutical potential began during the 
1950s with the work of Bergman and co-workers on the Caribbean sponge Cryptotethia crypta. 
The potent tumour inhibitor spongouridine (1.1) was isolated as a major metabolite, which led to 
the synthesis of a new class of arabinosyl nucleoside analogs such as arabinosyl cytosine (1.2 
ara-C). Ara-C is currently in clinical use for the treatment of acute myelocytic leukaemia and non-
Hodgkin’s lymphoma.1,3 
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The following selection of compounds not only illustrates the potent pharmacological activity 
displayed by sponge metabolites but also their remarkable structural variety. 
 
 
 
N
N
S
N
NMe2  
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
H
OH
OH
H
H
H
H
H
H H
HO
H
H
H
H
H
1.3 1.4 
 
The novel aminoacridine alkaloid dercitin (1.3) was isolated from a Caribbean deep water sponge 
Dercitus sp..12 Dercitin possesses in vitro cytotoxic activities in the low nanomolar concentration 
range, displaying activity against B-16 melanoma cells and small cell Lewis lung carcinoma. In 
animal studies, dercitin was found to prolong the life of mice bearing ascitic P-388 tumours 
(Treated / Control (T/C) 170, i.e. a 70 % increase in life span, at 5 mg/kg). Studies indicated that 
dercitin probably exerts its biological effects through DNA intercalation, which is also a 
mechanism of action for several clinically useful anticancer agents. 12 
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The development of halichondrin B (1.4) from the sponge Lissodendoryx sp.13 as an anticancer 
agent is of interest as it highlights the problem of supply which hampers the success of many 
marine compounds in clinical trials. Originally isolated in small amounts from the Japanese 
sponge Halichondria okadai,14 Munro, Battershill and co-workers have successfully engineered 
the first sustainable supply of a sponge metabolite for clinical trials via aquaculture3 of the related 
Lissodendoryx sp.. 
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Another Caribbean sponge Discodermia dissoluta produced the potent immunosuppressant 
discodermolide (1.5), a polyhydroxylated lactone.15 While in vitro assays showed that the 
immunosuppressive activity of 1.5 is approximately equivalent to that of the clinically useful 
immunosuppressive agent cyclosporin A, the in vivo assays showed that 1.5 was 100 – 1000 
times more powerful than cyclosporin A. 
 
Leucettamine A (1.6), an imidazole alkaloid from the Palauan sponge Leucetta microraphis,16 
displays anti-inflammatory activity by acting as a potent and selective antagonist for the 
leukotriene B4 (LTB4) receptor.  
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Another sponge metabolite with anti-inflammatory properties is contignasterol (1.7) isolated by 
Andersen and co-workers from the sponge Petrosia contignata.17 The Canadian pharmaceutical 
company Inflazyme has developed this compound and a more potent synthetic analogue IPL-576 
as anti-asthma agents. The synthetic derivative was scheduled to enter clinical trials in 1999.18 
 
An Indian Ocean sponge collection yielded a series of cytotoxic quinones, such as cribrostatin 1 
(1.8), isolated from the sponge Cribrochalina sp..19 Cribrostatin 1 (1.8) displayed selective activity 
against all nine melanoma cell lines in the NCI panel. 
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Manoalide (1.9), isolated from the sponge Luffariella variables by de Silva and Scheuer,20 initially 
showed immense promise as an anti-inflammatory agent. Unfortunately the insolubility of this 
compound precluded its clinical development. Nonetheless this compound still finds application 
today as an important molecular probe in phospholipase A2 inhibition. 
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The polycyclic guanidine alkaloids batzelladines A (1.10) and C (1.11) isolated from the 
Caribbean sponge Batzella sp. have shown potential as anti-HIV agents, exhibiting potent 
inhibition of CD4/gp120 binding in various assays. The fact that HIV-1 cannot replicate 
autonomously, provided a target for AIDS therapeutic agents i.e. the binding site for the HIV-1 
surface glycoprotein gp120 and CD4 receptors on T-cells.21   
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An important class of bioactive sponge metabolites are the pyrroloiminoquinone alkaloids 
confined to the sponge family Latrunculiidae. Wakayin (1.73), isolated from an ascidian (Phylum 
Ascidiacea) is the notable exception to this general trend (see pp. 17). As this thesis presents a 
comprehensive study of the pyrroloiminoquinone metabolites from four species of South African 
Latrunculid sponges, a review of this class of compounds is deemed necessary. This review limits 
its scope to a more thorough discussion of the isolation, identification, phyletic distribution, 
biosynthesis, bioactivity and synthesis of pyrroloiminoquinone and pyrroloamino-ortho-quinone 
alkaloids from the family Latrunculiidae than that presented in a recent review entitled “Bioactive 
Marine Alkaloids”.22  
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Pyrroloiminoquinones display significant biological properties, thus attracting both natural product 
and synthetic chemists alike, since almost all these alkaloids have been reported to exhibit 
significant cytotoxicity. The mechanism of this cytotoxicity includes inhibition of topoisomerase II, 
Ca2+ release activity and intercalation of DNA. For the natural products chemist these compounds 
provide challenging targets for structure elucidation studies given the paucity of resonances in 
their 1H NMR spectra. 
 
Interestingly pyrroloiminoquinones and pyrroloamino-ortho-quinone type compounds are not 
limited to the marine environment and two terrestrial sources of these compounds are known. The 
South American toad Bufo marinus was found to contain, as its principle indole constituent, 
dehyrobufotenine (1.12),23 while a pyrroloquinoline pigment, haematopodin (1.13) was isolated 
from the fungus Mycena haematopus. 24 
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1.2 Chemistry of pyrroloamino-ortho-quinone, pyrroloiminoquinone and bis-pyrroloimino-
quinone alkaloids 
 
Over sixty alkaloids containing the characteristic pyrroloiminoquinone (1.14), and to a lesser 
extent the pyrroloamino-ortho-quinone (1.15) core structures have been isolated from the genera 
Latrunculia, Zyzzya, Batzella, Prianos and Damiria. Traditionally pyrroloiminoquinone and 
pyrroloamino-ortho-quinone metabolites have been further subdivided into three broad structure 
subclasses based on either a pyrroloquinoline (1.16), bis-pyrroloquinoline (1.17) or pyrrole-[1,7]-
phenanthroline (1.18) skeleton. 
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Our review of the isolation and identification of pyrroloamino-ortho-quinone, pyrroloiminoquinone 
and bis-pyrroloiminoquinone metabolites from Latrunculid sponges has been subdivided 
according to the structural complexity of these compounds. The simpler, bicyclic and tricyclic 
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pyrroloquinoline metabolites precede the more complex pyrroloiminoquinones e.g. the tetracyclic 
makaluvamines and the penta-, hexa- and hepta-cyclic discorhabdins. 
 
1.2.1 Damirones 
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     1.19 R1 = CH3; R2 = CH3 
     1.20 R1 = H; R2 = CH3 
     1.21 R1 = H; R2 = H 
 
The damirones, named after the original sponge source of these compounds, are characterised 
by an ortho-quinone moiety in addition to the pyrroloquinoline ring structure common to all the 
compounds discussed in this review. Damirones A (1.19) and B (1.20) were isolated by Stierle 
and Faulkner25 from a Palauan sponge of the genus Damiria, which was subsequently 
reidentified26 as Zyzzya fuliginosa. The dichloromethane partition fraction of the methanol extract 
of the sponge was subjected to Sephadex LH-20 chromatography using dichloromethane : 
methanol (1:1) as the eluant, followed by silica gel flash chromatography. The structures of 1.19 
and 1.20 were based upon comparison with that of batzelline A (1.22) and corroborated with 
additional spectroscopic data such as nOe difference spectroscopy (NOEDS) experiments and 
UV data.25 
 
A third damirone, damirone C (1.21), was isolated by Schmidt et al.26 along with several 
makaluvamines from a Pohnpeian sponge Zyzzya fuliginosa. Damirone C (1.21) lacks the N-
methyl groups of 1.19 and 1.20 and the proposed structure was confirmed from one and two 
dimensional NMR data.26 
 
1.2.2 Batzellines 
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     1.22 R1 = CH3; R2 = SCH3 
     1.23 R1 = H; R2 = SCH3 
     1.24 R1 = CH3; R2 =H 
 
The batzellines, also named after the sponge source, feature a chlorine substituent in addition to 
the pyrrolo-ortho-quinone structure seen in the damirones. The chlorine functionality in these 
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compounds, as well as the thiomethyl ether group in compounds 1.22 and 1.23, are quite unusual 
and are rarely seen in marine natural products. Batzellines A-C (1.22 - 1.24) were obtained from a 
deep water collection of Batzella sp. from the Bahamas.27 The methanol : chloroform extract of 
the sponge was extracted with ethyl acetate and the latter extract fractionated by counter current 
chromatography  to give batzellines A to C. The structure of 1.22 was secured by a combination 
of NMR, HREIMS, UV absorption, chemical conversions and X-ray crystallographic analyses. The 
structures of 1.23 and 1.24 were established by comparison of their NMR data with those of 1.22 
and through chemical interconversion.  
 
1.2.3. Isobatzellines 
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     1.25 R1 = SCH3; R2 = Cl 
     1.26 R1 = SCH3; R2 = H 
     1.27 R1 = H; R2 = Cl 
     1.28 R1 = SCH3; R2 = Cl; ∆3 
 
An ongoing search for bioactive agents from Batzella sponges by the Sakemi and co-workers 
resulted in the isolation and characterisation of four additional alkaloids, the isobatzellines A-D 
(1.25 – 1.28), from the deep water Caribbean sponge Batzella sp..28 The isobatzellines posses 
the same pyrroloquinoline ring system as the batzellines, but contain an iminoquinone moiety 
instead of the amino-ortho-quinone moiety found in the batzellines. The four structurally related 
isobatzellines were characterised by chemical interconversion and spectral comparison with 1.22. 
Interestingly, auto-oxidation of 1.25 to 1.28 was observed on a thin layer chromatogram (TLC) 
containing 1.25 within a few hours or by treatment with 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ), suggesting that oxidation of 1.25 is facile to give the more aromatic 1.28. 
Isobatzelline A was converted to batzelline A by a diazotisation – substitution reaction in aqueous 
nitrous acid. Solvent partitioning of the chloroform : methanol extract and centrifugal counter 
current chromatography were used to purify compounds 1.25 – 1.28.28  
 
1.2.4 Secobatzellines 
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     1.29 R1 = NH 
     1.30 R1 = O 
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In a continuing search for new protein phosphatase inhibitors from marine organisms, two 
batzelline derivatives, the bicyclic secobatzellines A (1.29) and B (1.30) were isolated from a deep 
water Caribbean sponge of the genus Batzella sp..29 The structures of secobatzellines A and B 
were determined by a combination of one and two dimensional NMR spectroscopy as well as 
chemical interconversion.29 Secobatzelline A was found to possess the same basic 
pyrroloiminoquinone backbone reported for the structurally related isobatzellines A-D. 
Secobatzelline B was subsequently thought to be an isolation artefact.22 The ethanol extract of the 
Batzella sponge was partitioned between ethyl acetate and water and the former partition fraction 
subjected to silica gel chromatography using dichloromethane : methanol as the solvent and the 
fractions subsequently collected were monitored for inhibition of calcineurin (CaN). The CaN 
inhibitory fractions were then combined and purified using reversed phase HPLC.29   
 
1.2.5 Makaluvamines 
 
In 1993, as part of their ongoing search for potential antineoplastic agents from marine sources, 
Radisky et al.30 were the first to present the isolation and characterisation of seven new 
pyrroloiminoquinones, makaluvamines A-F (1.31 – 1.36) and makaluvone (1.37), together with the 
known compounds discorhabdin A (1.57) and damirone B (1.20) from a Fijian sponge Zyzzya cf. 
marsailis (an incorrect spelling of massalis was later corrected and the sponge reidentified as 
Zyzzya fuliginosa26) collected from Makaluva Island. Solvent partitioning of the methanol extract 
resulted in the cytotoxic activity being concentrated primarily in the chloroform layers. Routine 
silica gel flash chromatography followed by lipophilic Sephadex LH-20 chromatography yielded 
these pyrroloiminoquinones. Extensive two dimensional NMR data, together with comparison with 
the published data for a semisynthetic derivative of isobatzelline A (1.25) led to the initial structure 
of makaluvamine A. The structure of the ortho-quinone, makaluvone (1.37), established by 
comparison of the NMR data with isobatzelline C, followed the structure elucidation of the rest of 
the makaluvamine series.30 
 
 
N
N NHR4
O
R1
R2
R3
1
2
3
4
5
6
7
8
9
2a
5a
8a
8b
 
1
2
3
4
5
6
7
88a
2a
5a
8b
14
12
11
13
109
17
16
15
N
N N
O
R1
R2
H
OH 
1.31 
1.32 
1.33 
1.39 
1.40 
1.45 
R1 = CH3; R2 = H; R3 = H; R4 = H 
R1 = CH3; R2 = H; R3 = H; R4 = H; ∆3 
R1 = H; R2 = CH3; R3 = H; R4 = H 
R1 = CH3; R2 = CH3; R3 = H; R4 = H 
R1 = H; R2 = H; R3 = H; R4 = H 
R1 = H; R2 = H; R3 = Br; R4 = H 
 
1.34 
1.35 
1.38 
1.41 
1.42 
1.43 
1.44 
1.46 
R1 = H; R2 = H 
R1 = CH3; R2 = H; ∆10 
R1 = CH3; R2 = CH3; ∆10 
R1 = H; R2 = CH3 
R1 = CH3; R2 = H 
R1 = H; R2 = CH3; ∆10 
R1 = H; R2 = H; ∆10 
R1 = CH3; R2 = CH3 
 8
Chapter 1: Introduction 
 
 
NH
N N
O
H
H
S
OH
Br
1
2
3
4
5
6
7
88a
2a
5a
8b
14
12
11
13
109
17
16
15
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1.36  1.37 
 
Other members of the makaluvamine group have subsequently been reported. Carney et al.31 
isolated makaluvamine G (1.38) from a sponge collected from Indonesia of the genus 
Histodermella (later reidentified as Zyzzya fuliginosa26). Solvent partitioning of the 
dichloromethane : 2-propanol (1:1) extract followed by Sephadex LH-20 chromatography yielded 
makaluvamine G as the major cytotoxic product. Makaluvamines A and C together with 
damirones A (1.19) and B (1.20) were also isolated from the sponge.31 
 
Makaluvamines H-M (1.39 - 1.44) and damirone C (1.21) were isolated by Schmidt et al. from a 
Pohnpeian sponge, Zyzzya fuliginosa.26 The methanol : dichloromethane extract of the sponge 
was partitioned between ethyl acetate and water and the water soluble material chromatographed 
on Sephadex LH-20 using methanol as the eluant. The known compounds makaluvamines C 
(1.33), D (1.34) and G (1.38) were also isolated. The new compounds were identified by recourse 
to extensive two dimensional NMR data and by comparison of their spectral data with those of the 
known members in these series.  
 
Venables et al.32 reported the isolation of makaluvamine N (1.45), a pyrroloiminoquinone whose 
structure is reminiscent of the batzelline series. Makaluvamine N, which possesses a halogen at 
position 6 (uncommon for makaluvamines) was isolated from a Philippine sponge of the genus 
Zyzzya fuliginosa together with the known compounds makaluvamines A, C, D, E and I. The 
sponge was extracted with methanol and partitioned according to a modified Kupchan procedure. 
The methanol soluble material was purified on a reversed phase high performance liquid 
chromatography (HPLC) C18 column followed by final purification on a Sephadex LH-20, while the 
chloroform soluble material was subjected to repeated Sephadex LH-20 chromatography.32  
 
In an ongoing search for cytotoxic marine metabolites, the sponge Zyzzya fuliginosa was 
collected off the Vanuatu Islands and yielded makaluvamine P (1.46), the last new makaluvamine 
reported to date.33 The compound was identified by comparison of its spectral data with those of 
known compounds. The sponge was extracted with methanol and subsequently partitioned 
according to a modified Kupchan procedure. Fractionation of the bioactive chloroform soluble 
material was performed by droplet countercurrent chromatography (DCCC) followed by reversed 
phase HPLC on a C18 column. Makaluvamine P was isolated together with makaluvamines G, J, 
K and L.33 
 
 9
Chapter 1: Introduction 
 
1.2.6 Makaluvic acids 
2a 5a
8a
8b O
OH
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R1
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     1.47 R1 = H; R2 = CH3 
1.48 R1 = CH3; R2 = H 
 
Due to the co-occurrence of the substituted pyrrole carboxylic acids, makaluvic acids A (1.47) and 
B (1.48), with makaluvamines although they are not strictly pyrroloquinoline metabolites they have 
been included in this section. Fu et al.34 isolated makaluvic acids A and B from the sponge Zyzzya 
fuliginosus. The known makaluvamines A, E and K, together with 4-hydroxybenzoic acid and 3,7-
dimethylisoguanine were also found in the sponge. The sponge was extracted sequentially with 
methanol and methanol : dichloromethane (1:1) and the combined extracts subjected to Kupchan 
partitioning. The n-butanol and water fractions were found to exhibit significant cytotoxicity and 
contained the makaluvamine metabolites. 3,7-Dimethylisoguanine was obtained during the 
chromatography of the n-butanol partition fraction using a silica gel column and methanol : 
dichloromethane as the eluent. The makaluvic acids were obtained from silica gel 
chromatography using methanol : dichloromethane containing 1 % TFA as the eluent followed by 
reversed phase HPLC. The structure of makaluvic acid A was confirmed by X-ray analysis.34 
 
1.2.7 Discorhabdins 
 
A basic discorhabdin skeleton together with the atom numbering used by the original authors35 is 
given below: 
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The name discorhabdin is derived from the characteristic discorhabd spicules used to identify 
many Latrunculid sponges. Pyrroloiminoquinone discorhabdin metabolites isolated from marine 
sponges of the family Latrunculiidae have the following general structural features: the 
metabolites normally contain a pyrrolo-[1,7]-phenanthroline ring system together with a spiro 
cyclohexenone or spiro cyclohexadienone ring system. In addition, bromine is frequently 
incorporated into the skeleton, e.g. discorhabdin C (1.49), and some metabolites are also found to 
contain a tetrahydrothiophene bridge e.g. discorhabdin A (1.57). 
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Discorhabdin C was the first, and the simplest, of the discorhabdins to be isolated from a sponge 
of the genus Latrunculia du Bocage35 and was discovered through wide scale screening of New 
Zealand’s marine invertebrates for antiviral and antitumour activity. Discorhabdin C (1.49) thus 
represented a new class of potential antitumour agents.35 The structure of the highly cytotoxic 
discorhabdin C was shown by single-crystal X-ray diffraction to contain a previously unknown 
tetracyclic pyrroloiminoquinone chromophore linked to a spiro 2,6-dibromocyclohexadienone ring. 
The NMR assignments of discorhabdin C were subsequently established by Perry et al..36 Flash 
chromatography of the methanol : toluene extract followed by purification of the cytotoxic fractions 
by reversed phase LC afforded pure 1.49 which was characterised as its hydrochloride salt.35 
 
16
N
NH
N
O
R1
H
R6R3
R4 R5
R2
7
4
 
1.49 R1 = H; R2 = H; R3 = Br; R4 + R5 = O; R6 = Br; ∆4 
1.50 R1 = CH3; R2 = H; R3 = Br; R4 + R5 = O; R6 = Br; ∆4 
1.51 R1 = H; R2 = Br; R3 = Br; R4 + R5 = O; R6 = Br; ∆4 
1.52 R1 = H; R2 = Br; R3 = Br; R4 = OH; R5 = H; R6 = Br; ∆4 
1.53 R1 = H; R2 = H; R3 = Br; R4 = OH; R5 = H; R6 = Br; ∆4 
1.54 R1 = H; R2 = H; R3 = Br; R4 + R5 = O; R6 = H; ∆4 
1.55 R1 = H; R2 = H; R3 = Br; R4 + R5 = O; R6 = H; ∆4, ∆16 
1.56 R1 = H; R2 = H; R3 = Br; R4 + R5 = O; R6 = H; ∆7 
 
The nomenclature of the discorhabdins has been unnecessarily complicated by the relative 
inaccessibility of the structures of discorhabdins H-O. Although the structures of discorhabdins E-
M were presented by Munro et al.37 at the New Zealand Institute of Chemistry Conference (7-10 
December, 1993) and later at the 37th Annual Meeting of the American Society of Pharmacognosy 
(1996),38 their spectral data has never been published. The uncertainty surrounding the structures 
of discorhabdins H-O has been relieved to some extent by the appearance of these structures in 
the recent review by Urban et al.22 (unfortunately again without spectral data). We were in a 
fortunate position to have access to both the structures and the 1H NMR spectra of discorhabdins 
E-M39 and were confused by the inconsistency between the structures of discorhabdin G and 
discorhabdin M we had in hand and those presented in the recent review (see Chapter 3, Section 
3.2.3). In an attempt to clarify the structures of discorhabdins H-O we have presented these 
structures as per the Urban et al.22 review in Figure 1.1.   
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N
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Discorhabdin M 
(Discorhabdin L: ∆4)  
Discorhabdin N  
(Discorhabdin M: ∆4) 
Discorhabdin ? 
(Discorhabdin O) 
Discorhabdin O: R = OMe, ∆4 
(Discorhabdin P: R = OH) 
 
Figure 1.1 The structures of discorhabdins H-O (from Urban et al.).22 The former names39 
are given in parentheses, together with any structural differences. 
 
Discorhabdin P (1.50), i.e. N-13-methyl discorhabdin C, was isolated from a deep water 
Caribbean sponge of the genus Batzella by Gunasekera et al.40 in an ongoing search for new 
protein phosphatase inhibitors from marine organisms. The structure of discorhabdin P was 
solved using NMR spectroscopy and confirmed by X-ray diffraction analysis. The ethanol extract 
was partitioned between ethyl acetate and water and the ethyl acetate soluble material 
chromatographed over silica gel using gradient elution (methanol : dichloromethane) to afford 
discorhabdin P.40 
 
14-Bromo-discorhabdin C (1.51) and 14-bromo-3-dihydro-discorhabdin C (1.52) were isolated by 
Hooper et al. in 1996 from a South African marine sponge recently identified as Tsitsikamma 
favus. This was the first report of discorhabdin metabolites with a C-14 substituent. A combination 
of antibiotic assays and 1H NMR spectroscopy was used to guide the extraction and the 
chromatographic procedures. Gradient elution on a C18 Sep-Pak cartridge was used to achieve 
the initial separation of the sponge extract partition fractions followed by exhaustive reversed 
phase HPLC. Extensive one and two dimensional NMR spectroscopy ultimately established the 
structures for 1.51 and 1.52.41  
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In an ongoing search for cytotoxic metabolites from South African Latrunculid sponges, a third 
discorhabdin C analogue, 3-dihydrodiscorhabdin C (1.53) was isolated by Beukes42 as the second 
major metabolite from a sponge Strongylodesma coetzeei. The structure was established by 
comparison of the spectral data with those of discorhabdin C and 1.52 together with further one 
and two dimensional NMR data. Solvent partitioning of the methanol : dichloromethane extract  
with ethyl acetate and water (containing 0.1 % TFA) followed by gradient elution on a C18 Sep-
Pak and reversed phase HPLC (methanol : water, TFA pH 3) provided the pure compound 
1.53.42  
 
Discorhabdin E (1.54), a 4-debromo derivative of discorhabdin C (1.49) was isolated during a 
second investigation of the sponge Latrunculia du Bocage from New Zealand (L. cf. bocagei). The 
structure of discorhabdin E (1.54) was established based on comparison of the spectral data with 
those of discorhabdin C.43 Blunt et al. reported the isolation of discorhabdin F (1.55) from a New 
Zealand Latrunculid sponge in a review of New Zealand marine natural products. However, no 
spectroscopic data were reported.44 
 
Discorhabdin G (1.56), isolated from the Antarctic sponge Latrunculia apicalis by Yang et al.,45 
was found to exhibit significant bioactivity, including antibiotic activity and activity influencing the 
feeding behaviour of sea stars. Discorhabdin G, characterised from extensive one and two 
dimensional NMR data as well as by comparison of the spectral data with those of discorhabdin C 
(1.49), differs from 1.49 in that the ∆4 olefin is replaced with a ∆7 double bond in 1.56. In addition 
there is no bromine atom at C-4 in 1.56. Sponges were subjected to solvent extraction of 
increasing polarity from hexane to 7 : 3 water : methanol, which resulted in the significant 
bioactivity residing in the chloroform and methanol partition fractions. The methanol extract was 
subjected to Sephadex LH-20 chromatography followed by repeated reversed phase HPLC 
(mobile phase contained 0.05 % TFA), to afford discorhabdins C and G.45   
 
Bioassay guided analyses of the sponge extracts from three different species of Latrunculia 
sponges led to the isolation of discorhabdins A (1.57) and B (1.58) together with discorhabdin C.36 
The sponges were collected as part of an ongoing search for antitumour and antiviral agents from 
marine invertebrates from New Zealand. The structures of discorhabdins A, and B, both of which 
contain an additional ring formed by a tetrahydrothiophene bridge between C-5 and C-8, were 
assigned by comparison of the spectral data of both compounds with the spectral data of 
discorhabdin C and extensive one and two dimensional NMR data, especially nOe difference 
spectroscopy, HETCOR and COSY NMR experiments. Both 1.57 and 1.58 lack a bromine 
substituent at C-4, while discorhabdin A lacks a ∆4 double bond when compared with the 
structure of discorhabdin C. Following extraction of the sponge with methanol and 
dichloromethane, the methanol : dichloromethane extract was partitioned on a reversed phase 
column to give a number of cytotoxic fractions which were further purified using reversed phase 
LC to give 1.57. The methanol : toluene sponge extract was partitioned on a reverse phase 
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column followed by preparative and semipreparative reversed phase LC (using 0.05 % TFA) to 
give 1.58.36 
 
In an effort to identify new leads to antitumour agents from marine organisms, discorhabdin Q  
(1.59, 16, 17-dehyrodiscorhabdin B) was isolated from the sponge Latrunculia purpurea and 
interestingly, also from the sponges Zyzzya massalis, Z. fuliginosa and an unidentified Zyzzya 
spp..46 Spectroanalytical techniques, such as one and two dimensional NMR, together with 
comparison of spectral data with known compounds were used to solve the structure of 1.59. The 
1H NMR spectrum revealed that the usual pair of vicinally coupled methylene signals (H2-16 and 
H2-17) were replaced by a pair of mutually coupled olefinic methines. The methanol : 
dichloromethane extract was partitioned to give the cytotoxic chloroform and aqueous methanol 
partition fractions. Reversed phase gradient elution VLC of both these partition fractions followed 
by Sephadex LH-20 and VLC on silica gel afforded pure discorhabdin Q.46 
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1.57 R1 = Br; R2 = H 1.60 
1.58 R1 = Br; R2 = H; ∆4  
1.59 R1 = Br; R2 = H; ∆4; ∆16  
 
The last discorhabdin reported thus far is discorhabdin R (1.60), a novel epoxy discorhabdin 
isolated from a southern Australian Negombata sp. and an Antarctic Latrunculia sp.. The structure 
was assigned from spectroscopic data including one and two dimensional NMR data and upon 
comparison of the spectral data with those of discorhabdin B (1.58). Discorhabdin R lacks a 
bromine substituent at C-2 and a ∆1 olefin, containing instead two mutually coupled epoxy 
methine signals in the 1H NMR spectrum. The ethanol extracts of both the Latrunculia and 
Negombata species were subjected to reversed phase partitioning (with TFA) to give the TFA 
salts of 1.58 and 1.60. Although the authors were unable to assign the stereochemistry of the 
epoxide using nOe difference or NOESY experiments, they assigned the configurations of the 
remaining chiral centres of the molecule via spectroscopic comparisons with discorhabdin B 
(1.58).47 
The third class of discorhabdin alkaloids contains an additional ring formed by formation of a bond 
between N-18 and C-2. Discorhabdin D (1.61), a quaternary iminium salt, and discorhabdin A 
were isolated from two New Zealand sponges (Latrunculia brevis and Prianos sp.).48 The 
structure of 1.61 was established from spectral data (one and two dimensional NMR) and 
comparison of this spectral data with known discorhabdins. The heptacyclic discorhabdin D 
contains two more heterocyclic rings than discorhabdin C. The additional rings are formed 
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through a C-5 to C-8 tetrahydrothiophene bridge and a bond between N-18 and one of the spiro 
ring atoms (C-2). The methanol and methanol : toluene (for L. brevis) or acetone (Prianos sp.) 
sponge extracts were partitioned on a reversed phase column or with ethyl acetate, respectively. 
The methanol : toluene extract was subjected to further reversed phase chromatography using a 
sequence of preparative LC gave pure 1.61. The ethyl acetate partition fraction was, on the other 
hand separated by centrifugal counter current chromatography using chloroform : methanol : 
water. Selected fractions were further purified on silica gel (chloroform : methanol) to give pure 
discorhabdin D.48 
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1.61 R1 = H 
 
1.62 
 
 
The most complex of the discorhabdin D series is discorhabdin H (1.62), previously isolated by 
Munro et al. (Figure 1.1).22,37-39 Discorhabdin H (1.62), was however isolated and characterised as 
its TFA salt by Beukes42 from three South African Latrunculid sponges i.e. from Strongylodesma 
coetzeei, Latrunculia gibbonsi and Latrunculia lúnaviridis. The structure was established by 
extensive one and two dimensional NMR data as well as through the use of ozonolysis followed 
by chiral GC-MS to establish the stereochemistry of the histidine residue at C-1. The relative 
stereochemistry of the rest of the molecule was established using a combination of a ROESY 
NMR experiment and molecular modelling. The methanol : dichloromethane sponge extract was 
subjected to solvent partitioning between aqueous methanol and dichloromethane or ethyl acetate 
followed by gradient elution on a C18 Sep-Pak® cartridge and exhaustive reversed phase HPLC 
(TFA pH 3) of the dichloromethane / ethyl acetate partition fraction.42 
 
1.2.8 Prianosins 
 
Bioassay guided fractionation of the methanol : toluene extract of a tropical green Okinawan 
sponge (Prianos melanos) yielded the cytotoxic pigment prianosin A (1.57).49 The structure of 
1.57 which was found to be identical to discorhabdin A (1.57), isolated from a New Zealand 
sponge (Latrunculia brevis).36 The structure of prianosin A was determined by spectral 
comparisons of the NMR data of this compound with those of discorhabdin C, while the absolute 
stereochemistry of 1.57 was defined by X-ray crystallography. The methanol : toluene extract was 
initially partitioned between toluene and water and the chloroform soluble material from further 
partitioning of the aqueous phase was subjected to silica gel chromatography followed by LH-20 
and further silica gel chromatography to give prianosin A.49 
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Prianosin B (1.63), the 16, 17-dehydro derivative of discorhabdin A, was isolated from a second 
investigation of Prianos melanos by Cheng et al.50 in a continuing effort to isolate the bioactive 
compounds of this sponge. Prianosin B was isolated together with prianosins A, C (1.64) and D 
(1.65), all of which possess a C-5 to C-8 tetrahydrothiophene bridge. HMBC correlations were 
essential in establishing the structures of the prianosins (due to the paucity of protons and the 
abundance of heteroatoms present in the molecule). Bioassay guided fractionation in a manner 
similar to that described for the isolation of prianosin A was once again employed. The structures 
of 1.64 and 1.65, which contain the novel aminophenol moieties, were characterised as their 
acetate derivatives and were subsequently shown to be artefacts of the acetylation procedure.51 
The structures of 1.64 and 1.65 were thus revised to 2-hydroxy-discorhabdin D (1.66) and 
discorhabdin D (1.61), respectively.51 
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1.64 R = OH 1.66 
1.65 R = H  
 
1.2.9 Epinardins 
 
D’ Ambrosio et al.52 isolated epinardins A -D (1.67 - 1.70) from two undescribed South Indian 
ocean sponges. The epinardins are characterised by the presence of a cyclohexanol spiro ring 
instead of the typical cyclohexanone ring described in previous discorhabdins. The structures of 
the epinardins were determined using standard one and two dimensional NMR experiments 
including NOESY experiments. The ethanol sponge extract was subjected to gradient elution 
reversed phase flash chromatography, followed by further purification by TLC where necessary, 
to give 1.67 - 1.70.52 
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1.67 1.68 R1 = H 
 1.69 R1 = H, ∆7 
 1.70 R1 = OCH3  
 
1.2.10 Tsitsikammamines, veiutamine and wakayin 
 
Two bis-pyrroloiminoquinone alkaloids, tsitsikammamine A (1.71) and B (1.72) were isolated from 
the South African Latrunculid sponge of the new genus Tsitsikamma along with 14-bromo-
discorhabdin C (1.51) and 14-bromo-3-dihydro-discorhabdin C (1.52), described previously. The 
structures of 1.71 and 1.72 were proposed from extensive NMR data.41 
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A unique, related bis-pyrroloiminoquinone alkaloid, wakayin (1.73), was isolated from a Fijian 
ascidian of the genus Clavelina.53 Pyrroloiminoquinones have only previously been isolated from 
the phylum Porifera, suggesting that these compounds may be produced by symbiotic micro-
organisms. The structure of wakayin was obtained by interpretation of DQFCOSY, HMBC and 
HMQC NMR spectra. Wakayin (1.73), which has an ostensible structural affinity with the 
tsitsikammamines (1.71, 1.72), requires an additional tryptophan molecule in the biogenesis of 
this alkaloid.53 
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The isolation and characterisation of veiutamine (1.74) from a Fijian sponge of the genus Zyzzya 
fuliginosa was reported by Venables et al..54 The structure of veiutamine, suggestive of the 
makaluvamines, was the first reported pyrroloiminoquinone with a para-hydroxy benzyl 
substituent at position 6. The structure of 1.74 was established using standard one and two 
dimensional NMR experiments. Following partition of the methanol extract according to a modified 
Kupchan procedure, the chloroform and aqueous methanol soluble material were subjected to 
Sephadex LH-20, and silica gel (using TFA) together with LH-20 chromatography, respectively. A 
variety of makaluvamines (1.31 - 1.36), makaluvone (1.37), damirone B (1.20) and discorhabdin A 
(1.57) were obtained from the chloroform partition fraction, while the aqueous methanol partition 
fraction yielded veiutamine (1.74) and additional quantities of makaluvamines (1.31, 1.33 - 
1.35).54 
 
1.3 Taxonomy of the Family Latrunculiidae 
 
Sponges of the family Latrunculiidae are massive, encrusting, hemispherical, spherical or 
pedunculate with areolate porefields. Kelly and Samaai55 have described the texture of these 
sponges as leathery and is generally “brownish black with forest-green or blue tinges, liquorice 
brown, as fawn or forest green” in colour as observed with the sponges Latrunculia, 
Strongylodesma and Tsitsikamma or pale beige to white as seen with sponges of Sceptrella sp..55 
 
The sponge distribution is shallow sublittoral to bathybentic, while the geographic distribution is 
from polar to warm temperate regions. The Latrunculia and Tsitsikamma sponges are 
concentrated mainly at a depth of 30 m on a hard, rocky substrate in the temperate regions of the 
southern hemisphere, while sponges of the genus Strongylodesma are located also on hard, 
rocky substrates in the warm temperate regions or on dead coral rubble in sandy lagoon 
environments in the tropical regions of both the southern and northern hemisphere.55 Sponges of 
the genus Sceptrella are predominantly deep water (down to a depth of 2460 m) and are located 
in the northern temperate regions of the Atlantic Ocean.55 Sponges of the genus Tsitsikamma are 
exclusively located in sheltered coastal rocky reefs at depth of 25 - 40 m off the southeast coast 
of South Africa (Chapters 2 and 4). 
 
Taxonomy is crucially important in any marine natural products study. Many marine organisms, 
producing bioactive metabolites, either remain undescribed, are described only to genus level or 
are identified incorrectly.56 van Soest and Braekman57 aptly predicted that taxonomic uncertainties 
amongst the porifera would ultimately lead to a “babylonic confusion of sponge sources of 
interesting chemistry”. The sponge family Latrunculiidae (Topsent) first described in 1922 
produces the vast majority of pyrroloamino-ortho-quinone and pyrroloiminoquinone alkaloids 
described in the preceding section. Since its inception eight decades ago, generations of sponge 
taxonomists have juggled this family between two Orders viz Poeciloscleridae and Hadromerida.55 
In an attempt to resolve this taxonomic dilemma Kelly and Samaai55 have recently placed the 
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family Latrunculiidae within a new monophyletic suborder Latrunculina residing in the Order 
Poeciloscleridae (Scheme 1.1). 
 
PHYLLUM Porifera
CLASS Demospongia
SUBCLASS Tetractinomorpha Ceractinomorpha
ORDER Hadromerida Poecilosclerida
Zyzzya
Sceptrella
Latrunculia
Tsitsikamma n.g
Strongylodesma
Sigmosceptrella
Podospongia
Diacarnus
Negombata
FAMILY Latrunculiidae MycaliidaePodospongiidae
SUBORDER Latrunculina
Acarnidae
GENERA Mycale
 
 
Scheme 1.1 A recently revised taxonomic relationship between the sponges families 
Latrunculiidae, Acarnidae, Podospongiidae and Mycalliidae.55,58 
 
Kelly and Samaai’s reassignment of the family Latrunculiidae to its own suborder and their 
taxonomic reasons for confining membership of this family to four genera, Latrunculia, Sceptrella, 
Strongylodesma and the new South African genus Tsitsikamma were, as follows: the presence of 
similar microrhabd microscleres together with the arrangement of these microscleres in a dense 
layer in the outer ectosome and areolate porefield and distinctive short fistular oscules (exhalant 
pores).55 Tentative supporting evidence for this taxonomic revision was provided by the presence 
of related pyrroloiminoquinone chemotaxonomic markers. 
 
A major problem complicating the use of chemotaxonomic markers for sponge classification is 
their lack of consistency.  No marker appears to be ideal, due either to a report of its occurrence 
outside the group for which it is supposed to be a marker, or because the marked groups partially 
overlap. To be useful for classification, chemotaxonomic markers should either include or exclude 
taxonomic groups completely. For example, discorhabdins have been isolated from sponges of 
the genera Latrunculia, Strongylodesma, and Zyzzya. The genus Zyzzya is placed in the family 
Acarnidae. Although the families Latrunculiidae and Acarnidae possess enough morphological 
similarities to place them in the same Order they are sufficiently different to warrant splitting into 
separate families.58 Possible reasons for inconsistent distribution of chemical markers may 
include:  
 19
Chapter 1: Introduction 
 
1) Parallel biosynthetic pathways. Secondary metabolites are generated from primary metabolic 
precursors and parallel evolution of biosynthetic pathways may allow for the biosynthesis of 
structurally related compounds. 
2) Microsymbiotic involvement. Although the evidence for the involvement of microsymbionts is 
largely circumstantial, several studies have established that compounds suspected to be of 
microsymbiont origin were indeed produced by bacteria and fungi isolated from sponges.11 Perry 
et al.36 have suggested that microsymbionts may be involved in the production of the 
pyrroloiminoquinone alkaloids, though this has been shown to be unlikely by Munro et al.59 
3) Collection of sponge specimens. Field collections of sponges do not always follow a set 
protocol. Overgrowing algae and the epizootic invertebrates are often not removed from 
specimens and may be sources for compounds reported to be produced by the sponge. Mix-ups 
involving labelling and or sorting of samples can result in much confusion.60 
4) Some sponge groups are extremely difficult to identify to family or genus level and 
considerable taxonomic expertise is needed. 
 
Currently the degree of chemical marker inconsistency is such that direct use of chemical data to 
solve classification problems, or to erect new higher taxa, is tenuous. Large scale re-examination 
of voucher specimens, in collaboration with microbiologists and organic chemists, are necessary 
to demonstrate whether or not chemical marker compounds are true indicators of sponge 
systematics. Therefore in an attempt to establish the validity of using pyrroloamino-ortho-quinone 
and pyrroloiminoquinone metabolites as chemotaxonomic markers for the families Latrunculiidae 
and Acarnidae, Samaai58 has re-examined the taxonomy of many of the sponge voucher 
specimens used in the original natural products investigations described in Section 1.2. This is an 
important clarification of our knowledge of the distribution of pyrroloamino-ortho-quinone and 
pyrroloiminoquinone metabolites across the two families and the results of Samaai’s58 
investigation is summarised in Table 1.1. 
 
General trends evident from Table 1.1 are as follows. The simplest of the pyrroloquinoline 
alkaloids, the batzellines A-C, isobatzellines A-D and secobatzellines A and B were isolated from 
a deep water Caribbean sponge of the genus Batzella (renamed Strongylodesma n.sp1-2). The 
related damirones A-B from Palau, the makaluvamines A-G from Fiji and Indonesia, and 
makaluvamines H-M and damirone C from Pohnpei, have been isolated from sponges 
taxonomically assigned to the genus Zyzzya (Acarnidae). The related complex alkaloids, 
exemplified by discorhabdin C were originally reported from sponges of the genus Latrunculia. 
Interestingly, a recent comprehensive study of Latrunculia brevis collected from around the coast 
of New Zealand revealed that the two colour morphs of this sponge contained different profiles of 
discorhabdin metabolites (discorhabdin B and C predominate in brown and green L. brevis 
sponges respectively).56 Since then, the isolation of discorhabdins A-P and R from South Pacific 
sponges of the genera Latrunculia and Negombata, the South African Tsitsikamma and 
Strongylodesma sp. and the Japanese sponge of the genus Prianos (renamed Strongylodesma 
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sp.) indicated the ubiquitous occurrence of these metabolites. Epinardins were isolated from a 
deep water undescribed spinach-green sponge (-200 m) and the authors therefore surmised that 
the discorhabdins and epinardins could not be of cyanobacterial origin since a sponge emerging 
from the dark at a depth of 200 m in pre-Antarctic waters could be assumed to be free of 
cyanobacterial symbionts. Significantly, the isolation of discorhabdin A from Zyzzya fuliginosa, 
discorhabdin P from a Batzella sp. (reassigned to the genus Zyzzya) and discorhabdin Q from 
sponges of the genera Zyzzya sp., Zyzzya massalis and Zyzzya fuliginosa precludes the use of 
discorhabdins as a Latrunculiidae specific chemotaxonomic marker. 
  
The new genus Tsitsikamma (see Chapters 2 and 4) also produces discorhabdin type 
compounds. The internal morphology (in terms of choanosomal skeletal arrangement) of 
Tsitsikamma sponges has been taxonomically interpreted as being a mixture of both the internal 
morphology of Zyzzya and Latrunculia sponges.41 
 
The discovery of the unusual bis-pyrroloiminoquinones, tsitsikammamines A and B, in the T. 
favus extract was initially thought to have major chemotaxonomic significance, due to the 
intermediacy of the tsitsikammamine structures between those of the makaluvamines and 
discorhabdins. However, the absence of the tsitsikammamines in the T. pedunculata extracts (see 
Chapter 2) together with the obvious structural similarities between the tsitsikammamines and 
wakayin (1.73 previously isolated from an ascidian) tentatively suggests the intriguing possibility 
of a symbiotic source for these compounds. 
 
A notable omission from Table 1.1 is the absence of any reports describing the discovery of 
pyrroloiminoquinone metabolites or any other metabolites in the genus Sceptrella.61 A possible 
reason for this absence may be that the extreme depths at which Sceptrella occurs (ca. 2 kms) 
making this sponge inaccessible to the majority of marine natural product chemists. 
 
While sponges in the families Latrunculiidae and Acarnidae are linked by their common 
pyrroloiminoquinone metabolites these two families are clearly chemically distinct from the 
Podospongiidae and Mycalliidae. The macrocyclic compound latrunculin A (1.75)62 and cyclic 
peroxides (1.76)63 are characteristic of the types of compound found in the latter two families. 
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 21
Chapter 1: Introduction 
 
Table 1.1 Revision of the taxonomic assignments and phyletic distribution of the metabolites in the sponge families Latrunculiidae and Acarnidae.  
Compounds  Sponge ID (original) Sponge ID (reassigned)26,55,58 Locality Co-occurring Compounds  Ref. 
Damirones      
1.19 Damiria sp. Keller 
 
Zyzzya fuliginosa -20 m, Ngemelis drop off, Palau  
Makaluva Island and Mbengga harbour, Fiji Islands 
- 25  
1.20 Damiria sp. Keller 
 
Zyzzya fuliginosa - 20m, Ngemelis drop off, Palau  
Makaluva Island and Mbengga harbour, Fiji Islands 
- 25   
30 
1.21 Zyzzya fuliginosa  - -13 m, Nahpali Island, Pohnpei, Micronesia 1.33, 1.34, 1.38, 1.39 - 1.44 26 
Batzellines      
1.22 - 1.24 Batzella sp. Strongylodesma n.sp1 -120 m, Freeport and West End, Grand Bahama Islands - 27 
Iso-batzellines      
1.25 - 1.27 Batzella sp.  
 
Strongylodesma n.sp1 
Strongylodesma n.sp2 
-120 m, Freeport and West End, Grand Bahama Islands  
-141 m, Great Bahama Bank, Bahamas 
- 
 
28 
28 
1.28 Batzella sp.  Strongylodesma n.sp1 -120 m, Freeport and West End, Grand Bahama Islands - 28 
Seco-batzellines  
1.29 - 1.30 
 
Batzella sp.  
 
Strongylodesma sp. 
 
-152 m , Great Bahama Bank, Bahamas and 
-138 m, North Bimini, Bahamas  
 
- 
1.50 
 
29  
Makaluvamines      
1.31 - 1.36 Zyzzya marsailis 
 
Zyzzya fuliginosa Makaluva Island and Mbengga harbour, Fiji Islands 1.20, 1.57 30 
Makaluvone   
1.37 
 
Zyzzya marsailis  
 
Zyzzya fuliginosa 
 
Makaluva Island and Mbengga harbour, Fiji Islands 
 
1.20, 1.31 - 1.36, 1.57 
30 
1.38 Undescribed Histodermella Zyzzya fuliginosa 7 – 40 m, Manado Bay, Sulawesi, Indonesia 1.31, 1.33, 1.19, 1.20 31  
1.39 - 1.44 Zyzzya fuliginosa  - -13 m, Nahpali Island, Pohnpei, Micronesia 1.33, 1.34, 1.38 26  
1.45 Zyzzya fuliginosa - Cape S. Ildefonso, The Philippines 1.31, 1.33 - 1.35, 1.40 32  
1.46 Zyzzya fuliginosa  -   Vanuatu Islands 1.38, 1.41 - 1.43 33 
Makaluvic Acids      
1.47, 1.48 Zyzzya fuliginosus (Carter) 
 
 Chuuk State -20 m, Federated states of Micronesia 1.31, 1.35, 1.42, 3,7-dimethyl-
isoguanine, 4-hydroxybenzoic acid. 
34 
Discorhabdins 
 1.49 
 
Latrunculia du Bocage 
 
Latrunculia spp. 
 
New Zealand 
 
- 
 
35 
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Compounds  Sponge ID (original) Sponge ID (reassigned)31,54,57 Locality Co-occurring Compounds  Ref. 
1.50 Batzella sp. Zyzzya sp. -141 m, Great Bahama Bank, Bahamas - 40 
1.51 Tsitsikamma n.g Tsitsikamma favus Tsitsikamma Marine Reserve, South Africa 1.52, 1.71, 1.72 41 
1.52 Tsitsikamma n.g Tsitsikamma favus Tsitsikamma Marine Reserve, South Africa 1.51, 1.71, 1.72 41 
1.53 Strongylodesma sp. Strongylodesma coetzeei -15 m, Port Elizabeth, South Africa 1.57, 1.61, 1.62 42 
1.54 Latrunculia du Bocage Latrunculia spp. New Zealand 1.61 43 
1.55 Latrunculia apicalis 
 (Ridley and Dendy)  
Latrunculia biformis -6 to -40 m, Hut Point, Danger Slopes, and Cape Evans 
on Ross Island, Antartica 
1.49 45 
1.57 L. brevis (Ridley & Dendy) - - 110 to -145 m, Otago Peninsula 1.49, 1.58 36 
1.57 Prianos Melanos, Prianos Strongylodesma sp. 2-3 m, Motobu Peninsula Okinawa Is. - 49 
1.58 Undescribed Latrunculia  Latrunculia spp. -25 m, Kaikoura Peninsula 1.49, 1.57 36 
1.59 Zyzzya sp. 
Zyzzya massalis  
Zyzzya fuliginosa 
Latrunculia purpurea 
- 
Zyzzya fuliginosa 
- 
- 
Assail Bank, North Island & Wallab group, Australia 
Sphinx Head Wessel Island, Australia 
Bega Lagoon Fiji 
Horseshoe Reef Australia 
 46 
1.60 Negombata sp.* 
Latrunculia 
- 
- 
Port Campbell, Victoria, Australia 
Prydz channel, Prydz Bay, Antarctica  
1.58 47 
1.61 Latrunculia brevis48  - -30 m Sugar Loaf Islands, New Zealand  1.57  48 
1.62 Strongylodesma sp.,  
Undescribed Latrunculid 
Undescribed Latrunculid 
Strongylodesma coetzeei 
Latrunculia lúnaviridis 
Latrunculia gibbonsi 
-15 m, Port Elizabeth, South Africa 
-17 - 20 m, Cape Town, South Africa   
-28 m, Tsitsikamma Marine Reserve, South Africa 
1.57, 1.61 
1.57 
42 
42 
1.63 – 1.66 Prianos melanos Strongylodesma sp. -2-3 m, Okinawa Island, Motobu Peninsula 1.57 51 
Epinardins 
1.67-1.70 
 
Undescribed sponge  
  
-200 m, Apotres, Iles Crozet, South Indian Ocean 
 
- 
 
52 
Tsitsikammamines 
1.71, 1.72 
/ wakayin / veiutamine  
Tsitsikamma n.g 
 
Tsitsikamma favus 
 
-20 m, Tsitsikamma Marine Reserve, South Africa  
 
1.51, 1.52 
 
41 
       1.73 Clavelina sp. (ascidian) -  Fiji - 53 
1.74 Zyzzya Fuliginosa    Fiji Islands 1.20, 1.31 - 1.37, 1.57 54 
* The voucher of this species was not taxonomically re-examined. 
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1.4 Biosynthesis of pyrroloamino-ortho-quinone and pyrroloiminoquinone alkaloids 
 
Biosynthetic studies of metabolites from marine sponges is complicated by slow sponge growth 
rates, low incorporation rates as well as the presence of symbiotic micro-organisms. The 
makaluvamines (such as makaluvamines D (1.34) and F (1.36)) and the discorhabdins are 
structurally related, which prompted Munro et al.59 to propose a biosynthetic pathway linking these 
compounds (Scheme 1.2).  
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Scheme 1.2 Biogenesis of the discorhabdins as postulated by Munro et al..59 
 
The co-occurrence of discorhabdin A with makaluvamines A - F (1.31 - 1.36), damirone B (1.20) 
and makaluvone (1.37) in the sponge of the genus Zyzzya marsailis (reassigned massalis26), 
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together with the co-occurrence of makaluvamines D (1.34) and F (1.36) with makaluvamine G 
(1.38) from Latrunculia apicalis, provided compelling support for Munro’s proposed biosynthetic 
pathway. The amino acids tryptamine and phenylalanine are considered to be the precursors of 
the discorhabdin skeleton. Functionalisation and oxidation of tryptamine forms the backbone of 
the pyrroloiminoquinone core of the makaluvamines, damirones and discorhabdin skeletons. The 
incorporation of a tyramine residue in damirone C (1.21) would lead to makaluvamine D (1.34) 
and further cyclisation and elaboration would lead to the more complex discorhabdins. Some 
uncertainty exists as to how the hypothetical biosynthetic pathway proceeds. Munro et al.59 
investigated the production of discorhabdin metabolites in vivo by examining preparations of the 
marine sponge Latrunculia sp. B, where sponge tissue slices had been incubated with {U – 14C}-
L-phenylalanine. Results indicated that 14C from the {U – 14C}-L-phenylalanine was incorporated 
into discorhabdin B (1.58). Tissue slices of Latrunculia sp. B were presoaked in a broad spectrum 
antibiotic mixture before the addition of {U – 14C}-L-phenylalanine to determine whether 
discorhabdin B was produced by sponge cells or symbiotic micro-organisms. The unchanged 14C 
incorporation from {U – 14C}-L-phenylalanine into discorhabdin B indicated that discorhabdin B 
biosynthesis is a function of sponge cells. L-phenylalanine (the decarboxylated analogue of 
tyrosine the precursor of tyramine) was thus also established as a possible precursor of the 
discorhabdin skeleton.59 
 
The 2,6-dibromocyclohexadienone portion of discorhabdin C (1.49) is duplicated in compound 
1.77, which was isolated from the sponge Aplysina fistularis (Family Aplysinidae, order 
Verongida).64,65 The compound, a product of tyrosine metabolism, has both cytotoxic and 
antimicrobial properties. Discorhabdins have been suggested to play defensive roles in sponges, 
and sponges that contain antimicrobial metabolites are rarely observed to be overgrown, and no 
evidence of predation or of epibionts have been associated with Latrunculid sponges.36 Previous 
workers have suggested that batzellines27 and this sponge metabolite (1.77) may be the 
biosynthetic precursors of discorhabdins. In turn, the secobatzellines A (1.29) and B (1.30) are 
thought to be probable precursors of the simpler pyrroloiminoquinone alkaloids.29 
 
O
OH
NH2O
Br Br
 
1.77 
 
Interestingly, makaluvamine A (1.31) has also been isolated from a terrestrial myxomycete, 
Didymium bahiense.66 Authors also showed previously that a cultured myxomycete D. 
squamulosum produced clionasterol,67 which was previously isolated from marine sponges such 
as Cliona celata and Hymeniacidon perleve68 and marine microalgae such as Nitella flexilis and 
Chara vulgaris.69 
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The batzellines, isobatzellines or makaluvamines are thought to give rise to the makaluvic acids 
(1.47, 1.48) through standard biosynthetic oxidation processes. Interestingly, 4-hydroxybenzoic 
acid, which is an oxidation product of the tyramine-derived portion of makaluvamine E and K, was 
found to co-occur in the sponge of the genus Zyzzya fuliginosus (Carter).34 
 
1.5 Biological activity of pyrroloamino-ortho-quinone, pyrroloiminoquinone and bis-
pyrroloiminoquinone alkaloids 
 
Pyrroloiminoquinone compounds, such as the discorhabdins and isobatzellines, display potent in 
vitro toxicity to the P-388 murine leukaemia cell line, while no such activity is reported for 
compounds which lack the iminoquinone moiety, such as the batzellines or damirones. The 
pyrroloiminoquinone moiety may therefore be responsible for the cytotoxicity generally observed 
in Latrunculid sponge metabolites.30,70 Isobatzellines (1.25 - 1.28) were also found to exhibit 
moderate antifungal activity against Candida albicans. It is interesting to note that it is the 
isobatzellines, and not the batzellines, that are moderately antifungal.28 Secobatzellines were 
found to inhibit calcineurin (CaN) and secobatzelline A (1.29) shows some inhibition towards the 
peptidase activity of CPP32 (IC50 0.02 µg/mL).29 
 
CaN or Calcineurin – threonine protein phosphatase is involved in signal transduction and is 
recognised as one of the principal signalling molecules that regulates the immune response. 
Caspase e.g. CPP32, involves a group of at least ten cysteine proteases which play a major role 
in apoptosis. Inhibitors of caspase-3 (CPP32) have been shown to prevent apoptotic mediated 
cell death in cell lines and various tissues. CPP32 has also been shown to be involved in the 
stimulation of IL-8 secretion of synviocytes in rheumatoid arthritis, which serves to increase joint 
inflammation and the progress of the disease.29,40 
 
Makaluvamines D (1.34), G (1.38), H (1.39) and J-M (1.41 - 1.44) were shown to be inactive 
against topoisomerase in an assay that employed three genetically engineered yeast strains. One 
of the strains was insensitive to DNA damaging agents, another strain was hypersensitive to 
these agents and possessed a deleted DNA repair gene, while the third strain had neither 
topoisomerase I nor a DNA repair gene.26 Makaluvamines were, however, found to be cytotoxic 
against HCT-116 in vitro. In a semi quantitative assay, makaluvamines I (1.40) and L (1.43) were 
an order of magnitude more active than makaluvamines C (1.33), G, H and K (1.42), while 
makaluvamines D and M were found to be the least active.26  
 
Makaluvamine G (1.38) was only moderately cytotoxic toward several cell lines and displayed no 
antifungal activity against Aspergillus oryzae, C. albicans, Penicillium notatum, Saccharomyces 
cerevisiae or antiviral activity to Herpes simplex 1 and 2 and polio viruses. However, moderate 
inhibition of RNA (IC50 = 15 µM), DNA (15 µM) and protein (21 µM) synthesis was shown. In 
contrast to makaluvamines A (1.31), C, E (1.35), F (1.36), makaluvamine G showed no significant 
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inhibition of topoisomerase II and only moderate inhibition of topoisomerase I.31 Makaluvamine N 
(1.45) exhibited a greater than 90 % inhibition of topoisomerase II unwinding of pBR322 at 
concentrations of 5 µg/mL.32 
 
Antioxidant activity was displayed by makaluvamine P (1.46) in the two different 
spectrophotometric analyses used. Makaluvamine P showed high inhibition of xanthine oxidase 
(IC50 = i.e. 16.5 µM), an important biological source of superoxide radicals involved in oxidative 
stress in an organism. In the ABTS radical cation decolouration assay makaluvamine P showed 
moderate activity (TEAC = 0.341), where the standard employed is Trolox and the results are 
quoted as Trolox equivalent antioxidant activity (TEAC).33 
 
Discorhabdins C (1.49), A (1.57) and B (1.58) were found by Perry et al.36 to be highly active in in 
vitro P-388 assays, with respective ED50 values of 0.03, 0.05 and 0.1 µg/mL. However, in vivo 
testing in the P-388 leukaemia system in mice showed no increase in lifespan with either 
discorhabdins C or A, where they were found to be toxic to mice at about 2 mg per kg of body 
weight. Discorhabdin B did show some antitumour effect with a T/C of 117 % at a dose of 0.25 
mg/kg, without achieving the significance level of 120 %. In addition, the discorhabdins were 
shown to possess antimicrobial activity. In a disk assay, with 30 µg/disk, discorhabdins C and A 
were active against Escherichia coli, B. subtilis and C. albicans, but not against Pseudomonas 
aeruginosa. Discorhabdin B was active against E. coli and B. subtillus, but not against P. 
aeruginosa or C. albicans.36 Discorhabdins A, B and C are powerful cytotoxins in the in vitro P-
388 cell line but in the in vivo P-388 model these compounds were found to be inactive (T/C <120 
%). Discorhabdin D (1.61), on the other hand, had a more potent in vivo activity (T/C 132 % at 20 
mg/kg). Structural modification studies to ascertain the mode of action were underway to establish 
the site of biological activity for this compound, but fourteen years later no results have been 
reported.36 
 
Discorhabdin C (1.49) was found to be toxic toward L1210 tumour cells at very low levels (ED50 < 
100 ng/mL),35 while the in vitro IC50 cytotoxic activity of discorhabdin A was 37 and 14 ng/mL 
against L1210 and L5178Y murine leukaemia cells respectively.36 Discorhabdin A also induced 
Ca2+ release from sarcoplasmic reticulum and was found to be ten times more potent than 
caffeine in this assay.49 Similarly, prianosin D (1.61) also induced Ca2+ release from sarcoplasmic 
reticulum, at the same potency as discorhabdin A. Interestingly, prianosins B (1.63) and C (1.66) 
showed no activity in this assay.50 
 
Discorhabdins G (1.56) and C (1.49) showed similar activities against both Gram-positive and 
Gram-negative bacteria. In addition, discorhabdin G was shown to occupy a central position in the 
chemical ecology of Latrunculia apicalis by causing feeding deterrence behaviour in the major 
Antarctic sponge predator Perknaster fuscus as well as inhibiting in the growth of two common 
water column microorganisms isolated from the surrounding water.45 
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Discorhabdin P (1.50) inhibited CaN and CPP32 with IC50 values of 0.55 and 0.37 µg/mL, 
respectively. Positive controls for calcineurin and CPP32 assays consisted of the addition of both 
substrate and enzyme in the absence of test compounds. These levels of inhibition are highly 
significant as there are presently only a handful of compounds in the literature that demonstrate 
nM potency for inhibition of either calcineurin or CPP32 and calcineurin enzyme activity. 
Interestingly, the parent compound discorhabdin C indicated no activity against CPP32 and 
calcineurin enzymes at the highest dose of 5.0 µg/mL.40 
 
In the NCI 60 cell line antitumour screen, discorhabdin Q (1.59) exhibited moderate, generalised 
cytotoxicity (mean panel GI50 = 0.5 ug/mL), but no real differential cytotoxicity profile. The authors 
proposed that full aromatisation of the pyrroloiminoquinone system confers reduced cytotoxicity 
relative to the ∆16 saturated members of the family, but this remains to be confirmed.46 
 
Ethanol extracts of the Antarctic Latrunculia sp. and the southern Australian Negombata sp. 
demonstrated antibacterial activity against Gram positive (Straphylococcus aureus, Micrococcus 
luteus) and Gram negative (Serratia marcescens, E. coli) bacteria. Discorhabdins R (1.60) and B 
were found to be the antibacterial agents in the sponge extract.47 
 
Tsitsikammamines A (1.71) and B (1.72), together with 14-bromo-3-dihydro-discorhabdin C (1.52) 
and 14-bromo-discorhabdin C (1.51) exhibited antibacterial activity against B. subtillus.41 Initial 
studies indicated that the tsitsikammamines showed topoisomerase II inhibition comparable to 
that of wakayin (1.73). Wakayin was found to have a diverse array of bioactivities including 
murine cell line cytotoxicities, antifungal activity and topoisomerase II inhibition.53 
 
Epinardins A (1.67) and C (1.69) were assayed against L1210 and doxorubicin-resistant 
L1210/DX murine lymphocytic leukaemia cells in vitro.52 Epinardin C proved to be clearly active, 
though with a poor resistant index. Since the dienone parent compound discorhabdin C was more 
cytotoxic than the corresponding dienol form by one order of magnitude, the authors 
unsuccessfully attempted the selective C-3 oxidation of epinardin C with a variety of reagents. 
The biological assays indicated that the raw extract showed antibacterial activity against the 
Gram-negative wall-defective bacteria E. coli and Proteus vulgaris as well as the Gram-positive 
bacteria Xanthomonas vescicatoria and Sarcina lutea. The extract also demonstrated some 
antifungal activity against the human epidermal pathogen Trichophyton mentagrophytes and the 
rice pathogen Piricularia orizae. The assays were, however, not carried out on the pure 
compounds. The epinardins were instead assayed for in vitro cytotoxicity against both the L1210 
murine lymphocytic leukaemia cell lines and on the subline resistant to doxorubicin (L1210/Dx). 
The results were compared with those of doxorubicin itself. The IC50 values obtained for 
epinardins A and C were 6.8 µg/mL and 0.358 µg/mL, while doxorubicin was active at 0.711 
µg/mL for the L1210/Dx cell line and 0.0297 µg/mL for the L1210 cell line.52 
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Wakayin (1.73) was shown by the authors to inhibit the topoisomerase II enzyme at 250 µM as 
well as a 3-fold differential toxicity toward the CHO cell line EM9 (a strain which is sensitive to 
DNA-damaging genotoxic agents) versus BR1 (resistant to BCNU), suggesting that wakayin 
exhibits its cytotoxicity by interfering with or damaging DNA. Wakayin also showed some 
antimicrobial activity against B. subtilus (MIC ≈ 0.3 µg/mL).53 
 
Veiutamine (1.74) was found to be a potent in vitro cytotoxin. In a 25 cell line panel it exhibited a 
mean IC50 of 0.12 µg/mL with some selectivity against solid leukaemia tumours. Veiutamine was 
also shown to be 7 times more active than makaluvamine D (1.34, IC50 2.0 µg/mL) against the 
human colon tumour cell line HCT-116.54 The bioactivities of the pyrroloamino-ortho-quinone, 
pyrroloiminoquinone and bis-pyrroloiminoquinone alkaloids are summarised in Table 1.2. 
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Table 1.2 Summary of the biological activities reported for the pyrroloiminoquinones.       
      Compound HCT-116  L1210 L5178Y KB P-388 A-549 HT-29 MCF-7 Topo I Topo II CaN xrs - 6 Decat  inhibn Red. Cleav. DNA Ks Ref.
1.20 > 50           >  50 µM >500 µM >1000 µM 1.07 mM 30 
1.29             
            
   
            
              
              
              
            
          
              
            
             
              
              
              
              
              
 0.06 0.04  0.55  29 
1.30  1.22 2.86  2.21  29 
1.31 1.3 µM           0.41 µM 41 µM 2.1 µM 0.022 mM 30 
1.32 > 50           13.49 µM > 500 µM 181 µM 0.070 mM 30 
1.33 36.2 µM           5.4 µM 420 µM 1.2 µM 0.013 mM 30 
1.34 17.1 µM           14.0 µM 320 µM 52 µM 0.024 mM 30 
1.35 1.2 µM           1.12 µM 310 µM30 15 µM30 0.0046 mM 30 
1.36 0.17 µM           0.08 µM 25 µM 1.1 µM 0.021 mM 30 
1.37 > 50           > 50 µM >500 µM >1000 µM 1.16 mM 30 
1.38 -  0.35 0.50 0.50 0.50 0.50 3.0 µM & 31  
1.45 0.6 ⁪ 5  32 
1.46 3.2 33 
1.49 < 0.1* 0.03*  36 
1.50  0.025 0.41  0.55  40 
1.57 0.08 0.037 0.014 0.05* 0.02 >500 µM 33 µM 0.085 mM 30, 36, 49 
1.58 0.1*  36 
1.61 0.18 0.048 0.46 6.0  48, 50 
1.63 2.0 1.8 >5.0  50 
1.66 0.15 0.024 0.57  50 
1.67 1.7  52 
1.69 0.324  52 
1.73 0.5  250 µM  53, 91 
1.74 0.3  54 
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Values are all IC50 (µg/mL), except where indicated. KB human oral epidermoid carcinoma 
No values for 1.19 and 1.20 P-388  murine leukaemia 
# value is for 64% inhibition of cell growth. A-549 human non-small cell lung cancer 
 ⁪ LC50 value HT-29 human colon cancer 
*ED50 values MCF-7 human breast cancer 
Ks Measure of DNA intercalation (1.57 considered to 
be a poor intercalator) 
Topo  topoisomerase I and or II 
CaN calcineurin - threonine protein phosphates  
        involved in signal transduction 
CPP32 Caspase, cysteine proteases which play a major 
                role in apoptosis. 
 
1.6 Synthesis 
 
Numerous total syntheses have been reported of pyrroloamino-ortho-quinone and 
pyrroloiminoquinone metabolites. A key synthetic intermediate in the majority of the published 
syntheses is the tricyclic pyrroloamino-ortho-quinone heterocycle (1.78). The synthesis of this key 
intermediate has been generally tackled from two directions, from either a suitably substituted 
quinoline (e.g. 1.79) or an indole (e.g. 1.80). 
 
N
N
O
R
R
O
N
CHO
NO2
H3C
OMe
MeO
R2N
N
R
OMe
MeO
1.79 1.78 1.80  
 
In the following Section selected syntheses of damirones, batzellines, isobatzellines, 
makaluvamines and discorhabdins are presented. These syntheses incorporate the key 
intermediate 1.78 and illustrate the dual approach to its construction. 
 
1.6.1 Damirones 
 
The structures of damirone B (1.20) and its congener, damirone A (1.19), were confirmed by 
synthesis from 6,7-dimethoxydindole (1.81) via a tryptamine derivative (1.82), obtained by the 
conventional route illustrated in Scheme 1.3. De-O-methylation of 1.82, followed by oxidation 
yielded 1.83. Following deprotection of the side chain nitrogen, 1.83 was cyclised to give the 
desired pyrroloamino-ortho-quinone core skeleton (1.84). Removal of the tosyl protecting group 
and subsequent methylation led to damirone A.71 
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Scheme 1.3 Synthetic approach to damirones A and B.71 
a) (COCl)2, Et2O, 0 oC, 1 hr, 94 %; b) PhCH2NHCH3, H2O, 25 oC, 3 hr, 96 %; c) LiAlH4, THF + Et2O, reflux, 4 hr, 
96 %; d) TsCl, NaOH, CH2Cl2, CTAB, 25 oC, 12 hr, 90 %; e) ClCOOCH2CCl3, MeCN, 0 oC, 30 min, 76 %; f) 
BBr3, CH2Cl2, 0 to 25 oC, 12 hr, 90 %; g) CAN, CH3CN, 0 oC, 10 min, 86 %; h) dithienyl ditelluride, THF, NaBH4, 
H2O, NaOH, 67 oC, 6 hr, 36 %; i) 10 % NaOH, MeOH, 25 oC, 30 min, 76 %; j) K2CO3, MeI, MeOH, 25 oC, 86 %.71 
 
The key synthetic precursor (1.87, Scheme 1.4) of damirones A and B was also synthesised via a 
quinoline intermediate (1.86) by Joule et al.72 from 3,4-dimethoxyaniline (1.85). The exposure of 
1.86 to trimethyloxonium tetrafluoroborate (Me3O+F4B-) followed by reduction produced the indole 
1.87. Chemical transformations involving protection of the indole nitrogen of 1.87 followed by 
oxidation gave 1.84.72   
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Scheme 1.4 An alternative synthesis of 1.19 from 3,4-dimethoxyaniline.72 
a) CH2=CHCO.Me, FeCl3, AcOH, reflux, 66 %; b) HNO3, -50 to -40 oC, 64 %; c) I2, t-BuI, FeCl2, TFA, DMSO, 80 
oC, 73 %; d) Me3O+F4B-, 20 oC; e) NaBH4, NiCl2.6H2O, MeOH, 20 oC; f) TsCl, NaOH, CH2Cl2, Bu4N+HSO4-, 20 
oC, 14 %; g) BBr3, CH2Cl2, -78 to -20 oC, 37 %.72
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1.6.2 Batzellines and isobatzellines 
 
In 1994, Tao et al.73 presented a full account of the syntheses of discorhabdin C (1.49), batzelline 
C (1.24) and isobatzelline C (1.27) together with an evaluation of the cytotoxic activities of the 
synthetic intermediates. The synthesis of batzelline and isobatzelline C were carried out using a 
protected aromatic aldehyde (1.88) as the starting material (Scheme 1.5). The synthetic sequence 
involved the introduction of a carbamate functionality using a modified Curtius reaction followed 
by the formation of the indole 1.89. Since regiospecific chlorination could not be achieved cleanly, 
1.89 was first reduced and subsequently reacted with N-chlorosuccinimide (NCS) to give the 
chloro intermediate 1.90. The double bond was then reintroduced by reaction with 2,3-dichloro-
5,6-dicyano-1,4-benzoquinone (DDQ). Batzelline C was obtained following deprotection, 
cyclisation, reduction, de-O-methylation and oxidation of the subsequent indole derivatives, 
whereas oxidation of 1.91 with ceric ammonium nitrate (CAN) followed by reaction with 
ammonium chloride yielded isobatzelline C.73 
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Scheme 1.5 Synthesis of batzelline C and isobatzelline C.73 
a) i) MeI, NaH, 66 %, ii) Jones oxidation, 89 %; b) i) Imd2CO, ii) NaN3, heat, iii) trimethylsilylethanol, 86 %; c) i) 
H2, 10 % Pd/C, 100 %, ii) ethyl 4-acetoacetate, 87 %; d) NaBH3CN, 80 %, ii) NCS, 69 % (1.89); e) DDQ, 66 %; f) 
i) 60 % HClO4, ii) NaOH, iii) DCC, 58 %; g) BH3SMe2, 80 %; h) BBr3, 78 %; i) i) CAN, 64 %, ii) NH4Cl, 64 %.
73 
 
Joule and co-workers74 described the first preparation (Scheme 1.6) of a pyrroloquinoline nucleus 
containing a methylthioether substituent from a tetrahydroquinoline precursor (1.92). The 
synthetic approach initially involved the low temperature, regioselective mononitration of 6,7-
dimethoxy-4-methylquinoline. Reduction of the nitro quinoline (1.91) followed by oxidation of the 
C-4 methyl group, facile cyclisation of the C-5 amino and C-4 aldehyde moieties and finally 
reduction of the quinoline ring and formylation of the resultant piperidine nitrogen yielded 1.92. 
The key step in the synthesis was the formation of 1.93 by the regioselective introduction of the 
methylthioether group, using MeSCl, at the pyrrole α-position. Hydrolysis followed by oxidation 
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gave the iminoquinone 1.94 and replacement of the methoxyl group with an amino group was 
achieved smoothly with ammonium chloride to give isobatzelline B (1.26).74 
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Scheme 1.6 Total synthesis of isobatzelline B.74 
a) NaBH4, NiCl2.6H2O, MeOH, rt, 55 %; b) HCO2H, Ac2O, rt, 18 %; c) MeSSMe, SO2Cl2, CH2Cl2, 0 oC to rt, 35 %; 
d) NaH, MeI, THF, rt, 88 %; e) 2.5 M aq. NaOH, reflux; f) CAN, MeCN, H2O, rt, 29 %; g) NH4Cl, MeOH, 50 oC, 
sealed tube, 98 %.74 
 
A similar, alternative approach to the total syntheses of batzelline A, batzelline B, isobatzelline A 
and isobatzelline B was reported by Alvarez et al..75 The tricyclic rings were again prepared from 
a quinoline derivative, with batzelline B synthesised from the pyrroloquinoline in two steps.75 
 
1.6.3 Makaluvamines A - F 
 
Makaluvamine C was synthesised by Kraus and Selvakumar from an alternate route using a p-
anisidine derivative (Scheme 1.7).76  
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Scheme 1.7 An alternative synthetic approach to makaluvamine C.76 
a) HNO3, H2SO4; b) MeONa; c) t-BuOK, CAN; d) BH3; e) AcOCHO; f) BH3; g) H2, Pd/C; h) BOC2O; i) DIBAL; j) 
H2, Pd/C; k) TMSCl, NaI, Fremy’s salt.
76  
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An intramolecular nucleophilic aromatic substitution reaction mediated by potassium tert-butoxide 
gave the quinoline precursor 1.95; selective reduction of 1.95 using catalytic hydrogenation; and 
the use of Fremy’s salt (transformation of 1.97 to 1.33) to synthesise an iminoquinone from an 
amino phenol, formed the key steps in this synthetic sequence.76 
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Scheme 1.8 Preparation of makaluvamines A and K.97 
a) HCHO, HNMe2, AcOH, 98 %; b) i) NaH, THF, ii) (i-Pr)3SiCl, 97 %; c) i) t-BuLi, Et2O, 0 oC, 1hr, ii) Cl3CCCl3, 90 
%; d) i) MeI, ii) Me3SiCN, TBAF, 87 %; e) i) NaH, THF, ii) MeI, 99 %; f) BH3.THF, 52 % or LiAlH4, benzene-Et2O, 
92 %; g) LICA, THF, 0 oC, 1 hr, 78 %; h) O2, Salcomine; i) NH4Cl, MeOH, 40 % from 1.101; j) tyramine 
hydrochloride, MeOH, 44 % from 1.101.97 
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Scheme 1.9 Preparation of makaluvamines D and I.77 
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a) i) NaH, THF, ii) t-BuMe2.SiCl, 91 %; b) BH3.THF, 88% or LiAlH4, Et2O-benzene, 90 %; c) LICA, THF, 0 oC, 1 
hr, 75 %; d) TBAF, 95 %; e) Fremy’s salt, pH 7 phosphate buffer, MeOH, 0 oC, 5 min, 41 %; f) NH4Cl, MeOH, 67 
%; g) tyramine hydrochloride, MeOH, 78 %.77 
 
Iwao et al.77 accomplished the total synthesis of makaluvamines A, D, I and K (Scheme 1.8 and 
1.9) via a new entry into the makaluvamine nucleus using 6-methoxyindole (1.98, Scheme 1.8) as 
the starting material. The key intermediates 1.101 (Scheme 1.8) and 1.103 (Scheme 1.9) were 
prepared by aryne-mediated cyclisation of the tryptamine derivatives 1.100 and 1.102, 
respectively. The required substituents at positions 3 and 4 on the indole ring were introduced by 
consecutive directed lithiation and fluoride ion-induced elimination-addition reactions of the 
methiodide of 1.99.77 
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Scheme 1.10 Total synthesis of makaluvamine D.78 
a) (PhO)2PON3, EtOH, Et3N; b) KOH, EtOH; c) NaNO2, HCl; d) SnCl2, HCl; e) NaOH; f) HCl; g) ZnCl2, 
HOCH2CH2OH; h) AcONO2, Ac2O; i) H2, PtO2, EtOH; j) (i-Pr)2Et; k) CAN, MeCN, H2O; l) p-TsOH; m) i) tyramine, 
EtOH, heat, ii) TFA.78 
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A novel approach to the synthesis of the pyrroloquinoline system was developed by White et al. 
and is illustrated (Scheme 1.10) by the total synthesis of makaluvamine D. The approach involved 
a Fischer indole synthesis using hydrazine (1.104) and dihydrofuran, which led to tryptophol 
(1.105).78 The tryptophol, protected as its ditosylate (1.106a), was then subjected to nitration at 
the C-4 position on the indole ring to give compound 1.107. Reduction to the amine (1.108) 
followed by deprotection, oxidation and cyclisation gave 1.109, while selective demethylation and 
oxidation with CAN provided the iminoquinone core (1.110). Replacement of the methoxy group 
with an amine functionality followed by treatment with tyramine and TFA successfully yielded the 
natural product (1.34).78 
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Scheme 1.11 Synthetic approach to discorhabdin C and makaluvamine D.79 
a) NCS, DMF, 60 oC, 55 %; b) I2, t-BuI, FeCl2, TFA, DMSO, 80 oC, 78 %; c) MeOH, HCl, reflux, 90 %; d) NaBH4, 
NiCl2.6H2O, MeOH, 0 oC, 90 %; e) HCO2H, Ac2O, rt, 50 %; f) aq. NaOH, MeOH, CH2Cl2, rt, 82 %; g) MeI, NaH, 
THF, rt, 56 %; h) aq. 2N NaOH, reflux, 95 %; i) aq. 1N HCl, THF, 40 oC.79 
 
Roberts et al. employed 6,7-dimethoxy-4-methyl-5-nitroquinoline (1.111, Scheme 1.11) to give the 
key intermediate 1.113a which led to makaluvamine D. Following treatment of the amine-acetal 
1.112 with hydrochloric acid, the iminoquinone precursor of discorhabdin C was produced 
(Scheme 1.11).79 These intermediates had been shown in previous reports to lead to the total 
synthesis of makaluvamine D80 and discorhabdin C.81 
 
Lown et al. prepared a lexitropsin derivative of makaluvamine A, and the tricyclic systems were 
constructed from indole precursors.82 
 
Kita et al.83 accomplished the first total synthesis of makaluvamine F (1.36) in 1999. Key steps in 
this synthetic sequence included the formation of the pyrroloquinoline nucleus (1.113b, Scheme 
1.12), the formation of the dihydrobenzothiophene ring (1.114, Scheme 1.13) and the preparation 
of the α-azidodihyrobenzothiophene ring by hypervalent iodine (III) induced reactions (1.115, 
Scheme 1.13).83 
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Scheme 1.12 Preparation of pyrroloquinoline nucleus for makaluvamine F.83 
a) (COCl)2, Et2O, EtOH, 94 %; b) LiAlH4, THF (quant); c) I2, imidazole, PPh3, toluene, 68 %; d) AcCl, t-BuOK, 
THF, 91 %; e) PIFA-Me3SiOTf, (CF3)2CHOH-H2O (50:1).
83 
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Scheme 1.13 Total synthesis of makaluvamine F.83,84 
a) Br2, AcOH; b) BnBr, K2CO3, EtOH; c) LiAlH4, THF, 71 %; d) I2, PPh3, imidazole, PhMe, 65 %; e) AcSBn, 
NaOH, MeOH, 98 %; f) PIFA-BF3.OEt2; g) aq. MeNH2, 66 %; h) BF3.OEt2, EtSH; i) Ac2O, NaOAc, aq. NaOH, 83 
%; j) PhI=O-Me3SiN3, MeCN, -40 to  -25 oC, 46 %; k) 5 % NaOH, MeOH, 90 %; l) H2, 10 % Pd/C, EtOH-TFA, 
100 %; m) MeOH, rt, 86 %.83,84 
 
In order to construct the N,S-acetal moiety (Scheme 1.13) the authors83,84 designed a 
dihydrobenzothiophene system bearing a hydroxy group. Various dihydrobenzothiophene ring 
systems were therefore prepared from phenol ethers bearing an alkyl sulfide sidechain via an 
intramolecular cyclisation using phenyliodine(III) bis-(trifluoroacetate) (PIFA-BF3.Et2O) followed by 
treatment with aqueous methylamine which gave the 6-benzyloxy-5-bromo-dihydro-
benzothiophene intermediate (1.114). Azidation of 1.114 was carried out after debenzylation 
followed by acetylation of 1.114 to give the corresponding α-azido compound. After hydrolytic 
deprotection of the 6-acetoxy group, the 2-azido-5-bromo-6-hydroxy-dihydro-benzothiophene 
intermediate (1.115) was obtained. Catalytic hydrogenation of 1.115 in the presence of TFA 
followed by a final coupling reaction with 1.113b in methanol gave the TFA salt of 1.36. 
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1.6.4 Discorhabdins 
 
To generate the spirodienone ring system common in the discorhabdins, the coupling reactions 
have involved hypervalent iodine (III) reagents,85-87 electrochemical oxidations73,81 and an 
intramolecular Michael addition followed by copper (II) catalysed re-oxidation of the resultant 
amino phenol derivatives.88 
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Scheme 1.14 Total synthesis of discorhabdin C. 85-87 
a) C6H5CH2Br, K2CO3, EtOH, reflux; b) N3CH2CO2Et, NaOEt, EtOH, -15 oC; c) Xylene, reflux, 73 %; d) KOH, 
EtOH, reflux; e) Copper chromite, quinoline, 215 oC, 68 %; f) CH2=N+MeI2-, CH2Cl2, rt; g) MeI, 0 oC; h) NaCN, 
H2O, 80 oC, 36 %; i) H2, Raney Ni, NH3, EtOH, 3.3 atm; j) CF3COSEt, NaOMe, MeOH; p-
O2NC6H4OCO2(CH2)2SiMe3, NaOEt, EtOH, 0 oC, 78 – 89 %;  k) H2, 10 % Pd/C, EtOH, 3.3 atm; l) Fremy’s salt, 
KH2PO4, acetone-H2O 56 - 59 %; m) 3,5-dibromotyramine HBr, Et3N, EtOH, reflux, 55 – 58 %; n) 
MeCH=C(OMe)(OSiMe3), CH2Cl2, rt; o) PhI(OCOCF3)2 (PIFA), CF3CH2OH, rt, 58 – 62 %; p) TsCl, t-BuOK, THF, 
92 %; q) Anhydrous TsOH, MeCN; r) 3,5-dibromotyramine HBr, NaHCO3, EtOH, reflux, 51 %; s) 
MeCH=C(OMe)(OSiMe3), CH2Cl2, rt; t) PhI-(OCOCF3)2 (PIFA), CF3CH2OH, rt, 42 %.
85-87 
 
Kita et al. accomplished a total synthesis of discorhabdin C (1.49) in 1992.85-87 A general route to 
the spirocyclic quinones by an oxidative coupling reaction of various O-silylated aminoquinones 
using phenyliodine(III) bis-(trifluoroacetate)(PIFA) was described and this method was applied to 
a general synthesis of azacarbocylic spirodienone systems.85-87 Benzylation of 1.116 (Scheme 
1.14) followed by condensation with ethyl azidoacetate gave the vinyl azide which, upon 
decomposition gave the indole 1.117. Hydrolysis followed by decarboxylation gave the 
disubstituted indole 1.118. Following protection, hydrogenation and subsequent benzylation and 
oxidation, the quinone 1.119 was obtained. Protection of the indoloquinone to form the imine 
followed by coupling with 3,5 dibromotyramine hydrobromide afforded the phenol derivative 
1.121. Protection followed by oxidation afforded discorhabdin C. 
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Scheme 1.15 Total synthesis of discorhabdin C.88 
a) BnBr, K2CO3, DMF; b) Fe, HCl, H2O; c) ICI, Et2O, H2O, Na2CO3; d) BrCH2CH=CHCN, NaHCO3, acetone, 
H2O, 59 %; e) 5 mol % Pd(OAc)2, (o-MeC6H4)3P, Et3N, MeCN, reflux, 3 hr, 89 %; f) LiAlH4, Et2O; g) (BOC)2O, 
CH2Cl2; h) Ts2O, NaH, DMF, 60 %; i) H2, Pd/C, MeOH, 100 %; j) Fremy’s salt, acetone-H2O, 82 %; k) TFA, 
CH2Cl2; l) NaHCO3, EtOH, tyramine HCl; m) NaHCO3, EtOH, bromotyramine HCl; n) NaHCO3, EtOH, 
dibromotyramine HCl, 46 – 62 %; o) 3 eq. CuCl2, Et3N, O2, MeCN, 81 – 90 %; p) NaOMe, MeOH 67 – 80 %; q) 
H2, Pd/C, MeOH, 69 %; r) PhMe3N+Br-, CHCl3, TFA, s) basic alumina, 73 %.
88 
 
Alternatively, Heathcock and Aubart showed, following the preparation and the oxidation of a 
suitably substituted indole 1.122, that the iminoquinone 1.124 was able to undergo a nucleophilic 
amination with a suitably substituted tyramine to give 1.125. Oxidative cyclisation of 1.125 in the 
presence of excess copper dichloride followed by deprotection gave discorhabdin C and E. 
Further reaction with hydrogen over palladium of the debromo analogue, followed by 
regioselective bromination gave a bromoenone mixture which on contact with basic alumina 
afforded dethiadiscorhabdin D (1.126). Formation of the C-2-N-18 bond was achieved by 
nucleophilic displacement of the C-2 bromide by N-18. The authors thus showed a possible 
biomimetic approach to the synthesis of discorhabdins C and E. Discorhabdin C type structures 
indicate that the tryptamine substructure is incorporated in the iminoquinone moiety, while the rest 
of the molecule may be constructed from a tyrosine unit implicating the possibility that analogues 
of 1.120 (Scheme 1.14) act as intermediates in the biosynthetic pathway.88 However, on separate 
occasions, Kita85-87 and Heathcock88 in particular, both demonstrated through their attempts to 
synthesise discorhabdin C that this intermediate could not undergo the crucial iminoquinone 
cyclisation, thus negating analogues of 1.120 as possible biosynthetic intermediates. The key 
cyclisation step did, however, take place with the 1.121 (Scheme 1.14) and 1.125 intermediates 
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(Scheme 1.15). Heathcock also showed that a possible precursor to the pyrroloquinoline nucleus 
is likely to be analogous to 1.123, whereas an unsubstituted 1.123 (i.e. lacking the methoxy 
substituent) did not give rise to the pyrroloquinoline core 1.124 as reported previously by Kita and 
co-workers.88  
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Scheme 1.16 Total synthesis of discorhabdin A.89 
a) TrCl, Et3N, DMF, quant.; b) NBS, DMF, 65 %; c) 0.1 N HCl, MeOH, then 1.113, MeOH, 20 hr, 46 %; d) 
DIBAH, CH2Cl2, -78 oC to rt., 5 hr, 96 %; e) TBSCl, DBU, CH2Cl2, 0 oC, 1.5 hr, 87 %; f) TBAF, THF, 0 oC, 0.5 hr, 
quant.; g) 0.1 NH4Cl, MeOH, then 1.110, MeOH, 16 hr, 54 %; h) PIFA-MK10, CF3CH2OH, 0.5 hr, 45 %; i) 
BF3.Et2O, CH2Cl2, 0 oC to rt., 7 hr, 90 %; j) Pb(OAc)4, CH2Cl2-MeOH (2:1), 0 oC, 1.5 hr, 88 %; k) R1SH (where R1 
= p-MeOC6H4CH2), 30 % HBr-AcOH, CH2Cl2, -78 to 4 oC, 15 hr, 13 % for 1.132a, 19 % for 1.132b, 22 % for 
1.132c; l) NaOMe, THF-MeOH, 0 oC, 1 hr, 65 %.89  
 
Kita et al. described the first total synthesis of discorhabdin A (Scheme 1.16) in 2002.89 Key 
elements of the synthetic strategy, which employed L-tyrosine methyl ester (1.127) as the starting 
material, included the use of the iodine (III)-induced oxidative spirocyclisation to form 1.130 and in 
one of the final steps, and the introduction of the sulfur group (1.131) which led to the cross-linked 
core of 1.132a - 1.132c.89 Tritylation of 1.127 followed by monobromination, reduction, and 
silylation gave the bissilylated intermediate 1.128. Selective desilylation of 1.128 followed by a 
coupling reaction with 1.110 yielded 1.129. Spirodienone formation using phenyliodine (III) bis-
(trifluoroacetate) (PIFA) gave a mixture of two diastereomers (1.130a and 1.130b), which were 
subjected to desilylation, oxidative dealkylation. Introduction of a p-methoxybenzylthiol group 
gave 1.131 which on treatment with aqueous methylamine and detosylation afforded 1.57.89  
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1.6.5 Related pyrroloiminoquinones  
 
Moro-oka et al. completed the first total synthesis of veiutamine in 199990 (Scheme 1.17). The key 
steps in this synthesis involved the regioselective functionalisation at the C-6 position of the 
pyrroloquinoline nucleus (1.132 to 1.135) which was accomplished through directed lithiation 
procedures and the use of p-MOMO-C6H4-CH(OH) as an electrophile to generate the cyclic 
carbamate 1.132. Following hydrolysis, decarboxylation and deprotection, 1.134 was oxidised to 
the iminoquinone 1.135 and treated with ammonium chloride to give 1.74.90 
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Scheme 1.17 Total synthesis of veiutamine.90 
a) i) t-BuLi (1.2 equiv.), Et2O, 0 oC, 1 hr, ii) Cl3CCl3, 90 %; b) Ac2O (3 equiv.), toluene, 0 oC, 15 hr, 78 %; c) 
Et2AlCN (2 equiv.) toluene, 0 oC, 20 min, 80 %; d) LiAlH4 (5 equiv.) benzene-Et2O, reflux, 0.5 hr, 96 %; e) LICA 
(5 equiv.), THF, 0 oC, 15 min, 70 %; f) BOC2O (3 equiv.) reflux, 8 hr, 96 %; g) i) s-BuLi (1.5 equiv.), TMEDA, 
ether, -78 oC, 1 hr, ii) p-MOM-C6H4-CHO, 72 %; h) NaH (1.5 equiv.), THF, 0 oC, 20 min, 86 %; i) H2, Pd(OH)2/C, 
MeOH-AcOEt, rt, 6 hr; j) TBAF (1.2 equiv.), THF, rt, 15 min, 99 %; k) (KSO3)2NO (2 equiv.), pH 7 MeOH : 
phosphate buffer, 0 oC, 10 min, 33 %; l) i) NH4Cl (10 equiv.), MeOH, rt, 36 hr, ii) cat. HCl, reflux, 1 hr, iii) 
NaHCO3, iv) TFA, 89 %.90
 
 
1.7 Aim 
 
As described in Section 1.3 the taxonomy of the sponge family Latrunculiidae is presently the 
subject of some debate. For non-taxonomists it is especially difficult to keep track of all the 
changes. In an attempt to contribute to this debate we present in this thesis an in depth study of 
the major and minor pyrroloamino-ortho-quinone and pyrroloiminoquinone metabolites produced 
by four species of endemic South African Latrunculid sponges belonging to three genera 
Tsitsikamma, Latrunculia and Strongylodesma. The sponges were collected in our two main study 
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sites namely Algoa Bay and the Tsitsikamma Marine Reserve. Both these study sites are situated 
on the temperate south eastern coast of South Africa. The isolation and structure elucidation of 
eleven new and twelve known pyrroloamino-ortho-quinones and pyrroloiminoquinones are 
presented in Chapters 2 – 4. The dual role of these metabolites as both cytotoxic chemical agents 
and pigments piqued our interest in attempting to relate their photochemical properties to their 
cytotoxicity (Chapter 5). Pyrroloamino-ortho-quinones and pyrroloiminoquinone metabolites have 
been shown to exhibit interesting electrochemical behaviour30 which in certain instances may be 
related directly to the anti-cancer activity of these compounds. Our possession of a unique suite 
of twenty three pyrroloamino-ortho-quinones and pyrroloiminoquinone metabolites therefore put 
us in an excellent position to attempt to explore the correlation between the electrochemical 
properties and anti-cancer (HCT-116) activity of these compounds (Chapters 6 and 7). A later 
report on the topoisomerase I inhibitory activity (in contrast to that reported by Copp et al.54) of the 
bis-pyrroloiminoquinone wakayin (1.73)91 necessitated a similar investigation of topoisomerase I 
activity in the bis-pyrroloiminoquinones isolated from T. favus. 
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Chapter 2: Pyrroloiminoquinone metabolites from Tsitsikamma pedunculata 
 
2.1 Introduction 
 
The “golf ball shaped” latrunculid sponge Tsitsikamma pedunculata (Figure 2.2) was collected 
from Algoa Bay in 1999 and contained mainly discorhabdin-type pyrroloiminoquinone compounds. 
The very polar discorhabdins are difficult to purify giving broad peaks, even under optimised 
reversed phase HPLC conditions. As a result signals from small amounts of impurities are 
frequently observed in the NMR spectra of these compounds. Once recognised, however, these 
impurities do not impede the structure elucidation of the pyrroloiminoquinone metabolites. We 
have developed a standard isolation protocol which allowed us to minimise the amount of 
impurities present in the purified extracts. Thus, a methanolic extract of T. pedunculata was 
subjected to a sequence of solvent partitioning, solid phase extraction and high performance 
liquid chromatography to yield three known (1.51 – 1.53) together with six new discorhabdins (2.1 
– 2.6, Figure 2.1). Purified samples were subjected to direct injection low resolution LC-MS, 
which, from the isotope pattern of the pseudo-molecular ion, enabled the determination of the 
number of bromine atoms (if any) incorporated into the discorhabdin skeleton (e.g. Figure 2.3, p. 
49). 
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Figure 2.1 Summary of the compounds isolated from T. pedunculata. 
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The pyrroloiminoquinone structures were established using standard spectroanalytical techniques 
as well as by comparison of their spectroscopic data with those of known compounds in the 
series. Given the paucity of hydrogen atoms in pyrroloiminoquinone metabolites the structure 
elucidation is not trivial. To maximise the information available from exchangeable protons, the 
deuterated solvent DMSO-d6 was preferred over CD3OD (see Figure 2.10, p. 60). Unfortunately, 
many of the minor impurities alluded to above are also very soluble in DMSO-d6. The new 
compounds (2.1 – 2.6) are the minor metabolites in T. pedunculata and were obtained in small 
quantities (ca. 1 - 8 mg). The metabolites from T. pedunculata (OCDN 6451-V) are characterised 
by a) a reduced C-3 carbonyl; b) bromination at C-14; c) a discorhabdin C and a dethia-
discorhabdin D (discorhabdin S) type skeleton, i.e. a N-18 to C-2 bond; and d) a ∆7 olefin.   
 
2.2 Results and Discussion 
 
2.2.1 The taxonomy of the sponge Tsitsikamma pedunculata 
  
 
 
Figure 2.2 An underwater photograph of T. pedunculata. 
 
The “golf ball shaped” Latrunculid sponge, T. pedunculata (OCDN 6451-V) was collected by 
SCUBA from a depth of 38 – 40 m off Thunderbolt reef (34 03.14S and 25 41.35E), Algoa Bay, 
South Africa in 1999. Samaai et al.92 described the sponge as follows: “In life the sponge is 
pedunculate, up to 7 cm high and 3 cm wide. The surface is smooth, leathery with circular 
areolate porefields and raised volcano-shaped oscula. The texture is extremely tough, firm and 
leathery. The colour in life is salmon pink and between the oscula and areolate porefields it’s dark 
pink. Colour in preservative is dark brown. The choanosomal skeleton consists of a confused, ill-
formed, irregular reticulation of anisostyles, meandering vertically and horizontally within the 
choanosome (70 – 110 µm), with no distinction between the primary and secondary tracts.  
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Discorhabds are also found abundantly throughout the choanosomal tissue. The ectosome is 
composed of a thick dark, dense feltwork of tangential and paratangential oriented anisostyles 
approximately 1300 µm thick. A single layer of erect discorhabds (29 µm thick) lines the surface of 
the ectosome. Megascleres are anisostyles.  Microscleres are isodiscorhabds with two whorls of 
cylindrical, conical tubercules. Free end of conically rounded spines is acanthose.” The sponge is 
the second species to be described in the new genus Tsitsikamma within the Family 
Latrunculiidae. 
 
2.2.2 Extraction and isolation of pyrroloiminoquinone metabolites from T. pedunculata 
 
The frozen sponge was extracted with methanol and the aqueous methanol extract concentrated 
and partitioned according to a modified Kupchan procedure (Scheme 2.1). The known 
compounds 14-bromo-discorhabdin C (1.51),41 14-bromo-3-dihydro-discorhabdin C (1.52)41 and 
3-dihydro-discorhabdin C (1.53);42,44 together with five new compounds; 7,8-dehydro-3-dihydro-
discorhabdin C (2.1), 14-bromo-7,8-dehydro-3-dihydro-discorhabdin C (2.2), discorhabdin S (2.3), 
14-bromo-1-hydroxy-discorhabdin S (2.4), 1-bromo-2-hydroxy-4-debromo-discorhabdin S (2.5), 
and 2,4-debromo-3-dihydro-discorhabdin C (2.6), were isolated from T. pedunculata.   
 
Several methods are routinely used to work up frozen marine invertebrate material. The most 
common is lyophilisation followed by extraction with a polar solvent e.g. methanol of the frozen 
marine organism. One of the advantages of this approach is that it provides the dry mass of the 
marine organism prior to extraction which in turn is routinely used to calculate the yield of natural 
products isolated from the marine organism. The significance of this dry mass is, however, 
debatable given the prodigious and variable amounts of seawater-derived sodium chloride 
present in any filter feeding marine organism. The National Cancer Institute’s (NCI) protocol for 
extracting marine invertebrate and algal material is of interest. McCloud et al.93 have shown that 
initial lyophilisation of the frozen marine organism is not a prerequisite requirement for extracting 
bioactive marine metabolites. The NCI procedure which involves an initial aqueous extraction 
(grinding of the frozen material with dry ice, addition of water and subsequent centrifugation) has 
a number of advantages. The most important advantage to emerge from this procedure has been 
the discovery of many bioactive marine proteins which would have been denatured in an initial 
solvent extraction. The organic residue after centrifugation is lyophilised and extracted with a 
solvent combination of 1:1 dichloromethane : methanol. 
 
Previous investigations41,42 of the natural product chemistry of South African Latrunculid sponges 
used the former method of sponge extraction viz lyophilisation followed by solvent extraction. 
Unfortunately, this approach apparently did not provide access to minor pyrroloiminoquinone 
metabolites which increasingly became the focus of our research. A defunct freeze drier at the 
start of our investigations fortuitously forced us to soak the frozen Latrunculid sponges in 
methanol or a 1:1 dichloromethane : methanol solvent mixture. Although the concentration of the 
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initial aqueous methanol extracts on a rotary evaporator was laborious we were rewarded as the 
subsequent chromatographic separations resulted in the discovery of many minor metabolites in 
reasonable yield. Solid phase extractions on C18 Sep Paks®, as the first stage in the 
chromatographic sequence, proved effective in removing the problem of the ever-present sodium 
chloride. The sponge was air dried after extraction to provide its dry mass. It can be argued that 
the removal of most of the sodium chloride during the aqueous methanol : dichloromethane 
extraction process makes this dry mass of the sponge possibly more relevant than that from prior 
lyophilisation. 
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Scheme 2.1 Scheme for the extraction and isolation of pyrroloiminoquinone metabolites 
from T. pedunculata. The masses and yields (calculated relative to the dry mass of the 
sponge) of the T. pedunculata pyrroloiminoquinone metabolites are summarised below: 
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003I 1.51 22.7 mg 0.02 % 
002D;  011E 1.52 18.7 mg 0.02 % 
003J;  011C 1.53 90.4 mg 0.09 % 
002E 2.1 1.2 mg 0.001 % 
002F 2.2 7.7 mg 0.007 % 
012L 2.3 4.4 mg 0.004 % 
012P 2.4 4.2 mg 0.004 % 
012K 2.5 2.6 mg 0.003 % 
012T 2.6 1.2 mg 0.001 % 
 
Compounds 1.51 - 1.53, 2.1 and 2.2 were isolated from the chloroform partition fraction of the 
sponge extract, while 1.52, 1.53 and 2.3 – 2.6 were obtained from the butanol partition fraction. 
The structures of compounds 2.1 – 2.6 reported here, are based on spectral comparisons with 
known discorhabdins. Compared to the ring system found in dihydro-discorhabdin C, the 
structures of 2.3 – 2.5 possesses a further heterocyclic ring to give six interlocking rings (four 
heterocyclic and one spiro) which forms the basis of a discorhabdin D type skeleton.   
 
2.2.3 Structure elucidation of pyrroloiminoquinone metabolites from T. pedunculata  
 
a) 14-bromo-discorhabdin C (1.51) and14-bromo-3-dihydro-discorhabdin C (1.52) 
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HRFABMS analyses of the TFA salts of 1.51 (22.7 mg, 0.02% yield) and 1.52 (18.7 mg, 0.02% 
yield) provided molecular formulae of C18H14N3O279Br3 and C18H16N3O279Br3, respectively.41 The 
basic skeleton of discorhabdin C was evident from the 1H and 13C NMR data for both 1.51 and 
1.52,41 and the proton and carbon resonances were found to be consistent with those values 
published by Hooper et al..41 The 1H NMR spectrum of 1.51 is deceptively simple, showing only 
four methylene signals, one olefinic methine signal representing two protons, in addition to the 
three exchangeable NH protons. The absence of the H-14 signal in the 1H NMR spectrum, usually 
present at around δ 7 ppm (e.g. 1.53), together with the 13C shift obtained for C-14 (δC 112.4), 
placed the third bromine atom at C-14. The 13C NMR data for 1.51 showed the characteristic 
presence of two α,β-unsaturated ketone carbonyls corresponding to C-3 (δ 171.2) and C-11 (δ 
164.3).  
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Figure 2.3 The M + 1 ion isotopic cluster from the LC-MS spectrum of 1.51 clearly 
showing the presence of three bromine atoms. 
 
LC-MS is an ideal, quick and an exceptionally powerful analytical method because of this 
technique’s ability to achieve extremely low detection limits and to discriminate between peaks 
that co-elute during HPLC. LC-MS is therefore used extensively in the pharmaceutical industry for 
drug identification, metabolite profiling and identification, screening and quantitation.94 Many 
drugs contain basic nitrogen atoms which may be manipulated by protonation in the electrospray 
process and are therefore easily detected. An added advantage of LC-MS is that detailed 
structural information can also be obtained using MS-MS techniques. The atmospheric ionisation 
(API) sources that may be used include Atmospheric Pressure Chemical Ionisation (APCI) and 
Electrospray Chemical Ionisation (ESI) sources. Both sources utilise a “soft” ionisation technique 
which means that the molecular ion of a particular sample (unless the compound is extremely 
unstable) will remain intact. The isotopic ion cluster of the intact molecular ion in multi-
halogenated compounds e.g. the pyrroloiminoquinone metabolites from Latrunculid sponges, is 
particularly useful in providing initial information about the degree and type of halogenation in the 
molecule. The isotopic ion cluster for the M+1 ion of the tribrominated 1.51 is reproduced in 
Figure 2.3. 
 
A Finnigan Mat LCQ system fitted with an ion trap analyser was used to obtain the low resolution 
molecular ion data in this thesis research. Although ionisation of the pyrroloiminoquinones was 
easily achieved with both sources, the ESI source was chosen over APCI because of the general 
absence of background noise (APCI sources employ a vaporiser which from experience often 
leads to the deposition of carbon based material in the source and consequently background 
noise). During the isolation of the discorhabdins, TFA was used in the HPLC mobile phase to 
improve the resolution of the peaks obtained during chromatography. Unfortunately, the presence 
of TFA in the mobile phase unexpectedly proved problematic during LC-MS analyses. The TFA 
was observed to produce multiply charged ion clusters from approximately 500 to 1200 amu 
which, although this does not normally interfere with the molecular ions typically observed for 
halogenated pyrroloiminoquinones, leads to a large amount of background noise and the total ion 
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chromatograms (TIC) thus obtained were therefore often disappointing. Not surprisingly, the 
manufacturers (Finnigan Mat) do not recommend the use of TFA in the LCQ system.95 
Consequently, to avoid problems associated with TFA in the HPLC mobile phase, the HPLC 
separations of the pyrroloiminoquinone metabolites were performed independently. The TFA 
containing HPLC eluent was removed from the HPLC fractions and the purified metabolites 
reconstituted in methanol to provide solutions with concentrations of approximately 100 µg/mL. 
Aliquots (20 µL) of each solution were introduced into the LC-MS source by standard direct 
injections techniques. After exhaustive attempts to optimise the ESI conditions the following 
settings were employed to record the mass spectra to give maximum sensitivity for 
pyrroloiminoquinone metabolites (after tuning); positive ion mode, capillary temperature 200 oC, 
capillary voltage 7.0 V, discharge voltage 4.5 kV, tube lens offset –60.0 V, discharge current 50 
µA, octapole 1 offset –5.8 V, octapole 2 offset –7.5 V, interoctapole lens –58.0 V, with the sheath 
and auxiliary gases set to 30 and 0 arbitrary units. 
 
The 1H NMR spectrum of 1.52 also revealed the absence of the H-14 signal, while an extra 
oxymethine singlet signal (H-3, δ 4.68) was observed. The 13C NMR data for 1.52 once again 
indicated that a bromine atom resided at C-14 (δ 112.1) and a signal corresponding to δ 70.8 for 
C-3 (which implicates a hydroxyl group functionality on C-3) was observed. The analogous 
chemical shift for C-3 in 1.51 is δ 171.2. Not unexpectedly an energy minimised three-dimensional 
model of compound 1.52 shows that the spiro ring lies perpendicular to the plane of the rest of the 
molecule (Figure 2.4).   
 
3-OH
Spiro Ring
Pyrrole ring
 
 
Figure 2.4 A three-dimensional model of 14-bromo-3-dihydro-discorhabdin C (1.52). 
(Spartan ’02, Wavefunction, Inc., CA, USA. A semi-empirical force field was used to convert the 2D 
structures to 3D models). 
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b) 3-dihydro-discorhabdin C (1.53) 
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The known compound 1.53 was previously isolated and characterised from another Algoa Bay 
Latrunculid sponge (Strongylodesma coetzeei).42 Interestingly, Blunt et al.44 synthesised 1.53 
from discorhabdin C (1.49) via reduction with NaBH4 as part of a synthetic programme to gain 
access to 1H-azepine analogues of discorhabdin C (2.7).44 Compounds 1.53 and 2.7 were far 
less active in vitro against the P-388 murine leukaemia cell line (IC50 530 and 3050 ng/mL) than 
1.49 (IC50 40 ng/mL). Our data for 1.53 matched those reported by Beukes42 and Blunt et al..44 
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Scheme 2.2 Blunt et al.’s synthetic modification of the discorhabdin skeleton.44 
 
Compound 1.53 (90.4 mg, 0.09 % yield) showed a molecular ion peak at m/z 464.9688 (M+1: ∆ 
+0.1 mmu) in the HRFABMS analyses corresponding to a molecular formula of C18H17N3O279Br2. 
The 1H and 13C NMR spectra also indicated a basic discorhabdin C type skeleton with the proton 
NMR spectra showing eight non-exchangeable and four exchangeable sets of protons. The 13C 
NMR spectrum showed resonances corresponding to all eighteen carbons and a DEPT 
experiment confirmed that the eleven non-exchangeable protons were attached to carbons. 
Deshielded proton signals corresponding to H-3 (δ 4.60) and H-14 (δ 7.40) were observed in the 
1H NMR spectrum, with the oxymethine and vinylic 13C carbon chemical shifts at δ 69.2 and 127.4 
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in agreement with the presence of a hydroxyl group at C-3 and the absence of a bromine at C-14 
(compared to the analogous chemical shifts obtained for 1.51 and 1.52). The NMR data obtained 
for this compound is consistent with the literature values.42,44 Figure 2.5 shows the M + 1 isotope 
ion cluster in the LC-MS spectrum of 1.53 indicative of a compound containing two bromine 
atoms. 
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Figure 2.5 The M + 1 ion isotopic cluster in the LC-MS spectrum of 1.53 clearly showing 
the presence of two bromine atoms. 
 
c) 7,8-dehydro-3-dihydro-discorhabdin C (2.1) 
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To establish the structure of 2.1 (1.2 mg, 0.001 % yield), the available NMR data was compared 
to that of 1.53. The molecular formula C18H15N3O279Br2 for 2.1 was determined by HRFABMS (m/z 
462.9532, M+1; ∆ -0.1 mmu). The 1H NMR spectrum showed seven non-exchangeable and four 
exchangeable sets of protons, and was relatively simple showing three deshielded sp2 methine 
signals at δ 7.37 (s, H-14), 6.64 (s, H-1 and H-5), and 6.33 (dd, J = 4.3, 7.6 Hz, H-8), another 
deshielded vinylic resonance δ 4.72 (d, J = 7.6 Hz, H-7) and an oxymethine resonance at δ 4.55 
(s, H-3). Three of the four exchangeable protons at δ 13.23 (br s), 10.59 (br s) and 8.31 (br s) 
were assigned as NH-13, NH-9 and NH-18 respectively, by analogy with the 1H NMR data of 
known compounds e.g. 1.51,41 1.52,41 1.53,42 and 1.69.52 The 13C NMR spectrum revealed 
fourteen carbon signals and a DEPT experiment confirmed the presence of eight protonated 
carbons as shown in Table 2.1. The quaternary carbon chemical shifts for C-2, C-4, C-6, C-10, C-
11, C-12, C-14, C-15, C-19, C-20 and C-21 were assigned initially by analogy to related 
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compounds.42,52 The characteristic 13C shift of C-16, together with the COSY and HMBC 
correlations obtained for 2.1, enabled C-16 and C-17 and their methylene protons to be assigned. 
The two and three bond HMBC correlations from H2-16 and H2-17 to their surrounding carbon 
atoms confirmed the chemical shifts of the quaternary carbons C-14, C-15, C-19 and C-21. An 
HMQC experiment linked the two sp2 methine protons at δ 4.72 (H-7) and 6.33 (H-8) to carbons δ 
112.5 and 122.2, respectively, implying the presence of a double bond between C-7 and C-8. The 
position of the olefin was confirmed by the J7,8 coupling constant (7.6 Hz) and the COSY 
correlations from H-8 to H-7 and NH-9. The third sp2 methine proton (δ 7.37), which showed a 
COSY correlation to NH-13, was thus assigned to H-14, in accordance with published values.42,52 
Epinardin C52 (1.69) differs from the structure proposed for 2.1, in that it lacks a ∆1 olefin. This 
difference probably accounts for the differences in the C-7 chemical shifts observed for 2.1 (δ 
112.5) and (1.69) (δ 105.5). The fully assigned NMR spectral data for 2.1 is presented in Table 
2.1. 
 
Table 2.1 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 2.1. 
 
Atom No. δC δH (mult, J, Hz)  COSY HMBC 
C1 132.1 (d) 6.64 (s), 1H H-8 (5J ) C2, C3, C4, C5, C6 
C2 122.2 (s)    
C3 68.7 (d) 4.55 (s), 1H - C1, C2, C4, C5 
C4 122.2 (s)    
C5 132.1 (d) 6.64 (s), 1H H-8 (5J)  C2, C3, C4, C5, C6 
C6 45.4 (s)    
C7 112.5 (d) 4.72 (d), 1H, 7.6 Hz H-8  - 
C8 122.2 (d) 6.33 (dd), 1H, 4.3, 7.6 Hz H1/H5 (5J), H-7, NH-9 - 
NH-9 - 10.59 (br s), 1H H-8 - 
C10 -    
C11 -    
C12 122.5 (s)    
NH-13  13.23 (br s), 1H H-14 - 
C14 126.2 (d) 7.37 (s), 1H NH-13 C12/C21 
C15 119.5 (s)    
C16 17.7 (t) 2.88 (t), 2H, 7.6 Hz H-17 C15, C17 
C17 44.0 (t) 3.82 (t), 2H, 7.6 Hz H-16, NH-18 C15, C16, C19 
NH-18 - 8.31 (br s), 1H  - 
C19 158.0 (s)    
C20 -    
C21 -    
5J = five bond long range COSY coupling. 
 
Of interest to note in Table 2.1 are the long range (5J) COSY couplings which are common in 
discorhabdins. Long range proton proton couplings (5J ≤ 1Hz) are particularly prevalent when the 
coupling path contains one or more sp2 carbons e.g. indolazine (2.8).96 
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J1-3  =  1.1 Hz 
J1-4  =  1.2 Hz 
J1-5  =  0.9 Hz 
J4-7  =  0.7 Hz 
 
d) 14-bromo-7,8-dehydro-3-dihydro-discorhabdin C (2.2) 
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Compound 2.2 (7.7 mg, 0.007 % yield) gave a molecular ion at m/z 540.8635 (∆ +0.1 mmu) in its 
HRFABMS spectrum, which is consistent with the molecular formula C18H14N3O279Br3. The 1H 
NMR spectrum of 2.2 was relatively simple and, upon comparison with the proton spectrum of 
compound 2.1, the only difference noted was the disappearance of the H-14 proton signal at 
around δ 7.3 again implying the presence of a bromine atom at C-14. Bromination at C-14 was 
confirmed by the carbon chemical shift of C-14 (δ 111.6). Two olefinic sp2 methine signals at δ 
6.52 (s, H-1 and H-5) and 6.25 (dd, J = 4.8, 7.3 Hz, H-8) and another two deshielded methine 
signals at δ 4.82 (d, J = 7.3 Hz, H-7) and 4.59 (s, H-3) were observed in the 1H NMR spectrum of 
2.2. The 1H NMR spectrum also showed three exchangeable protons at δ 14.13 (br s), 10.64 (br 
s) and 8.62 (br s) that correspond to NH-13, NH-9 and NH-18 respectively. Data obtained from a 
DEPT experiment indicated the presence of two methylene groups (δ 44.3 and 17.3), three sp2 
methine groups at δ 133.9 (overlapped), 122.5 and 114.6, one sp3 methine group at δ 71.0. The 
HMQC data established that the deshielded methine signals at δ 4.82 and 4.59 resided on 
carbons resonating at δ 114.6 (C-7) and 71.0 (C-3) respectively, while the vinylic methine protons 
were attached to carbons at δ 133.9 (C-1 / C-5) and 122.5 (C-8). Consequently, the presence of a 
double bond between C-7 and C-8 was again suggested and confirmed through the observation 
of COSY correlations between H-8 and H-7 and between H-8 and NH-9. Even though apparently 
adequate amounts of 2.2 were obtained (7.7 mg) for NMR analyses, four of the eleven quaternary 
(and one sp2 methine carbon signal) carbons were not observed in the 13C NMR spectrum. In 
order to compensate for the possible longer T1 relaxation times of these missing quaternary 
carbons, the relevant NMR delay time (d1) parameter was varied (1.0 and 1.5 s) and numerous 
scans acquired (18 000 - 31 000). Frustratingly, the four quaternary carbons remained undetected 
and we therefore elected to exploit the sensitivity of more sensitive inverse detection techniques, 
such as HMBC correlations, to yield the missing carbon data. After assigning the nearby protons 
via COSY and / or HMQC correlations, the protons were used to identify the surrounding 
quaternary carbon chemical shifts e.g. HMBC correlations from H-1, H-5 and H-8 were used to 
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identify the carbon chemical shift of C-6 (δ 44.7). Likewise, the HMBC correlations from the H-8, 
NH-9 and H2-16 protons were used to identify the carbon chemical shifts of C-10 (δ 144.2), C-20 
(δ 97.3) and C-14 (δ 111.6). (The HMQC data provided the carbon chemical shift for C-7 at δ 
114.6). 
 
Table 2.2 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 2.2. 
 
Atom No. δC δH (mult, J, Hz)  COSY HMBC 
C1 133.9 (d) 6.52 (s), 2H H-7 (4J) C2, C3, C4, C5, C6,* C20* 
C2 124.5 (s)    
C3 71.0 (d) 4.59 (s), 1H - C1, C2, C4, C5 
C4 124.5 (s)    
C5 133.9 (d) 6.52 (s), 2H H-7 (4J) C1, C2, C3, C4, C6,* C20* 
C6 44.7* (s)    
C7 114.6* (d) 4.82 (d), 1H, 7.3 Hz H-8 - 
C8 122.5 (d) 6.25 (dd), 1H, 4.8, 7.3 Hz H-7, NH-9 C6,* C10* 
NH-9 - 10.64 (s), 1H H-8 C20,* C11 
C10 144.2* (s)    
C11 165.2 (s)    
C12 122.4 (s)    
NH-13  14.13 (br s), 1H - - 
C14 111.6* (s)    
C15 119.1 (s)    
C16 17.3 (t) 2.78 (t), 2H, 7.6 Hz H-17 C14,* C15, C17, C21 
C17 44.3* (t) 3.90 (t), 2H, 7.6 Hz H-16, NH-18 C15, C16, C19 
NH-18 - 8.62 (s), 1H H-17 C21 
C19 156.4 (s)    
C20 97.3* (s)    
C21 122.6 (s)    
*Note: Chemical shifts of 13C resonances obtained from HMQC or HMBC data. 
4J = four bond long range COSY correlation. 
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High resolution FABMS established a molecular formula of C18H18N3O279Br (m/z 387.0582; M+1; 
∆ -0.1 mmu) for 2.3 (4.4 mg, 0.004 % yield). The 1H NMR spectrum (Figure 2.6) indicated thirteen 
non-exchangeable and two exchangeable sets of protons. Well-resolved resonances for 
seventeen carbons were observed in the 13C NMR spectrum. The DEPT NMR experiment 
disclosed the presence of five methylene signals (δ 19.2, 29.1, 34.6, 37.7 and 52.7), two sp3 
methines (δ 60.6 and 70.5), two sp2 methines (δ 126.5 and 136.6), seven sp2 quaternary carbons 
(δ 96.6, 118.0, 122.6, 122.8, 126.4, 146.4 and 150.0), together with an α,β-unsaturated ketone (δ 
166.7), accounting for all, except one, of the carbons of 2.3. Despite varying the 13C NMR 
acquisition parameters as described previously, the quaternary spiro C-6 signal was not 
observed. Unfortunately, a relative paucity of HMBC data prevented the assignment of the C-6 
chemical shift via correlations from surrounding protons. 
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Figure 2.6 The fully assigned 1H NMR spectrum of 2.3 (400 MHz, DMSO-d6) with the 
signals for the two NH protons offset. (Imp = impurity). 
 
The olefinic proton at δ 7.28 (d, J = 2.5 Hz, H-14) was shown by an HMQC experiment (Figure 
2.7) to reside on a carbon at δ 126.5 and displayed strong HMBC correlations to C-15 and C-21. 
The two pairs of diastereotopic methylene protons at δ 3.03 (m, H-16b) and 2.93 (m, H-16a), and 
δ 4.14 (m, H-17b) and 3.99 (m, H-17a) were attached to carbons at δ 19.2 and δ 52.7, 
respectively. The H2-16 and H2-17 methylene protons were also shown to be vicinally coupled in a 
COSY experiment. Typical HMBC correlations were observed from H2-16 and H2-17 to two 
groups of carbon atoms δ 118.0 (C-15), 52.7 (C-17) and 122.6 (C-21) and 118.0 (C-15), 19.2 (C-
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16) and 150.0 (C-19), respectively. An HMQC experiment also established that the methylene 
protons at δ 3.64 ppm (m, H2-8) were attached to the carbon at δ 37.7; the pair of diastereotopic 
methylene protons at δ 1.95 (d, J = 13.4 Hz, H-7b) and 1.51 (m, H-7a) resided on a carbon at δ 
29.1; and that the olefinic proton at δ 6.31 (s, H-5) was attached to the carbon at δ 136.6. A 
COSY experiment established that the H2-8 methylene group was vicinally coupled to the H2-7 
methylene protons. 
 
The HMQC experiment also positioned the diastereotopic methylene protons at δ 2.28 (d, J = 
13.1 Hz, H-1b) and δ 1.82 (dd, J = 2.3, 13.1 Hz, H-1a) on C-1 (δ 34.6), and revealed that the 
methine protons at δ 4.24 (dd, J = 3.8, 5.3 Hz, H-2) and 4.53 (d, J = 5.3 Hz, H-3) resided on 
carbons at δ 60.6 (C-2) and δ 70.5 (C-3), respectively. The COSY experiment confirmed that the 
sp3 methine proton H-2 was coupled to the methylene protons H2-1. The HMBC data (Table 2.3) 
showed that H2-7 correlated to the carbons at δ 136.6 (C-5), 37.7 (C-8) and 96.6 (C-20) and that 
H2-1 correlated to carbons at δ 60.6 (C-2), 70.5 (C-3), 136.6 (C-5) and 96.5 (C-20). The carbon 
resonance at δ 70.5 was assigned as C-3 on the basis of the COSY and HMBC correlations from 
H-2. HMBC correlations from H2-1 and H-5 to C-2, C-3, C-5, C-20 and C-1, C-3, C-4, C-7 
respectively confirmed the structure of the spiro ring and confirmed that H2-1 and H-5 reside on 
opposite sides of the ring. Additional HMBC correlations (Figure 2.8) from H-2 to C-1, C-3, C-4 
and especially to C-17 implied the basic structure of a discorhabdin D (1.61) type skeleton.  
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Figure 2.7 A section (F1 = δ 15 – 80 ppm, F2 = δ 1.0 – 5.2 ppm) of the HMQC spectrum 
of compound 2.3 (400/100 MHz, DMSO-d6). (Imp = impurity). 
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Figure 2.8 A section (F1 = δ 10 – 100 ppm, F2 = δ 1.0 – 8.0 ppm) of the HMBC spectrum 
of compound 2.3 (400/100 MHz, DMSO-d6). (Imp = impurity). 
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Initial evidence for a discorhabdin D (1.61) type heptacyclic structure followed from the absence 
of the NH-18 signal in the 1H NMR spectrum of 2.3. This resonance is conspicuous in the 1H NMR 
spectra of compounds 1.51 – 1.53, 2.1 and 2.2 occurring between δ 7.8 - 8.5 and is easily 
identifiable from a COSY correlation with the methylene protons (H2-17). Conclusive evidence for 
the bond between N-18 and C-2 was provided firstly by the approximate 10 ppm downfield shift of 
the C-17 resonance (cf. compounds 1.51 – 1.53, 2.1 and 2.2) and the three bond HMBC 
correlation between H-2 and C-17 (Figure 2.8). 
 
A model proved (Figure 2.9) to be particularly helpful in assessing the possible stereochemistry at 
C-3, assuming a similar relative stereochemistry to discorhabdin D48 (1.61) and epinardin A 
(1.67).52 A geminal coupling constant of 13.1 Hz was observed for the protons at position 1 while 
the vicinal coupling between the H-2 and H-3 protons (J2,3 = 5.3 Hz) was consistent with a 
possible axial-equatorial arrangement of these two protons. From the modified Karplus equation, 
if both H-1a and H-1b are quasi-equatorial relative to H-2 (i.e. have the same bond angle ~ 60o) 
the resultant coupling will be very small (~1 Hz). 
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Figure 2.9 A three dimensional model of 2.3 clearly showing a possible quasi-di-
equatorial arrangement of the two H2-1 protons relative to H-2. The 2S,* 6R* relative 
stereochemistry of discorhabdin D (1.61) is arbitrarily adopted. (Spartan ’02, Wavefunction, 
Inc., CA, USA. A semi empirical forcefield was used to generate the 3D molecular structure). 
 
Table 2.3 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 2.3. 
 
Atom No. δC δH (mult, J, Hz)  COSY HMBC 
C1 34.6 (t) 1.82 (dd), 1H, 2.3, 13.1 Hz 
2.28 (d), 1H, 13.1 Hz 
H-1 C2, C3, C5 
C3, C20 
C2 60.6 (d) 4.24 (dd), 1H, 3.8, 5.3 Hz H-1 C1, C3, C4, C17  
C3 70.5 (d) 4.53 (d), 1H, 5.3 Hz H-5 C4, C5 
C4 126.4 (s) - - - 
C5 136.6 (d) 6.31 (s), 1H H-3, H-1b C1, C3, C4, C7 
C6 -*    
C7 29.1 (t) 1.51 (m), 1H 
1.95 (d), 1H, 13.4 Hz 
H-7, H-8 C5, C20, C8  
C5, C8 
C8 37.7 (t) 3.64 (m), 1H H-7 - 
NH-9 - 9.50 (s), 1H H-8 - 
C10 146.4 (s)    
C11 166.7 (s)    
C12 122.8 (s)    
NH-13 - 12.99 (s), 1H H-14 C14, C15  
C14 126.5 (d) 7.28 (d), 1H, 2.5 Hz NH-13 C15, C21 
C15 118.0 (s)  - - 
C16 19.2 (t) 2.93 (m), 1H 
3.03 (m), 1H 
H-17 C15, C17, C21 
C15, C17 
C17 52.7 (t) 3.99 (m), 1H 
4.14 (m), 1H 
H-16 
H-16 
C15, C16, C19 
C15, C16, C19 
NH-18 - - - - 
C19 150.0 (s)  - - 
C20 96.6 (s)  - - 
C21 122.6 (s)  - - 
* 3C resonance not seen in 13C and HMBC data. 
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Although compound 2.3 could possibly be referred to as 3-dihydro-4-bromo-dethiadiscorhabdin D, 
in accordance with the general trends in discorhabdin nomenclature compound 2.3 is sufficiently 
different to discorhabdin D to warrant its own name and was accordingly given the next available 
alphabetical letter in the discorhabdin series and named discorhabdin S. 
 
f) 14-bromo-1-hydroxy-discorhabdin S (2.4) 
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Based on the NMR data, compound 2.4 (4.2 mg, 0.004% yield) was proposed as having a similar 
structure to that of 2.3 differing only in the addition of a hydroxyl group at C-1 and a bromine atom 
at C-14. Compound 2.4 gave a M+1 ion at m/z 480.9638 (∆ +0.1 mmu) by HRFABMS analysis, 
consistent with the molecular formula C18H17N3O379Br2.  
 
234567891011121314 ppm
OH-3
OH-1
NH-9
NH-13
DMSO-d6
H2O
H2O
CDCl3 CD3OD
 
 
Figure 2.10 1H NMR spectra for 2.4 (400 MHz) obtained in a) CD3OD/CDCl3 mix and b) 
DMSO-d6. 
 
a) 
b) 
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The proton NMR spectra (Figure 2.10) indicated twelve non-exchangeable and four exchangeable 
protons. Well-resolved resonances for sixteen of the eighteen carbon signals were observed in 
the 13C NMR spectrum. Unfortunately, the 13C resonances for the two adjacent quaternary 
carbons C-12 and C-21 were not seen in the 13 C NMR spectrum of 2.4 and could not be resolved 
indirectly through HMBC correlations from surrounding protons. The DEPT data revealed the 
presence of four methylene signals (δ 18.7, 23.9, 37.8 and 53.0), three sp3 methines (δ 65.4, 66.5 
and 70.5), one sp2 methine (δ 134.8); and one sp3 (δ 36.8) and six sp2 quaternary carbons (δ 
94.0, 118.1, 123.1, 126.2, 148.3 and 148.9), and an α,β-unsaturated ketone (δ 165.5), thus 
accounting for sixteen of the carbon resonances observed in the 13C NMR spectrum of 2.4.  
 
Table 2.4 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 2.4. 
 
Atom No. δC δH (mult, J, Hz)  COSY HMBC 
C1 65.4 (d) 4.04 (m), 1H - C20 
C2 66.5 (d) 4.05 (m), 1H H-3 C1, C3, C4, C17, C19 
C3 70.5 (d) 4.63 (s), 1H H-2, H-5 - 
C4 126.2 (s) - - - 
C5 134.8 (d) 6.24 (s), 1H H-3 C1, C3, C4, C6, C7 
C6 36.8 (s) - - - 
C7 23.9 (t) 1.68 (d), 1H, 13.4 Hz 
1.90 (m), 1H 
H-8 
H-8 
C6  
C5, C8 
C8 37.8 (t) 3.65 (m), 2H H-7, NH-9 - 
NH-9 - 9.65 (s), 1H H-8 - 
C10 148.3 (s)    
C11 165.5 (s)    
C12 -*    
NH-13 - 13.85 (s), 1H - C14, C15 
C14 118.1 (s)    
C15 123.1 (s)    
C16 18.7 (t) 2.81 (m), 1H 
2.95 (m), 1H 
H-17 
H-17 
C14, C17 
C14, C17 
C17 53.0 (t) 3.88 (m), 1H 
4.11 (m), 1H 
H-16 
H-16 
- 
- 
NH-18 - - - - 
C19 148.9 (s)    
C20 94.0 (s)    
C21 -*    
OH-1  6.184 (br s), 1H - - 
OH-3  5.78 (s), 1H - - 
*Signals for C-12 and C-21 could not be resolved from the HMBC spectrum. 
†Overlapping signals of H-1 and H-2 made it difficult to unequivocally determine the HMBC correlations.  
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HMQC experiments established that the methine protons at δ 4.05 (m, H-2) were attached to the 
carbon at δ 66.5, while the two remaining sp3 methine protons, at δ 4.04 (m, H-1) and 4.63 (s, H-
3), resided on the carbons at δ 65.4 and 70.5 respectively. COSY correlations were observed 
between H-2 and H-3 and the 13C chemical shifts observed for C-2 and C-3 were similar to those 
observed in 2.3, while the downfield shift of C-1 from δ 34.6 to 65.4 indicated the possible 
presence of a hydroxyl group at this carbon. The substitution of a secondary alcohol functionality 
at C-1 was also consistent with the requirements of the molecular formula. Again, the signal 
corresponding to NH-18 in the 1H NMR spectrum of 2.4 was absent, while the C-17 signal, 
observed to be approximately 10 ppm further downfield (when compared to the known 
compounds 1.51 – 1.53), confirmed that 2.3 and 2.4 shared the same basic skeleton. In 
accordance with the NMR data of 2.3, the chemical shifts of C-2, C-3, C-4 and C-17 (Table 2.4) 
confirmed the structure of the spiro ring and allowed the formation of the additional ring through a 
bond between N-18 and C-2. Further confirmation of the hexacyclic structure of 2.4 came from 
the HMBC correlation between H-2 and C-17. No COSY correlations were observed between NH-
13 and H-14 suggesting, together with the carbon chemical shift observed for C-14 (δ 118.1) (cf. 
C-14 in 1.51 has a carbon shift of δ 112.4), that a bromine atom was attached at C-14. HMBC 
correlations between H-5 and C-1, C-3, C-4, C-6 and C-7, and between H-2 and C-1, C-3, C-4, C-
17 and C-19 contributed significantly to the structure proposed for 2.4. 
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Figure 2.11 A three dimensional model of 2.5 clearly showing that bromination is possible 
at both positions 1 and 2. (Spartan ’02, Wavefunction, Inc., CA, USA. A semi empirical forcefield 
was used to generate the 3D molecular structure). 
 
The molecular formula C18H18N3O379Br for compound 2.5 (2.6 mg, 0.003 % yield) was determined 
by HRFABMS (m/z 403.0532, M + 1). Compound 2.5 (Figure 2.11) is structurally similar to 
compounds 2.3 and 2.4 from the available NMR data. The proton NMR spectra (Figure 2.12) 
showed eleven non-exchangeable and four exchangeable sets of protons. Once again, a proton 
chemical shift normally attributed to NH-18 was absent. The 13C NMR spectrum (Figure 2.13) 
  H-1 
  OH-2 
  H-1 
  Br-2 
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showed seventeen well resolved carbon signals with a DEPT experiment confirming the presence 
of nine protonated carbons. The DEPT data also revealed four methylene signals (δ 19.4,27.8, 
37.7 and 42.7), two sp3 methines (δ 59.5 and 66.8), three sp2 methine signals (δ 124.9, 126.9, 
131.4); and one sp3 (δ 87.8) and six sp2 quaternary carbons (δ 94.7, 118.6, 122.4, 123.0, 148.3 
and 148.7), and an α,β-unsaturated ketone (δ 166.0), thus accounting for the seventeen carbons 
observed in the 13C NMR spectrum of 2.5. The 13C signal of the spiro carbon C-6 was again not 
observed. The 1H and 13C signals for compound 2.5 were assigned from COSY, HMQC and 
HMBC correlations in the usual manner. The quaternary carbon chemical shifts of the 
pyrroloiminoquinone skeleton for C-10, C-11, C-12, C-19, C-20, C-21 (δ 148.3, 166.0, 123.0, 
148.7, 94.7 and 122.4, respectively) were tentatively assigned by analogy to the respective 
carbon chemical shifts of related compounds (e.g. 1.53, 1.61, 2.3) and confirmed where possible 
using 2D NMR data (Table 2.5). The chemical shift of H-14, initially assigned from its 
characteristic 1H chemical shift (δ 7.29) and later confirmed by HMBC correlations to C-15, C-
12/C-21 (the close proximity of the C-12 and C-21 signals made an unequivocal assignment 
impossible), was assigned to the carbon signal resonating at δ 126.9 from HMQC data. Two of 
the four methylene carbon signals assigned to C-16 and C-17 (Table 2.5) were initially assigned 
using the characteristic C-16 chemical shift (δ 19.4) and later confirmed by a combination of 
COSY and HMQC correlations. The absence of an NH-18 exchangeable proton (~ δ 8 ppm) in the 
1H NMR spectrum suggested that 2.5 possessed the same hexacyclic structure as 2.3 and 2.4. 
 
2.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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H-3 H-17
H-4
H-14
OH-3
OH
H-5 H-16
H-7
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NH-13 NH-9
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Figure 2.12 1H NMR spectrum of 2.5 (400 MHz, DMSO-d6) with the NH-9 and NH-13 
protons offset. 
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The deshielded carbon chemical shift at δ 66.8 was assigned to C-3, and is consistent with an 
hydroxyl functionality attached to this carbon. HMQC data placed the oxymethine proton on C-3 
(δH 4.18, δC 66.8), with the H-3 proton subsequently showing COSY correlations to H-4 and H-5. 
The fact that the C-3 signal was shifted slightly further upfield than usual (Figure 2.13) indicated 
the possible presence of a strong electron withdrawing group on a neighbouring carbon i.e. either 
C-2 or C-4. Since C-4 was clearly an sp2 methine signal, the upfield shift was attributed to the 
substituent present on C-2 (an sp3 quaternary carbon). COSY correlations between two of the sp2 
methine signals at δ 5.75 and 5.99 and their subsequent attachment to the carbon signals 
resonating at δ 124.9 and 131.4 from HMQC data, resulted in the assignment of these signals as 
C-4 and C-5.  
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Figure 2.13 Comparison of the 13C NMR spectra (100 MHz, DMSO-d6) of the structurally 
similar compounds 2.3 (a), 2.4 (b) and 2.5 (c). *Note the positions of the signals for 
carbons 1, 2, 3 and 17  (δ 40 – 90 ppm) in particular. 
 
According to the molecular formula, two substituents (a hydroxyl group and a bromine atom) 
remained to be assigned and could therefore only reside on either C-1 or C-2. C-1 is an sp3 
methine signal and was assigned to the carbon resonance at δ 59.5 (following HMBC correlations 
observed between H-1 and C-2, C-7, C-8 and C-20, as well as between H-5 and C-1), while C-2 
was assigned as an sp3 quaternary carbon resonating at δ 87.8 (also following HMBC correlations 
from H-1). Since the carbon shift for C-3 is further upfield than usual, the stronger electron 
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withdrawing substituent, i.e. the hydroxyl group, is tentatively assigned to C-2. This is in 
agreement with the chemical shift of C-1 at δ 59.5 which implicates a substituent such as bromine 
at this carbon. In support of this rather unusual structure, d’ Ambrosio et al. isolated epinardin A8 
(1.67) from an unidentified deep water Antarctic sponge reported the resonance of the C-1 and C-
2 signals at δ 44.8 and 89.0 respectively, which may support our C-1 and C-2 assignments for 
2.5. 
N
N
N
H O H
OH
HO
 
1.67 
 
Table 2.5 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 2.5. 
 
Atom No. δC δH (mult, J, Hz)  COSY HMBC 
C1 59.5 (d) 4.85 (s), 1H - C2, C7, C8, C20 
C2 87.8 (s)    
C3 66.8 (d) 4.18 (d), 1H, 3.0 Hz H4, H5 - 
C4 124.9 (d) 5.75 (dd), 1H, 14.2 Hz H3, H5 C2, C5, C8 
C5 131.4 (d) 5.99 (d), 1H, 9.9 Hz H3, H4 C1, C3, C7, C8 
C6 -*    
C7 27.8 (t) 1.84 (d), 1H, 12.9 Hz 
2.04 (m), 1H 
H8 
H8 
C5, C8 
C5, C8 
C8 37.7 (t) 3.68 (m), 2H H7 - 
NH-9  9.87 (s), 1H - - 
C10 148.3 (s)    
C11 166.0 (s)    
C12 123.0 (s)    
NH-13  13.08 (s), 1H - - 
C14 126.9 (d) 7.29 (s), 1H - C15, C12/C21 
C15 118.6 (s)    
C16 19.4 (t) 2.94 (m) , 2H H17 C15, C17 
C17 42.7 (t) 3.87 (m) , 1H 
3.96 (m), 1H 
H16 
H16 
C15, C16, C19 
NH-18  - -  
C19 148.7 (s)    
C20 94.7 (s)    
C21 122.4 (s)    
OH -1/2   5.86 (s), 1H -  
OH-3  7.39 (s), 1H -  
*Signal assumed to be under the DMSO-d6 solvent peak. 
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h) 2,4-debromo-3-dihydro-discorhabdin C (2.6) 
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Mass spectral analysis of the salt 2.6 (1.2 mg, 0.001 % yield) provided a molecular formula for 
C18H18N3O2 (M+, m/z 308.1400, ∆ +0.1). The proton NMR spectra (Figure 2.14) revealed eight 
non-exchangeable and four exchangeable sets of protons. A well-resolved 13C NMR spectrum of 
only a milligram of sample material did not unexpectedly prove difficult to obtain even after 65 000 
scans (fortunately, recourse to HMQC and HMBC data provided sufficient information to assign 
the 13C data) and the structure is thus assigned by comparison with literature values42,52 and the 
available 2D NMR data.  
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 Figure 2.14 1H NMR spectrum with the proton assignments for 2.6 (400 MHz, DMSO-d6). 
 
HMQC correlations provided the characteristic carbon assignment for C-16 (δ 18.1). Following the 
establishment of the C-16 and H2-16 assignments, COSY correlations showed H2-16 to be 
coupled to H2-17, which in turn were attached to a carbon at δ 42.3. Following the observation of 
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a long range COSY correlation from H2-16 to H-14 (δ 7.34), HMQC data (Figure 2.15) 
subsequently provided the 13C chemical shift of C-14 (δ 127.2). HMBC correlations from H-14 to 
carbons resonating at δ 118.7 and 123.3 resulted in the assignment of C-15 and C-12 or C-21 
(the latter two carbons often resonate close to each other). However, because H2-16 also 
exhibited an HMBC correlation to the signal at δ 123.3, this resonance was assigned as C-21. A 
COSY correlation between H2-17 and one of the exchangeable protons provided the assignment 
of NH-18 (δ 10.41), which is shifted further downfield than expected (cf. compounds 1.51 – 1.53). 
HMBC correlations from H2-17 to carbons resonating at approximately δ 118.7 and 157.0 yielded 
the chemical shifts for C-15 and C-19 respectively.  
 
Table 2.6 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 2.6. 
 
Atom No. δC δH (mult, J, Hz)  COSY HMBC 
C1 129.8 (d) 7.04 (d), 2H, 8.1 Hz H-2/H-4 C5, C7, C10 
C2 115.5 (d) 6.70 (d), 2H, 8.1 Hz H-1/H-5 C1/C5, C4, C10 
C3 84.1 (d) 5.46 (s), 1H  C-21 
C4 115.5 (d) 6.70 (d), 2H, 8.1 Hz  C1/C5, C2, C10 
C5 129.8 (d) 7.04 (d), 2H, 8.1 Hz  C1, C7, C10 
C6 - -   
C7 32.6 (t) 2.79 (t), 2H, 16.0 Hz H-8 C1/C5, C8  
C8 45.2 (t) 3.47 (q), 2H, J7,8  16.0 Hz 
J8,NH9 7.2 Hz 
H-7, NH-9 C1/C5, C10/C20 
NH-9  9.02 (t), 1H, 7.2 Hz H-8  
C10 155.9 (s)    
C11 - -   
C12 - -   
NH-13  13.09 (s), 1H H-14  
C14 127.2 (d) 7.34 (s), 1H NH-13, H-16 C15, C21  
C15 118.7 (s) -   
C16 18.1 (t) 2.88 (t), 2H, 7.6 Hz H-14 (lr), H-17 C14, C15, C17, C21 
C17 42.3 (t) 3.81 (t), 2H, 7.6 Hz H-16, NH-18 C16, C15, C19 
NH-18  10.41 (s), 1H H-17  
C19 157.0 (s) -   
C20 - -   
C21 123.3 (s) -   
OH - 9.27 (s), 1H  C2/C4, C10 
 
COSY correlations between H2-8 and H2-7, and also to the exchangeable proton NH-9 (δ 9.02), 
established the proton chemical shifts as δ 3.47 (q, J = 16.0, 7.2 Hz), 2.79 (t, J = 16.0 Hz) and 
9.01 (t, J = 7.2 Hz), respectively. HMQC data revealed that H2-8 and H2-7 resided on carbons 
resonating at δ 45.2 and 32.6 respectively, while the methylene spin system at δ 7.04 (d, 2H, J = 
8.1 Hz) was positioned on a carbon at δ 129.8 (C-1), which was in turn (from the COSY data) 
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coupled to a spin system at δ 6.70 (d, 2H, J = 8.1 Hz) attached to a carbon at δ 115.5 (C-2). The 
olefinic 1H NMR resonances for the spiro ring (δ 6.70 and 7.04) integrated to two protons each 
suggesting that they were overlapping signals in a symmetrical magnetically equivalent 
environment. Only two protons remained to be assigned. The proton residing at δ 5.46 (s, 1H) 
was shown via the HMQC experiment to be attached to a carbon resonating at δ 84.1, which 
implied that the substituent attached to this carbon is a strong electron withdrawing group e.g. a 
hydroxyl functionality.  The molecular formula allowed for an additional hydroxyl group and this is 
in agreement with the 13C shift observed. Therefore, despite the absence of 13C NMR data, the 
relative simplicity of this very minor metabolite and the adequate HMQC/HMBC data enabled the 
structure of this compound to be tentatively proposed as a 2,4-debrominated analogue of 3-
dihydrodiscorhabdin C (1.53). 
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Figure 2.15 A section (F1 = δ 15 – 140 ppm, F2 = δ 1.0 – 8.0 ppm) of the HMQC 
spectrum of compound 2.6 (400/100 MHz, DMSO-d6). (Imp = impurity). 
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Chapter 3: Pyrroloiminoquinone metabolites from Latrunculia lorii  
 
3.1 Introduction 
 
A second latrunculid sponge was collected off Riy Banks in Algoa Bay during the summer of 
1999. The sponge was collected as part of a collaborative research programme between Rhodes 
University, the NCI and the Coral Reef Research Foundation (CRRF).  
 
The 1H NMR spectrum of the crude methanol extract of Latrunculia lorii showed typical 
discorhabdin signals. The crude extract was fractionated by a sequence of solvent-solvent 
partitioning, preparative C18 chromatography, semi-preparative reversed phase high performance 
liquid chromatography and molecular exclusion (LH-20) chromatography. Five known 
compounds; makaluvamine C,30 damirone B,25 makaluvic acid A,34 discorhabdin G*,37-39 and 
discorhabdin M37-39 (1.33, 1.20, 1.47, 3.1, 3.2), and three new pyrroloiminoquinones; 1-amino 
discorhabdin D (3.3), 1-methoxy discorhabdin D (3.4) and 1-alanyl discorhabdin D (3.5) were 
subsequently isolated, and characterised, from L. lorii (Figure 3.1). Although compounds 3.1 and 
3.2 are known, their data as yet remains unpublished and will be presented in this Chapter. In 
addition, since there are two have been two structures assigned the trivial name discorhabdin G, 
the discorhabdin isolated from this sponge refers to the compound isolated by Munro et al. 37-39 
and will be referred to as discorhabdin G*.  
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Figure 3.1 Summary of the compounds obtained from L. lorii. 
Chapter 3: L. lorii 
 
 70
The range of compounds isolated from the L. lorii sponge is characterised by simple tricyclic 
pyrroloiminoquinones, a substituted bicyclic pyrrolecarboxylic acid and five discorhabdin type 
metabolites, all of which, with the exception of discorhabdin G* (3.1), contain a discorhabdin D 
basic skeleton.  
 
3.2 Results and Discussion 
 
3.2.1 The taxonomy of the encrusting sponge Latrunculia lorii 
 
 
 
 Figure 3.2 An underwater photograph of L. lorii. 
 
A taxonomic description of L. lorii (OCDN 6428-V) by Kelly and Samaai55 follows: “The sponge 
was collected at -24 m on Riy Banks, Algoa Bay, South Africa, on 23 February 1999, and is 
encrusting, 10 mm thick in life, growing in 50 cm square patches, with only spherical areolate 
porefields and conical oscules visible through a dense covering of algal epiphytes and sand. The 
texture is compressible and fleshy, the colour in life olive to very dark emerald green. The sponge 
is an undescribed species of Latrunculia (Order Poecilosclerida: Family Latrunculiidae), similar to 
recently described Latrunculia oxydiscorhabda Alvarez, Bergquist & Battershill, 2002 from New 
Zealand, but lacks oxydiscorhabd spicules present in L. oxydiscorhabda.” The sponge has been 
named Latrunculia lorii and a taxonomic description of this new sponge is in preparation. Voucher 
specimens are held at CRRF, NIWA, Rhodes University and the Smithsonian Institution.  
 
3.2.2 Extraction and isolation of pyrroloamino-ortho-quinone and pyrroloiminoquinone 
metabolites from L. lorii 
 
The frozen latrunculid sponge was thawed and extracted three times with methanol and then 
once with methanol : dichloromethane (1:1). The combined extracts were concentrated and 
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subjected to a modified Kupchan partition procedure to give hexane, chloroform, n-butanol and 
aqueous methanol partition fractions (Scheme 3.1). 
 
Solvent extraction
Solvent partitioning
Hexane Aq. MeOH C18 SepPak (Gradient Elution)
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HPLC
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HPLC
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     HPLC
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LH-20 (MeOH)
Concentrated Aqueous MeOH : CH2Cl2 extract 
Latrunculia Lorii (dry mass after extraction 138.2 g)
 
 
Scheme 3.1 Scheme for the extraction and isolation of pyrroloamino-ortho-quinone 
pyrroloiminoquinone metabolites from L. lorii. The masses and yields (calculated relative 
to the dry mass of the sponge) of the L. lorii pyrroloiminoquinone metabolites are 
summarised below: 
 
006C, 008D, 018E 1.33 22.6 mg 0.02 % 
004P, 007M, 014B 1.20 70.2 mg 0.05 % 
017G 1.47 2.7 mg 0.002 % 
010J, 013H 3.1 18.2 mg 0.01 % 
007K, 018F 3.2  35.1 mg 0.03 % 
007L, 013D 3.3 56.9 mg 0.04 % 
013I 3.4 4.1 mg 0.003 % 
007P 3.5 16.3 mg 0.01 % 
 
The chloroform and n-butanol partition fractions were adjudged from their 1H NMR spectra to 
contain discorhabdin-type compounds and therefore selected for further purification. Following 
solid phase extraction, reversed phase HPLC and LH-20 chromatography, the n-butanol fraction 
was found to contain the more complex discorhabdins (3.1 – 3.3 and 3.5) together with the 
simpler pyrroloiminoquinones (1.20 and 1.47), while the chloroform fraction afforded the 
compounds 1.33, 1.20, 1.47, 3.1 - 3.4. 
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3.2.3 Structure elucidation of pyrroloamino-ortho-quinone and pyrroloiminoquinone metabolites 
from L. lorii 
 
a) Makaluvamine C (1.33) 
 
N
N
H
O
NH2
CH3
1
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4
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9
2a 5a
8a
8b
 
1.33 
 
The known compound makaluvamine C (1.33) (22.6 mg, 0.02 % yield) showed a molecular ion at 
m/z 202.0980 by HRFABMS analysis, in agreement with the molecular formula C11H12N3O.  
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Figure 3.3 1H NMR spectrum for 1.33 (400 MHz, DMSO-d6) with the signals for the three 
NH protons offset. Note: The water signal in the 1H NMR spectrum is quite small 
compared to the previous spectra obtained due to the higher concentration of the sample.  
 
The 13C NMR spectrum revealed eleven well resolved resonances comprising two sp2 methine 
signals (δ 126.5 and 85.4), four sp2 quaternary signals (δ 156.5, 123.3, 123.2 and 117.7), two 
methylene sp3 signals (δ 18.8 and 52.5), one methyl signal at δ 38.9, as well as the characteristic 
pyrroloiminoquinone core carbon resonances at δ 155.6 (C-5a), 156.5 (C-7), 167.3 (C-8). 
Characteristic pyrroloiminoquinone resonances in the 1H NMR spectrum of 1.33 (Figure 3.3) 
included mutually coupled methylene signals at δ 2.91 (t, J = 7.6 Hz, H-3) and 3.89 (t, J = 7.6 Hz,  
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H-4), a pyrrole H-2 proton at δ 7.26, an olefinic proton resonance at δ 5.73 (H-6), an N-Me signal 
at δ 3.31, together with the exchangeable proton signals at δ 8.61 (1H, s, NH-9a), 9.43 (1H, s, 
NH-9b) and 13.07 (1H, s, NH-1). Upon comparison of the 1H NMR data of 1.33 with the published 
values for makaluvamine C, the methyl group was placed on N-5, in accordance with the NH-1 
and the N-Me proton chemical shifts (δH 13.10 and 3.31) reported for makaluvamine C (1.33).1 
 
b) Damirone B (1.20) 
NH
N
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O
CH3
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1.19 R = Me 1.20 R = H 
 
HRFABMS established the molecular formula C11H11N2O2 (m/z 203.0821) for compound 1.20 
(70.2 mg, 0.05 % yield). The 1H NMR spectrum was relatively simple and revealed five sets of 
non-exchangeable protons, including an indole proton at δ 7.06 (d), an sp2 methine at 5.20 (s), 
two mutually coupled sp3 methylene signals at δ 3.61 (t, J = 6.6 Hz, H-4) and 2.81 (t, J = 6.6 Hz, 
H-3) and a methyl signal at 3.05 (s). Two exchangeable protons corresponding to NH-1 (δ 12.42) 
and NH-5 (δ 6.66) were also observed. The 13C NMR spectrum (CD3OD) contained two α,β-
unsaturated carbonyl signals at δ 177.5 (s) and 170.2 (s) together with six pyrroloiminoquinone 
core olefinic signals at δ 153.8 (s), 124.7 (s), 124.2 (s), 124.0 (d), 116.4 (s) and 92.6 (d), two sp3 
methylene signals at δ 51.3 and 19.6 and, finally, a methyl signal at δ 37.8. Placement of the 
methyl on position N-5 was based on comparison of the NMR data of 1.20 with known 
compounds damirone A (1.19) and B (1.20).25 The N5-methyl signal in the 13C NMR spectrum of 
for damirone B resonated at δ 38.6, compared to δ 39.8 for 1.19, while the N-1-methyl carbon 
chemical shift for 1.19 occurred at δ 35.9 (360/90 MHz, CD3OD).25 
 
c) Makaluvic acid A (1.47) 
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1.47 
The known pyrrolecarboxylic acid, makaluvic acid A (1.47) (2.7 mg, 0.002 % yield) was identified 
by comparison of its MS, 1H and 13C NMR data with published values.34 A protonated molecular 
formula of C9H11N2O3 was established for 1.47 by HRFABMS (m/z 195.0760, ∆ –1.0 mmu) and 
supported by 13C NMR data. The 13C NMR spectrum revealed the presence of one sp2 methine at 
δ 118.2 (d) and three sp2 quaternary carbons at δ 123.2, 122.1 and 115.1. 13C NMR signals at 
165.0 (s) and 159.8 (s) indicated the presence of carboxylic acid and amide functionalities when 
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compared with the spectra of the makaluvic acids. Inspection of the 1H NMR spectrum (Figure 
3.4) revealed four non-exchangeable and two exchangeable sets of protons at δ 12.29 (1H, br s, 
NH-1) and 16.05 (1H, s, OH-8). As expected, the position of the COOH 1H NMR signal was found 
to be dependent on both the solvent, the concentration of the sample solution and the presence of 
other exchangeable protons. Very broad signals are induced by intermediate rates of proton 
exchange (i.e. neither fast nor slow), resulting in the signals occasionally not being detected.97 For 
example, the COOH signal observed in the 1H NMR spectrum of 1.47 (Figure 3.4) was a sharp 
singlet, while the proton signals corresponding to hydroxyl group functionalities for compound 4.1 
(Figure 4.5) are broad. Two mutually coupled sp3 methylene signals at δ 2.81 (2H, t J = 7.1 Hz, H-
3) and 3.63 (2H, t, J = 7.1 Hz, H-4), together with a methyl singlet (δ 3.06) and a doublet at 6.89 
(1H, J = 2.8 Hz, H-2) led to structure 1.47 for makaluvic acid A. The 13C and 1H NMR data for 1.47 
is in accordance with the literature values for makaluvic acid A.34  
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Figure 3.4 1H NMR spectrum for makaluvic acid A (1.47) (400 MHz, DMSO-d6) with the 
signals for the NH and OH protons offset.  
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The 1H NMR spectrum of compound 3.1 was found to be consistent with that of discorhabdin G 
first proposed by Munro et al.37-39 Unfortunately the relative inaccessibility of Munro et al.’s fully 
assigned spectral data necessitated a complete assignment of the NMR data for 3.1 from careful 
analysis of both 1D and 2D NMR data (described below and presented in Table 3.1). As 
discussed in Chapter One, the inaccessibility of the data for Munro et al.’s discorhabdins E-M in 
the mainstream chemical literature has led to a number of inconsistencies in the naming of 
discorhabdins in the A –Z sequence. Yang et al.’s published structure for a compound they 
named discorhabdin G (1.56) from the Antarctic sponge Latrunculia apicalis45 reflects the 
confusion that abounds in the literature. To avoid confusion with Yang et al.’s structure for 
discorhabdin G, compound 3.1 is referred to as discorhabdin G*. Even though Munro’s 
discorhabdin G has been renamed discorhabdin I in a subsequent review,22 we have retained the 
former name for the sake of simplicity and clarity. 
 
A molecular ion at m/z 336.0807 was established by HRFABMS for compound 3.1 (18.2 mg, 0.01 
% yield) suggesting a molecular formula of C18H14N3SO2 for this compound. Thirteen signals were 
observed in the 1H NMR spectrum (Figure 3.5) of 3.1, which, at first glance, appeared quite 
complicated for the 1H NMR spectrum for a typical a discorhabdin skeleton. These signals 
included an indole proton at δ 7.38 (s), two coupled olefinic doublets at δ 7.31 (d) and δ 6.53 (dd), 
a sharp vinylic doublet at δ 6.18, a thiomethine doublet at δ 5.69, methylene multiplets at δ 3.89 
and 3.75, and a multiplet at approximately δ 2.80, as well as an sp3 methylene doublet signals at 
δ 2.73 and 2.33 (dd). The H-8 methine signal (δ 5.69), which resonates at δ 5.37 and 5.60 in 
discorhabdin A and D, respectively, suggested a thioether functionality. The presence of sulfur in 
3.1 was confirmed from the HRFABMS data. 
 
The 13C NMR (Figure 3.6) spectrum of 3.1 showed the expected eighteen well resolved signals, 
with no indication of any overlapped signals. The pyrroloiminoquinone structure followed from 
characteristic carbon signals at δC 165.1, 154.1, 151.0 and 97.1 corresponding to C-11, C-19, C-
10 and C-20. The 13C NMR spectrum indicated two α,β-unsaturated carbonyls at δ 181.0 and 
165.1 corresponding to C-3 and C-11 upon comparison with the published data for discorhabdin A 
(1.57). All the protonated carbon signals were assigned from HMQC data. The proton signal at δ 
5.69, attached to a carbon resonating at δ 60.3, confirmed the thioether functionality implied by 
the molecular formula. Analysis of the COSY spectrum indicated that H-8 (d, J = 3.5 Hz) was 
coupled to two diastereotopic methylene protons at δ 2.73 (d, J = 11.6 Hz) and 2.33 (dd, J = 3.5, 
11.6 Hz) which in turn resided on a single carbon resonating at δ 41.9. The methylene proton spin 
system was thus assigned as H-7.  
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Figure 3.5 1H NMR spectrum of discorhabdin G* (3.1) (400 MHz, DMSO-d6) with the 
signals for the three NH protons offset. (Imp = impurity). 
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Figure 3.6 13C NMR spectrum of discorhabdin G* (3.1) (100 MHz, DMSO-d6). 
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The HMQC data showed that the two proton multiplet at δH 2.80 (H2-16) resided on the carbon at 
δ 17.6 enabling the subsequent assignment of the mutually coupled H2-16 and H2-17 spin 
systems from the COSY data. A three bond HMBC correlation showed H2-16 to be correlated to 
an sp2 methine carbon resonating at δ 127.3 (C-14), which in turn was coupled to NH-13 in the 
COSY experiment. HMBC correlations from H-14, H2-16 and H2-17 provided the assignments of 
C-12, C-15, C-19 and C-21. The COSY experiment also showed the sp2 methine signals at δ 7.31 
(d, J = 9.9 Hz) and 6.53 (dd, J = 9.9 Hz, 1.3 Hz) were coupled and could be assigned as H-1 and 
H-2 respectively. The signal for H-2 appears as a double doublet reflecting the vicinal coupling 
with H-1 (3J1,2 = 9.9 Hz) and long range W coupling with the H-4 proton (4J2,4 = 1.3 Hz). Further 
support for the discorhabdin A (1.57) basic skeleton for 3.1 was established from analysis of the 
HMBC data (Table 3.1). The presence of the spiro cyclohexadienone moiety was confirmed by 
the HMBC correlations from the doublet at δ 7.31 (H-1) to carbons at δC 41.9 (C-7), 48.3 (C-6), 
97.1 (C-20), 169.6 (C-5) and 181.0 (C-3), and from δ 6.53 (H-2) to C-6, C-4 (δ 120.0) and C-3, 
thus completing the structural assignment of 3.1.  
 
Table 3.1 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 3.1. 
 
Atom 
No. 
 
δC 
 
δH (mult, J, Hz)  
 
COSY 
 
HMBC 
C1 145.0 (d) 7.31 (d), 1H, J = 9.9Hz  H-2 C3, C5, C6, C7, C20 
C2 132.5 (d) 6.53 (dd), 1H, J  = 9.9 Hz, 1.3 Hz H-1, H-4 (4J) C3, C4, C6 
C3 181.0 (s) -   
C4 120.0 (d) 6.18 (d), 1H, J  = 1.3 Hz H-2 (4J) C2, C5, C6 
C5 169.6 (s) -   
C6 48.3 (s) -   
C7 41.9 (t) 2.73 (d), 1H, J  = 11.6 Hz  
2.33 (dd), 1H, J  = 3.5 Hz, 11.6 Hz 
H-7b, H-8 
H-7a, H-8 
C1, C5, C6, C8, C20 
C5, C6, C8, C20 
C8 60.3 (d) 5.69 (d), 1H, J  = 3.5 Hz  H-7a, H-7b C5, C6, C7, C10 
NH-9 - 10.65 (br s), 1H -  
C10 151.0 (s) -   
C11 165.1 (s) -   
C12 123.5 (s) -   
NH-13 - 13.27 (s), 1H H-14  
C14 127.3 (d) 7.38 (s), 1H NH-13, H-16 C12, C15 
C15 120.3 (s) -   
C16 17.6 (t) 2.80 (m), 2H H-17 C15, C17, C21 
C17 44.6 (t) 3.89 (m), 1H 
3.75 (m), 1H 
H-16, NH-18 
H-16, NH-18 
C15, C16, C19 
C15, C16, C19 
NH-18 - 8.34 (br s), 1H H-17  
C19 154.1 (s) -   
C20 97.1 (s) -   
C21 122.9 (s) -   
4J = four bond long range COSY coupling. 
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e) Discorhabdin M (3.2) 
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The next four structures all possess a basic discorhabdin D skeleton i.e. containing an additional 
ring formed by a bond from N-18 to C-2 on the spiro ring. Discorhabdin D (1.61, Figure 3.7) was 
first isolated from a New Zealand latrunculid sponge L. brevis (Ridley and Dendy) and was found 
to co-occur with discorhabdin A (1.57).48  
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Figure 3.7 Discorhabdin D (1.61) together with the energy minimised 3D models of its 
two possible C-8 epimers. (Spartan ’02, Wavefunction, Inc., CA, USA. A semi-empirical 
minimization force field was used to generate the 3D model). 
 
A molecular formula of C20H17N4SO4 was inferred from the molecular ion at m/z 409.0971 for 
compound 3.2 (35.1 mg, 0.03 % yield) in the high resolution FABMS spectrum. The 1H NMR 
spectrum of 3.2 in DMSO-d6 (Figure 3.8) showed two olefinic methine signals (δ 7.28 and 6.17) 
and another two deshielded methine resonances at δ 5.68 (d, J = 2.3 Hz, H-8) and 4.34 (d, J = 
2.8 Hz, H-2). Only two exchangeable protons at δ 13.15 (NH-13, s) and 10.75 (NH-9, br s), were 
observed in the 1H NMR spectrum of 3.2, with NH-18 (usually resonating at approximately δH 8.0) 
conspicuously absent.  
 
The 13C (Figure 3.9) and DEPT-135 NMR data revealed all twenty well resolved signals including 
four methylene carbons, five methine carbons and eleven quaternary carbons. Two α,β-
unsaturated ketone carbonyls were evident from the carbon signals at δ 182.9 and 173.4, while 
the iminoquinone moiety was discernible from the signals at δ 166.3, 147.4 and 146.2. A thioether 
functionality was again suggested by the presence of carbon chemical shifts at δ 168.6 (C-5) and 
a carbon resonance at δ 62.2 (C-8). COSY correlations from H-8 (δ 5.68) to H2-7 (δ 3.10 and 
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~2.50) were observed and these assisted the assignment of the carbon chemical shifts for these 
protons via an HMQC experiment (Table 3.2).  
 
The mutually coupled methylene protons H2-16 and H2-17 (assigned via the COSY experiment) 
as well as the indole proton (δ 7.28, s, H-14) were used to assign, and in some cases confirm, the 
carbon resonances of C-11, C-12, C-15, C-19 and C-21 (Table 3.2). The absence of the NH-18 
signal in the 1H NMR spectrum, the lack of a COSY correlation between H2-17 and NH-18 as well 
as HMBC correlations from H-2 to C-17, suggested the formation of an additional ring by a bond 
between N-18 and C-2, as typically found with discorhabdin D skeletons.48 Further evidence in 
support of this basic structure was provided by the presence of a carbon chemical shift at δ 63.8 
(C-2), which certainly complies with the discorhabdin D type skeleton.48 The H-2 (δ 4.34, d, J = 
2.8 Hz) and H-1 (δ 3.63, d, J = 2.8 Hz) methine signals were shown to be coupled in a COSY 
experiment, while their HMBC correlations confirmed their placement as well as the presence of 
the spiro cyclohexadienone moiety. 
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Figure 3.8 1H NMR Spectrum of 3.2 (400 MHz, DMSO-d6) with the signals for the two NH 
protons offset. (Imp = impurity). 
 
All that remained was the assignment and the elucidation of the substituent at position 1. Mutual 
HMBC correlations between H-1 and the sp3 methylene H-2’ signal at δ 47.8 (C-2’), resulted in the 
tentative establishment of a -X1-CH2-X2 fragment (where X1 is a heteroatom and X2 is the 
remainder of the side chain) at position 1. 
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Figure 3.9 13C NMR spectrum of 3.2 (100 MHz, DMSO-d6). 
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3Jbd = 4.5 
2Jcd = -14.5 
 
Interestingly, a large coupling constant was observed for the H2-2’ protons (J = 17.9 Hz). Such 
large coupling constants have been typically observed where the vicinal conformations are fixed 
(3JHH ≈ 0 – 18 Hz), whereas with systems where the conformation is not fixed, the geminal 
coupling constants tend to be 3JHH ≈ 7 Hz.97 Similar large geminal couplings of methylene protons 
(where the conformation is fixed) have been observed in the amino acids tryptophan (3.6) and 
phenylalanine (3.7).97 
 
 
Chapter 3: L. lorii 
 
 81
Table 3.2 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 3.2. 
 
Atom 
No. 
 
δC 
 
δH (mult, J, Hz) 
 
COSY 
 
HMBC 
C1 56.5 (d) 3.63 (d), 1H, J = 2.8 Hz H-2 C2, C2', C3, C5, C20 
C2 63.8 (d) 4.34 (d), 1H, J = 2.8 Hz H-1, H-4 C1, C3, C4, C6, C17, C19 
C3 182.9 (s) -   
C4 113.1 (d) 6.17 (s), 1H H-2, H-7 (lr), H-8 (lr) C2, C5, C6, C20 
C5 168.6 (s) -   
C6 45.9 (s) -   
C7 36.2 (t) 3.10 (m), 1H 
2.50 (m), 1H 
H-7b, H-8 
H-4 (lr), H-7a, H-8 
C5, C6, C8, C20 
C5, C6, C8, C20 
C8 62.2 (d) 5.68 (d), 1H, J = 2.3 Hz H-4 (lr), H-7a, H-7b C5, C6, C10 
NH-9 - 10.75 (br s), 1H -  
C10 146.2 (s) -   
C11 166.3 (s) -   
C12 123.6 (s) -   
NH-13 - 13.15 (s), 1H H-14 C12, C15, C21 
C14 126.7 (d) 7.28 (s), 1H NH-13 C11, C12, C15, C19, C21 
C15 117.5 (s) -   
C16 19.1 (t) 3.00 (m), 2H - C14, C15, C17, C21 
C17 51.1 (t) 4.02 (m), 1H 
3.79 (m), 1H 
H-16, H-17b 
H-16, H-17a 
C15, C16, C19 
C15, C16, C19 
C19 147.4 (s) -   
C20 100.6 (s) -   
C21 121.1 (s) -   
C2' 47.8 (t) 3.52 (dd), 2H, J = 17.9, 31.6 Hz - C1, C3' 
C3' 173.4 (s) -   
NH-1' - 5.30 (br s)* -  
* Note: extremely broad singlet, which may be due to an intermediate rate of exchange with other protons. 
The 1H NMR signal for COOH was not observed and is also likely to be due to an intermediate rate of 
exchange with other protons (Section 3.2.3, c) as well as the presence of other exchangeable protons (i.e. 
NH-9 and NH-13).97 
 
A deshielded carbon resonance at δC 173.4 remained to be assigned and because only the H-2’ 
proton showed a correlation to the carbon at δC 173.4 in the HMBC experiment, the fragment was 
thus altered to -X1-CH2-COOH. The carbon chemical shift for a carboxylic acid carbonyl may be 
accommodated at δ 173.4 (C-3’) and the molecular formula does indeed show an additional two 
oxygen atoms (as opposed to the usual two for discorhabdins) that need to be accounted for. The 
molecular formula required an additional amino group at position 1. The chemical shift at δ 56.5 
(C-1) supported the assignment of an NH substituent at C-1 and confirmed the structure of the 
substituent as –NH-CH2-COOH. The structure obtained for compound 3.2 is thus identical to that 
obtained by Munro et al. and compared favourably to the 1H NMR data (kindly supplied to us by 
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Professor Munro).39 This compound, named initially discorhabdin M,37-39 was later referred to as 
discorhabdin N in a subsequent publication by Urban et al.,22 but the compound lacked a ∆4 
olefin, which is inconsistent with the original 1H NMR spectra supplied by Munro and unfortunately 
contributes to the confusion surrounding the nomenclature of the discorhabdins. We have thus 
retained the former name here. 
 
The 3D model of one of the isomers of 3.2 is shown in Figure 3.10 to give an indication of the 
complexity of the heptacyclic discorhabdin M structure. The stereochemistry at the four chiral 
carbon atoms (C-1, C-2, C-6 and C-8) remains unassigned. 
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Figure 3.10 Proposed structure and three dimensional model for discorhabdin M (3.2) 
with an arbitrarily assigned 1R,* 2S,* 6R,* 8S* configuration. (Spartan ’02, Wavefunction, 
Inc., CA, USA. A semi-empirical minimization force field was used to generate the 3D model). 
 
f) 1-amino discorhabdin D (3.3) 
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The new compound 1-amino discorhabdin D (3.3) (56.9 mg, 0.04 % yield) was identified by 
comparison of its MS and 1H (Figure 3.11) and 13C NMR data with 3.2. A molecular formula of 
C18H15N4SO2 was established for 3.3 by HRFABMS (M+, m/z 352.0995 (∆ +0.1 mmu)) and 
supported by 13C NMR data.  
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Figure 3.11 1H NMR spectrum of 1-amino discorhabdin D (3.3) (400 MHz, DMSO-d6) with 
the signals for the two NH protons offset. (Imp = impurity). 
 
The 13C and DEPT 135 NMR spectrum revealed the presence of eighteen well resolved carbon 
signals with two sp2 methine signals at δ 126.8 and 112.7, three sp3 methine signals at δ 66.6, 
65.7 and 62.3, only three sp3 methylene signals at δ 50.9, 35.9 and 19.1, one sp3 quaternary at δ 
46.8, eight sp2 quaternary carbons as well as an α,β-unsaturated carbonyl at δ 182.5 (Table 3.3). 
Inspection of the 1H NMR spectrum (Figure 3.11) revealed nine non-exchangeable and only two 
clearly exchangeable protons at δ 13.20 (1H, s) and 10.81 (1H, br s). Once again, the absence of 
an NH-18 proton signal, together with a methine doublet at δ 5.66 (d, J = 2.5 Hz, H-8) and the 
presence of only three methylene groups (from the DEPT 135 data) suggested the presence of a 
discorhabdin D skeleton with its thioether functionality. A COSY experiment established the 
contiguous coupling sequence between H-8 and NH-9 and the two protons at δ 2.77 (1H, dd, J = 
3.5 Hz, 12.1 Hz, H-7b) and possibly at δ 2.50 (m, H-7a). The HMQC experiment showed that H-8 
was attached to a carbon at δ 62.3, which is in accordance with the expected 13C chemical shift of 
C-8 in a discorhabdin D skeleton, and that the protons at δ 2.77 (H-7b) and 2.50 (H-7a) resided 
on the same carbon at δ 35.9 (C-7).  
 
H-1 (δ 4.55) and H-2 (δ 4.15) were shown to be mutually coupled by a COSY experiment and the 
difficulty in the structure determination of 3.3 lay in assigning the carbon chemical shifts at δ 66.6 
and 65.7 to either C-1 or C-2. HMBC correlations from H-4 and H-7 to carbon resonances at δ 
65.7 (C-2) and 66.6 (C-1) respectively, were noted. Based on previous observations e.g. 3.1 and 
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3.2 that H-4 displays HMBC correlations to C-2 and similarly H-7 to C-1, enabled a tentative 
assignment of C-1 and C-2. The molecular formula requires an additional amino group and as C-1 
is a methine carbon resonating at δ 66.6, a primary amine functionality is thus assigned to C-1. 
The possibility of a hydroxyl functional group was eliminated on the basis of the requirements of 
the molecular formula, as well as the carbon chemical shift obtained for 3.3.  
 
Table 3.3 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 3.3.   
 
Atom 
No. 
 
δC 
 
δH (mult, J, Hz) 
 
COSY 
 
HMBC 
C1 66.6 (d) 4.55 (d), 1H, J = 3.5 Hz H-2  
C2 65.7 (d) 4.15 (d), 1H, J = 3.5 Hz H-1  
C3 182.5 (s) -   
C4 112.7 (d) 6.16 (s), 1H H-7b (lr) C2, C5, C6 
C5 169.0 (s) -   
C6 46.8 (s) -   
C7 35.9 (t) 2.77 (dd), 1H, J = 3.5 Hz, 12.1 Hz 
2.50 (m) 
H-7b, H-8 
H-4 (lr), H-7a, H-8 
C1, C5, C6, C17 
C1, C5, C6, C17 
C8 62.3 (d) 5.66 (d), 1H, J = 2.5 Hz H-7a, H-7b C5, C6 
NH-9 - 10.81 (br s), 1H -  
C10 146.7 (s) -   
C11 166.2 (s) -   
C12 123.6 (s) -   
NH-13 - 13.20 (s), 1H H-14  
C14 126.8 (d) 7.27 (s), 1H NH-13 C15 
C15 117.6 (s) -   
C16 19.1 (t) 3.01 (m), 2H -  
C17 50.9 (t) 4.04 (m), 1H 
3.78 (m), 1H 
H-16, H-17b 
H-16, H-17a 
C5 
C19 147.5 (s) -   
C20 99.9 (s) -   
C21 121.1 (s) -   
NH-1' - 4.10 (br s) -  
 
The signals for the amine protons were not observed in the 1H NMR spectrum of 3.3. Because of 
the rapid intermolecular exchange of amine protons, the coupling of amine protons with vicinal 
hydrogen atoms is usually not seen in aliphatic amines.97 Where the exchange rate is slower, 
however, coupling with neighbouring hydrogen atoms is usually detected (splitting is often 
observed), for example with aromatic amines, amides and enamines. In addition, the signals 
belonging to NH protons are often broad (Figure 3.11, for example NH-9) due to intermediate 
exchange rates. The amino and especially ammonium proton signals are broadened further due 
to the 14N-1H coupling which is only partly eliminated by the quadrupole relaxation of 14N (spin 
quantum number, I = 1; natural abundance, 99.6 %; 1JNH ≈ 60). Sharp multiplets are, however, still 
Chapter 3: L. lorii 
 
 85
observed for neighbouring H atoms, as this line broadening has no effect on the vicinal H-C-N-H 
coupling.97 
 
The HMBC correlations established by the remaining mutually coupled sp3 methylene signals at δ 
3.01 (2H, m, H-16) and 4.04 (1H, m, H-17b) and 3.78 (1H, m, H-17a), together with the indole 
proton at δ 7.27 (which showed a COSY correlation to NH-13 and was thus assigned as H-14) 
enabled, through HMBC correlations, the carbon chemical shift assignments for the 
pyrroloiminoquinone core structure of 3.3 (Table 3.3).    
 
g) 1-methoxy discorhabdin D (3.4) 
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1-Methoxy discorhabdin D (3.4) (4.1 mg, 0.003 % yield) exhibited a molecular ion peak at m/z 
366.0912 (∆ -0.1 mmu) in the HRFABMS spectrum corresponding to a molecular formula of 
C19H16N3SO3. The 1H NMR spectrum in DMSO-d6 (Figure 3.12) showed eleven non-
exchangeable and, once again, only two exchangeable protons corresponding to NH-9 and NH-
13 at δ 10.84 and 13.16 respectively.  
 
The non-exchangeable signals appeared as two sp2 methine signals at δ 7.30 (d, J = 2.3 Hz, H-
14) and 6.19 (s, H-4), three sp3 methylene signals at δ 2.74 (d, J = 3.5 Hz, 12.1 Hz, H-7b) and 
2.59 (d, J = 12.1 Hz, H-7a), 3.05 (m, H2-16) together with δ 4.05 (m, H-17b) and 3.83 (m, H-17a), 
three sp3 methine signals at δ 4.30 (d, J = 3.3 Hz, H-1), 4.57 (d, J = 3.3 Hz, H-2) and at 5.65 (d, J 
= 2.3 Hz, H-8). A methyl signal at δ 3.50 (s, H-1’) suggested the presence of a methoxy 
substituent. The 13C NMR spectrum (Figure 3.13) showed eighteen well resolved signals with 
typical quaternary pyrroloiminoquinone carbons resonating at δ 166.1 (C-11), 146.7 (C-10), 123.6 
(C-12), 147.4 (C-19), 99.3 (C-20), and 121.0 (C-21). An α,β-unsaturated carbonyl signal (C-3) 
resonating at δ 182.5 was again observed and the above assignments were later confirmed 
through the use of 2D NMR experiments. A DEPT 135 experiment revealed the presence of four 
methine signals at δ 75.8, 62.1, 112.81 and 126.9 and, upon comparison with the 13C NMR data 
of 3.3, the latter two were assigned as C-4 and C-14 respectively and confirmed through 2D NMR 
experiments. In addition, three sp3 methylene signals at δ 35.6 (C-7), 19.1 (C-16) and 51.0 (C-17) 
as well as a methyl carbon at δ 58.3 (C-1’) were observed. In accordance with the methoxy 
singlet observed in the 1H NMR spectrum, the carbon chemical shift at δ 58.3 confirmed a 
methoxy type substituent. 
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Figure 3.12 1H NMR spectrum for 3.4 (400 MHz, DMSO-d6) with the signals for the three 
NH protons offset. (Imp = impurity). 
 
Various COSY and HMQC correlations once again established the assignments of C-7 and C-8 
as well as C-16 and C-17, with the spin system at δH 5.65 (H-8) and δC 62.1 (C-8) implying a 
thioether functionality as obtained with the previous compounds. A discorhabdin D type skeleton 
was evident from the absence of a NH-18 proton signal, the lack of a COSY correlation and the 
long range HMBC correlation from an sp3 methine proton resonating at δ 4.57 to C-17, which also 
resulted in the assignment of the proton as H-2. The 13C NMR spectrum of 3.7 (Figure 3.13) only 
showed eighteen of the expected nineteen carbon resonances. The HMQC data revealed that H-
2 was shown to be attached to the same carbon at δ 62.1 as H-8 (Figure 3.14). An enlargement 
of the carbon signals at δ 62 ppm showed the carbon signal to be slightly broader than the carbon 
signal corresponding to C-1’ (see offset resonances in Figure 3.13) suggesting that C-2 and C-8 
were overlapped. A COSY correlation showed that H-2 was coupled to H-1 (δ 4.30, d, 1H) 
whereas an HMQC experiment showed H-1 to be attached to a carbon resonating at δ 75.8, 
implicating a strong electron withdrawing group residing on C-1, which therefore supported the 
placement of the methoxy substituent at position 1. This was confirmed through an HMBC 
correlation (Table 3.5) between H-1 and C-1’ (OMe).  
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Figure 3.13 13C NMR spectrum for 3.4 (100MHz, DMSO-d6) with the expansions for C-2, 
C-8 and C-1’ offset. 
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Figure 3.14 A section (F1 = δ 15 – 130 ppm, F2 = δ 2.0 – 7.5 ppm) of the HMQC 
spectrum of compound 3.4 (400/100 MHz, DMSO-d6). (Imp = impurity). 
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The final quaternary carbon resonating at δ 168.9 was initially assigned by a process of 
elimination, and later confirmed, as C-5 from comparison with the 13C NMR data of compounds 
3.1 and 3.2 and discorhabdin D (1.61). Methoxy substituents have not been reported in the 
discorhabdins and this may suggest that compound 3.4 is an artefact. 
 
Table 3.4 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 3.4. 
 
Atom 
No. 
 
δC 
 
δH (mult, J, Hz) 
 
COSY 
 
HMBC 
C1 75.8 (d) 4.30 (d), 1H, J = 3.3 Hz H-2 C3, C5, C1' 
C2 62.1 (d) 4.57 (d), 1H, J = 3.3 Hz H-1, H-4 C1, C3, C6, C17, C19 
C3 182.5 (s) -   
C4 112.8 (d) 6.19 (s), 1H H-2, H-7 (lr) C2 / C8, C5, C6 
C5 168.9 (s) -   
C6 45.9 (s) -   
C7 35.6 (t) 2.74 (d), 1H, J = 3.5 Hz, 12.1 Hz 
2.59 (d), 1H, J = 12.1 Hz 
H-7b, H-8 
H-7a, H-8, H-4 (lr) 
C5, C6, C20 
C5, C6, C2 / C8, C20 
C8 62.1 (d) 5.65 (d), 1H, 2.3 Hz H-7a, H-7b, NH-9 C5, C6, C10 
NH-9 - 10.84 (br s), 1H H-8  
C10 146.7 (s) -   
C11 166.1 (s) -   
C12 123.6 (s) -   
NH-13 - 13.16 (s), 1H H-14  
C14 126.9 (d) 7.30 (d), 1H, J = 2.3 Hz NH-13, H-16 C15, C12, C21 
C15 117.6 (s) -   
C16 19.1 (t) 3.05 (m), 2H H-14, H-17 C14, C15, C17, C21 
C17 51.0 (t) 4.05 (m), 1H 
3.83 (m), 1H 
H-16, H-17b 
H-16, H-17a 
C15, C16, C19 
C16, C19 
C19 147.4 (s) -   
C20 99.3 (s) -   
C21 121.0 (s) -   
C1' 58.3 (q) 3.50 (s), 3H - C1 
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The structure of 3.5 (16.3 mg, 0.01 % yield) was in part established from comparison of the NMR 
data for compounds 3.2, 3.3 and 3.4 with the data obtained for 3.5 and supported by careful 
analysis of the 2D NMR data. Analysis of the HRFABMS spectrum gave an M+ peak at m/z 
423.1127 corresponding to a molecular formula of C21H19N4SO4 for 3.5.   
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Figure 3.15 1H NMR spectrum showing the absence and presence of exchangeable 
protons NH-9 and NH-13 in 3.5 (400 MHz) in a) CD3OD and b) DMSO-d6 respectively. 
The NH-9 and NH-13 signals are offset. (Imp = impurity). 
 
The 1H NMR spectrum of 3.5 (Figure 3.15) revealed a number of overlapped non-exchangeable 
signals as well as the now familiar two exchangeable protons (corresponding to NH-9 and NH-
13). Inspection of the 13C and DEPT 135 NMR data revealed twenty one well resolved carbon 
signals with two α,β-unsaturated carbonyl resonances at δ 182.9 (C-3), 166.2 (C-11) and 172.5 
(C-3’), in addition to two sp2 methines at δ 113.1 and 126.7 (initially assigned and eventually 
confirmed as C-4 and C-14 respectively (on comparison with the NMR data of compounds 3.2, 
3.3 and 3.4), and four sp3 methine signals at δ 63.7, 62.1, 56.4, and 51.2, four sp3 methylene 
resonances at δ 51.0, 47.7 36.1 and 19.1. The quaternary carbon resonances for the 
pyrroloiminoquinone core structure were also clearly evident at δ 146.2 (C-10), 166.2 (C-11), 
123.5 (C-12), 117.5 (C-15), 147.4 (C-19), 100.6 (C-20) and 121.1 (C-21), while an sp3 quaternary 
carbon at δ 45.8 was initially assigned and later confirmed as C-6 from the HMBC data. The 
HMQC data verified that the proton resonating at δ 5.68 (d, H-8) was attached to a carbon 
resonating at δ 62.1 implying a thioether functionality, while a carbon signal at δ 168.5 (C-5) 
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supported the thioether assignment. HMBC correlations from a proton at δ 6.17 (H-4) to C-2, C-5, 
C-6 and C-20 positioned C-4 as well as providing the initial assignment of C-2, while the HMQC 
experiment showed that H-2 (δ 4.33, d, 1H) was attached to C-2 (δ 63.7). COSY correlations 
between H-2 and H-1 (δ 3.64, s, 1H), in conjunction with HMQC data, led to the assignment of C-
1 (δ 51.2). All that remained to be assigned was the substituent at position 1.   
 
Table 3.5 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 3.5. 
 
Atom 
No. 
 
δC 
 
δH (mult, J, Hz) 
 
COSY 
 
HMBC 
C1 51.2 (d) 3.64 (m), 1H H-2 C4' 
C2 63.7 (d) 4.33 (d), 1H, J = 3.2 Hz H-1, H-4, H-7 (5J) C1, C3, C4, C6, C3', C19 
C3 182.9 (s) -   
C4 113.1 (d) 6.17 (s), 1H H-2, H-7 C2, C5, C6, C20 (lr) 
C5 168.5 (s) -   
C6 45.8 (s) -   
C7 36.1 (t) 3.08 (dd), 1H, J = 3.3 Hz, 12.4 Hz 
2.50 (m), 1H 
H-7b, H-8 
H-4, H-7a, H-8 
C1, C5, C6, C8, C20, C21 
C1, C5, C6, C8, C20 
C8 62.1 (d) 5.68 (d), 1H, J = 2.8 Hz H-7a, H-7b, NH-9 C5, C6, C7, C10 
NH-9 - 10.74 (br s), 1H H-8  
C10 146.2 (s) -   
C11 166.2 (s) -   
C12 123.5 (s) -   
NH-13 - 13.13 (s), 1H H-14 C12, C15, C21 
C14 126.7 (d) 7.28 (d), 1H, J = 1.8 Hz NH-13, H-16 C11, C12, C15, C21 
C15 117.5 (s) -   
C16 19.1 (t) 3.02 (m), 1H H-14, H-17 C14, C15, C17, C21 
C17 51.0 (t) 4.00 (m), 1H 
3.79 (m), 1H 
H-16, H-17b 
H-16, H-17a 
C5, C15, C16, C19 
C5, C15, C16, C19 
C19 147.4 (s) -   
C20 100.6 (s) -   
C21 121.1 (s) -   
C1' 47.7 (t) 3.54 (q), 2H, J = 17.9, 34.4 Hz  - C1, C2', C3' 
C2' 56.4 (d) 3.61 (d), 1H, J = 3.3 Hz - C2, C3, C5, C6, C20 
C3' 172.5 (s) -   
NH2-2' - -* -  
5J = five bond long range COSY coupling. 
*Note: Proton chemical shift not observed for NH2-2’. The 1H NMR signal for COOH was once again also not 
observed and is also likely to be due to an intermediate rate of exchange with other protons (Section 3.2.3, 
c) as well as the presence of other exchangeable protons (i.e. NH-9, NH-13 and NH-2’).97 
 
HMQC correlations (Figure 3.16, Table 3.5) showed the methylene and the methine protons at δ 
3.54 (H-1’, q, 2H) and 3.61 (H-2’, d, 1H) to be attached to carbons resonating at δ 47.7 and 56.4, 
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respectively. An HMBC correlation between H2-1’ and C-1 and to carbons resonating at δ 56.4 
and 172.5 tentatively attached the methylene moiety to C-1. The carbon resonance C-3’ (δ 172.5) 
implied a carboxylic acid functionality which would also fulfil the requirements of the molecular 
formula (which shows an additional two oxygen atoms as opposed to the usual two for 
discorhabdins). The carboxyl carbonyl is therefore placed at one end of the fragment i.e. CH2-X-
COOH. Finally, the carbon chemical shift of the methine carbon at δ 56.4 (C-2’) implied an 
electron withdrawing substituent such as a hydroxyl or an amino group. An amino substituent, 
would satisfy the carbon chemical shift of C-2’ as well as the requirements of the molecular 
formula. Due to the multiplicity of the methine proton at δ 3.61 (d), the only position available for 
H-2’ was at position X (in the fragment CH2-X-COOH). Following this construction of the fragment, 
the structure of the C-1 substituent is thus proposed as CH2-CH(NH2)-COOH. As established with 
compound 3.2, a very large geminal coupling constant (J = 17.9 Hz) was once again observed for 
the H2-1’ protons. 
 
The close proximity of the resonances for the H2-1’ protons and the H-2’ and H-1 methine protons 
proved problematic in unequivocally establishing the contiguous coupling (H-1-H2-1’-H-2’) 
sequence from the COSY spectrum. The absence of the amino and carboxylic acid exchangeable 
protons in the 1H NMR spectrum of 3.5 was also noted. 
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Figure 3.16 A section (F1 = δ 15 – 70 ppm, F2 = δ 2.0 – 7.5 ppm) of the HMBC spectrum 
of compound 3.5 (400/100 MHz, DMSO-d6). (Imp = impurity). 
 
The attachment of the α-amino acid substituent to the pyrroloiminoquinone structure via a carbon-
carbon bond is, however, rather unusual in biosynthetic terms. Although the structure completely 
satisfied the molecular formula, confirmation of the proposed structure through various NMR 
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experiments and / or chemical degradation methods, especially in the absence of an unequivocal 
COSY correlation between H-1 and H2-1’, was necessary. An HSQC-TOCSY NMR experiment 
(Figure 3.17) was acquired (since the proton signals corresponding to H-1, H2-1’ and H-2’ were 
better resolved in CD3OD, Figure 3.15) in a further attempt to unambiguously establish the 
coupling between H-1, H2-1’ and H-2’, since the experiment should be able to show the carbon 
atoms contiguously linked to H-1 proton. Regrettably, the ever elusive contiguous coupling was 
not observed. 
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Figure 3.17 A section (F1 = δ 44 – 70 ppm, F2 = δ 2.5 – 4.6 ppm) of the HSQC-TOCSY 
spectrum of compound 3.5 (400/100 MHz, CD3OD). (Imp = impurity). 
 
A NOESY experiment provided additional evidence for the attachment of the H2-1’ methylene 
group to H-1 (Figure 3.18). Because the water signal in CD3OD is further downfield than that in 
DMSO-d6, we used CD3OD since it offered less likelihood of the water resonance overlapping any 
relevant signals. In addition, the proton signals corresponding to H-1, H2-1’ and H-2’ were better 
resolved in the 1H spectrum of 3.5 acquired in CD3OD (Figure 3.15). Due to the presence of a 
strong water signal in the deuterated solvent, transfer of magnetisation between the water and 
various proton signals were, however, observed which necessitated the use of a presaturated 
NOESY experiment. Long d1 relaxation delays as well as mixing times (d8) at 2.5 seconds (s) and 
1.0 s, respectively, were found to be necessary, while the o1 value (solvent resonance to be 
irradiated) was set at 1924.05 Hz. Figures 3.18 and 3.19 and Table 3.6 show the NOESY 
correlations obtained for 3.5 at these settings. Figure 3.18 shows a NOESY correlation between 
H-1 and one of the H2-1’ protons providing some evidence in support of our assignment. The 
structure is thus tentatively proposed for 3.5. 
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Figure 3.18 A section (F1, F2 = δ 3.50 – 3.80 ppm) of the NOESY spectrum of compound 
3.5 (400 MHz, CD3OD). 
 
The nOe enhancements observed for 3.5 are given in Figure 3.19 in which the stereochemistry at 
C-1, C-2, C-6 and C-8 in 3.5 has been arbitrarily assigned based on the stereochemistry 
established for discorhabdin D. 
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Figure 3.19 Enhancements observed in the NOESY spectra of 3.5 (400 MHz, CD3OD). 
For the sake of clarity, weak enhancements have been omitted (please see Table 3.6). 
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Table 3.6 NMR (CD3OD, 400 MHz for 1H and 100 MHz for 13C) data for compound 3.5. 
 
Atom 
No. 
 
δC 
 
δH (mult, J, Hz) 
 
COSY 
 
HMBC 
 
NOESY 
C1 58.5 (d) 3.71, (s), 1H H-2 C-2, C-3, C-5, C-6, C-3’  H-2; H-1’; H-2’; H-
7a, H-7b (w) 
C2 66.2 (d) 4.33 (m), 1H H-1, H-4 C-1, C-3, C-6, C-19 H-1; H-17b, a (w) 
C3 184.7 (s)     
C4 114.5 (d) 6.14 (s), 1H H-2, H-7a C-2, C-6, C-5, C-20  
C5  171.6 (s)     
C6 48.0 (s)     
C7 38.1 (t) 3.17⁪ (m), 1H 
2.62 (d), 12.4 Hz, 
1H 
H-7a, H-8 
H-4, H-7b, H-8 
C-6, C-8, C-20 
C-6, C-8, C-20 
H-7a;  
H-1; H-7b  
C8 63.9 (d) 5.59 (s), 1H H-7 C-5, C-6, C-10 H-7b, a (w) 
NH-9 - -    
C10 148.1 (s)     
C11  167.5 (s)     
C12  125.5 (s)*     
NH-13 - -    
C14 127.2 (d) 7.09 (s), 1H H-16 C-11, C-12, C-15, C-21 H-16b, a (w) 
C15 119.3 (s)     
C16 20.7 (t) 3.17⁪  (m) 
3.05 (m) 
H-17, H-16a 
H-17, H-16b, H-14 
C-15 H-17; H-16 
C17  53.0 (t) 4.01 (m), 1H 
3.90 (m), 1H 
H-17a, H-16 
H-17b, H-16 
C-19 
C-19 
H-16; H-17a; H-2   
H-16; H-17b; H-2 
(w) 
C19 150.3 (s)     
C20  102.8 (s)     
C21 122.8 (s)*     
C1' 49.4 (t) 3.60 (q), 1H, 8.8 
Hz  
 C-1, C-3’ - 
C2'  49.4 (d) 3.56 (d), 1H, 4.4 
Hz 
 C-1, C-3’ - 
C3' 174.7 (s)     
NH-2' - -  - - 
Note: 
*C-12 and C-21 are interchangeable 
(w) = weak enhancement (NOESY) 
⁪H-16 and H-7b protons are overlapped 
C-1’ and C-2’ carbon signals are overlapped. 
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Interestingly, the large coupling constants observed for 3.5 in DMSO-d6 were not observed when 
the same sample was run in CD3OD. 
 
3.3 Summary and Conclusion 
 
The co-occurrence of makaluvamine C, damirone B and makaluvic acid A together with 
discorhabdins in the same latrunculid sponge is significant as it supports the proposed 
biosynthetic pathway outlined by Munro et al. (Chapter 1, Scheme 1.2).59 Discorhabdins and 
makaluvamines (which are considered to be the probable biosynthetic precursors of the 
discorhabdins26) have been isolated primarily from sponges of the genera Latrunculia (Family 
Latrunculiidae) and Zyzzya, respectively. Following taxonomic revisions, all the makaluvamines 
and damirones described thus far have been isolated from sponges of the genus Zyzzya.26 
Discorhabdins A and P have, however, been isolated from the sponges of the genera Zyzzya 
fuliginosa30 and Batzella40 respectively (Chapter 1, Section 1.2), while more recently, discorhabdin 
Q was isolated from sponges of the genera Latrunculia and Zyzzya.46 The previously unrecorded 
isolation of makaluvamine C, damirone B and makaluvic acid A (together with discorhabdins) from 
a latrunculid sponge is therefore noteworthy. It is indeed surprising that given the biosynthetic 
relationship between the damirones, makaluvamines and discorhabdins that these compounds 
have not been isolated from the same latrunculid sponge before. 
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Chapter 4: Pyrroloiminoquinone metabolites from Tsitsikamma favus and 
Strongylodesma sp.  
 
4.1 Introduction 
 
Discorhabdin and bis-pyrroloiminoquinone type compounds predominated in the extract of the 
Latrunculid sponge Tsitsikamma favus (SAF 94-006) collected by SCUBA from the Tsitsikamma 
Marine Reserve. The sponge T. favus was the first species of a new genus of Latrunculid sponge 
to be discovered off the coast of South Africa.  
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Figure 4.1 Summary of the compounds isolated from T. favus. 
 
Although the major natural product constituents of this sponge had been examined previously by 
Hooper (as part of his PhD research),41,98 improvements in chromatographic and spectroscopic 
techniques warranted a re-investigation of the minor pyrroloiminoquinone metabolites of this 
sponge. Accordingly, the frozen sponge was soaked in methanol and the aqueous methanol 
extract partitioned between hexane, chloroform and n-butanol. Extensive chromatography of the 
concentrated chloroform and n-butanol partition fractions yielded three known (1.71, 1.72, 1.52) 
and five new pyrroloiminoquinones (4.1, 4.2, 2.1, 2.4 and 2.6) (Figure 4.1). Discorhabdins 2.1, 2.4 
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and 2.6 were also isolated from T. pedunculata (Chapter 2). The co-occurrence of compounds 
1.52, 2.1, 2.4 and 2.6 in T. favus and T. pedunculata provides some chemotaxonomic evidence in 
support of both species belonging to the same genus.55 Of particular note is the bromination at C-
14 in compounds 1.52 and 2.4 a structural feature that appears to be unique to 
pyrroloiminoquinone metabolites from the new genus Tsitsikamma. Another structural feature 
shared by the discorhabdin type metabolites (including the new discorhabdin S analogues) of the 
two species in this genus is the allylic secondary alcohol functionality at C-3. Interestingly, the bis-
pyrroloiminoquinone metabolites, common in the extracts of T. favus, are absent in the abstracts 
of T. pedunculata and the tentative chemotaxonomic significance of this unusual skeleton, in 
defining species from the new genus Tsitsikamma alluded to by Hooper et al.,41 appears to be 
misplaced. 
 
As described in previous chapters LC-MS was initially used to establish an approximate molecular 
mass and provide details of the degree of bromination within the molecule. The structures were 
solved using standard spectroanalytical techniques as well as by comparison of their 
spectroscopic data with those of known compounds in the series. Compounds 4.1, 4.2 and 
particularly 2.1, 2.4, 2.6 were isolated from T. favus as minor metabolites. As discussed 
previously (Chapter 2) DMSO-d6 was the preferred solvent used for the NMR analyses to 
maximize the information available from the exchangeable protons.  
 
A fourth Latrunculid sponge belonging to the genus Strongylodesma and commonly known as 
Philip’s Green sponge, also a new species, was collected from Algoa Bay in 1996. The 1H NMR 
spectra showed primarily discorhabdin type pyrroloiminoquinones in its methanol extract. The 
frozen sponge was steeped in methanol and the concentrated extract partitioned between 
hexane, chloroform and n-butanol. Exhaustive chromatography carried out on the concentrated 
chloroform and n-butanol partition fractions yielded three known (1.57, 1.61, 1.53) and one new 
pyrroloiminoquinone (3.3) (Figure 4.2). The new discorhabdin 3.3 was also isolated from L. lorii 
(Chapter 3). The samples were routinely subjected to direct injection low resolution LC-MS 
following solid phase extraction (Section 4.3.2) and meticulous HPLC chromatography. The 
structures were also solved using standard spectroanalytical techniques as well as by comparison 
of their spectroscopic data with those of known compounds in the series. All NMR spectra were 
recorded in DMSO-d6.  
 
The Strongylodesma sp. sponge contained the highly cytotoxic discorhabdin A as its major 
metabolite in addition to discorhabdin D. The Strongylodesma sp. metabolites were also 
characterised by a) either a reduced carbonyl and a ketone at C-3; b) bromination at C-2 and / or 
C-4; and c) a discorhabdin D and / or C type skeleton. 
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Figure 4.2 Summary of the compounds isolated from Strongylodesma sp.. 
 
4.2 Results and Discussion 
 
4.2.1 The taxonomy of the sponge Tsitsikamma favus 
 
 
 
Figure 4.3 An underwater photograph of T. favus. 
 
The brown nodular Latrunculid sponge T. favus (Figure 4.3) was collected by SCUBA at a depth 
of -20 m in the Tsitsikamma Marine Reserve, South Africa in 1994. Samaai and Kelly55 described 
the sponge as follows: “Sponge is massive, ovo-spherical, sometimes thickly encrusting, 1 – 8 cm 
high and 10 – 15 cm wide. Texture is hard and only slightly compressible, resilient and leathery; 
surface smooth and crowded with large single to multichambered cylindrical lance-shaped 
oscules, 1 – 4 mm wide, 8 mm high and many pedunculate cauliform areolated porefields, 3 mm 
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wide, 5 – 6 mm high, with no membrane; colour in life is dark brown or liver brown and between 
cauliform structures dark turquoise, choanosome dark brown. The choanosome is divided into 
honeycomb-like chambers and convoluted layers by very thick reinforced tracts of anisostyles, 
these tracts range in width from 1000 – 1700 µm thick, forming meshes that are elliptical in shape 
and 5800 µm wide. These tracts are lined with microscleres, suggesting that they may represent 
an early ectosermal surface, and that the sponge grows in size and volume by putting on new 
chambers, as in many species of Petrosia and Coelocarteria. Within and between the chambers 
and convoluted layers the skeleton consists of an ill-formed, irregular reticulation of small 
anisostyles, these tracts range in width from 100 – 150 µm. Microscleres are isodiscohabds and 
these are abundant throughout the choanosome. The ectosome is composed of a thick dense 
feltwork of tangential and paratangential anisostyles approximately 900 µm wide. This layer is 
present in the fistulae with anisostyles disposed in a compact regular vertical to oblique 
arrangement supporting the cauliform areolate structures. A single layer of erect 
isochiadiscorhabds (48 µm wide) lines the surface of the ectosome. Megascleres in two 
categories of anisostyles, (1) slightly curved and thickened centrally, 621(537-700) x 14(14) µm, n 
= 20; (2) thinner slightly curved centrally: 530(480-566) x 9.6(9.6) µm. Microscleres are 
ischiadiscorhabds with three whorls of cylindrical, conical tubercles, the apex of each tubercular 
projection is acanthose: 48(41-60) x 9(7.2-9.6) µm. Reproduction: oocytes present in specimens 
but no further indication of reproductive mode yet corroborated. The huge spicule tracts that 
compartmentalize the body of Tsitsikamma favus are remarkable and clearly differentiate it from 
Latrunculia, Strongylodesma and Sceptrella, and other related demosponges. The characters that 
link the genera are the base pigmentation, chemistry, the surface palisade of microscleres and 
the soft skeletal parts.” 
 
4.2.2 Extraction and isolation of pyrroloiminoquinone metabolites from T. favus 
 
The frozen sponge (SAF 94-006) was steeped in methanol overnight and the aqueous methanol 
extract partitioned according to a modified Kupchan procedure (Scheme 4.1). The sponge was 
dried after the extractions to provide an approximate dry mass.  
 
The known compounds tsitsikammamine A (1.71)41,98 and B (1.72)41,98 as well as 14-bromo-3-
dihydro-discorhabdin C (1.52),41,98 together with the four new compounds, namely 
tsitsikammamine A N-oxime (4.1), tsitsikammamine B N-oxime (4.2), 7,8-dehydro-3-dihydro-
discorhabdin C (2.1), 14-bromo-1-hydroxy-discorhabdin S (2.4), and 2,4-debromo-3-dihydro-
discorhabdin C (2.6), were isolated from T. favus. Compounds 2.1, 2.4 and 2.6 were previously 
isolated from T. pedunculata and their structure elucidation is described in Chapter 2.  
 
The tsitsikammamines (1.71 and 1.72) and compound 1.52 were isolated from the chloroform 
partition fraction of the sponge extract, while the new compounds (4.1, 4.2, 2.1, 2.4, 2.6) were 
obtained from the n-butanol partition fraction. The structures of the known compounds reported 
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here, were determined from a combination of 2D-NMR spectroscopy and spectral comparisons 
with known discorhabdins and bis-pyrroloiminoquinones, particularly discorhabdin C and D and 
tsitsikammamine A and B.  
 
Frozen Tsitsikamma favus (dry mass after extraction: 473.3 g)
Solvent extraction
Aqueous MeOH Extract (81.6 g)
Solvent partitioning
Hexane CHCl3
F GEDCBA
B CA D E F G H
CBA A B C D E
A B C D E F G H
F G H I J K LEDCBA M N O
n-Butanol Aq. MeOH
C18 SepPak
Gradient Elution
010
014
018
017 023
027
026
020
019
015
024
EDC FBA
A B C
A C E G I KB D F H J
D ECB F GA
GFEDCB H I J KA L M N O
A B C D
P
A B C D E F G
A B C
CBA
A B C D E F
BA C D E F G H
BA
B C D EA
A B C D
C D EB FA
EDCBA
FDCBA E
C D E FB GA
016
021
022
033
025
029
028
005
009
031032
008
006
C18 SepPak
Gradient Elution
                                    HPLC
70:30:0.05 (H2O:MeOH:TFA)
HPLC   60:40:0.05 (H2O:MeOH:TFA)
HPLC
60:40:0.05 (H2O:MeOH:TFA)
                        HPLC
                 55:45:0.05 
(H2O:MeOH:TFA)
HPLC
55:45:0.05 
(H2O:MeOH:TFA)
  LH-20
(MeOH)
HPLC 67.5:32.5:0.05 
      (H2O:MeOH:TFA)
   HPLC
60:40:0.05 (H2O:MeOH:TFA)
HPLC 
70:30:0.05 
(H2O:MeOH:TFA)
HPLC 
72.5:27.5:0.05 
(H2O:MeOH:TFA)
HPLC 67.5:32.5:0.05 (H2O:MeOH:TFA)
LH-20
(MeOH)
HPLC
65:35:0.05 
(H2O:MeOH:TFA)
HPLC 65:35:0.05 
(H2O:MeOH:TFA)
HPLC 62.5:37.5:0.05 
      (H2O:MeOH:TFA)
LH-20
(MeOH)
HPLC 67.5:32.5:0.05 
      (H2O:MeOH:TFA)
HPLC 67.5:32.5:0.05   (H2O:MeOH:TFA)
LH-20   (MeOH)
                                          HPLC 
62.5:37.5:0.05 (H2O:MeOH:TFA)
HPLC 
62.5:37.5:0.05 
(H2O:MeOH:TFA)
 
 
Scheme 4.1 Extraction and pyrroloiminoquinone isolation scheme for T. favus. The 
masses and yields (calculated relative to the dry mass of sponge) of the T. favus 
pyrroloiminoquinone metabolites are summarized below: 
 
006-I, 008-C 1.71 10.3 mg 0.002 % 
008-E, 009-B 1.72 36.8 mg 0.008 % 
021-D 4.1 4.7 mg 0.001 % 
021-E 4.2 2.9 mg 0.0006 % 
009-D 1.52 9.6 mg 0.002 % 
018-L 2.4 2.1 mg 0.0004 % 
026-E 2.7 4.3 mg 0.001 % 
018-M 2.9 2.0 mg 0.0004 % 
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4.2.3 Structure elucidation of pyrroloiminoquinone metabolites from T. favus 
 
a) Tsitsikammamine A (1.71) 
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HRFAB mass spectral analysis of the known compound tsitsikammamine A (1.71) (10.3 mg, 
0.002 % yield) indicated an M+ ion at m/z 304.1087 thus establishing the molecular formula of 
1.71 as C18H14N3O2. Although the 13C NMR spectrum of 1.71 revealed only sixteen distinct carbon 
resonances, the molecular formula, as well as the enhanced intensity of two of the 13C signals (δ 
116.2 and 128.9), implied that two resonance pairs were overlapped. The DEPT NMR experiment 
revealed two methylene and four methine signals (two of which were overlapped), supporting the 
presence of ten quaternary carbons. The characteristic 1H NMR spectrum of tsitsikammamine A, 
with its pair of exchangeable 1H NMR signals at approximately δ 13.1, is deceptively simple 
(Figure 4.4).  
 
3.03.54.04.55.05.56.06.57.07.5 ppm
910111213 ppm
H-14
H-1/H-5H-2/H-4
H-8
NH-9
NH-13
H-17
Water
DMSO-d6
H-16
ImpImpImp
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Figure 4.4 1H NMR spectrum of tsitsikammamine A (1.71) (400 MHz, DMSO-d6) with NH-
9 and NH-13 offset. (Imp = impurity). 
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The typical pyrroloiminoquinone substructure is evident from the mutually coupled methylene 
signals at δ 2.93 (2H, t, J = 8.0 Hz, H2-16) and δ 3.85 (2H, t, J = 8.0 Hz, H2-17) as well as the 
coupling of NH-13 (1H, br s) at δ 13.01 to δ 7.10 (1H, d, J = 1.6 Hz, H-14), observed in the COSY 
NMR spectrum. These spin systems, together with the pyrroloiminoquinone 13C resonances at δ 
166.3 (C-11), 127.8 (C-12), 123.1 (C-14), 119.2 (C-15), 17.6 (C-16), 44.9 (C-17), 157.8 (C-19) 
and 120.7 (C-21), characteristic of the left hand hemisphere of a typical discorhabdin type 
substructure, accounted for eight of the fourteen degrees of unsaturation implied by the molecular 
formula. Evidence for the characteristic para-substituted phenol ring of the tsitsikammamines was 
provided by the mutually coupled two proton doublets at δ 7.37 (d, J = 8.4 Hz, H-2 and H-4) and δ 
6.87 (d, J = 8.4 Hz, H-1 and H-5), as well as the distinctive 13C quaternary signals at δ 127.2 (C-6) 
and 157.5 (C-3). The remaining 13C signals at δ 122.4 and 125.0 were assigned to C-7 and C-8 in 
a trisubstituted pyrrole ring system. The 1H and 13C NMR data of 1.71 was consistent with those 
published for tsitsikammamine A.1,2 
 
As mentioned previously, the related bis-pyrroloiminoquinone, wakayin (1.73) was isolated from a 
Fijian ascidian Clavelina sp. and is the first and only reported pyrroloiminoquinone metabolite to 
be isolated from a marine phylum other than Porifiera.53 The question of whether bis-
pyrroloiminoquinones originate from the invertebrate organism alone or from associated 
microorganisms was therefore raised. Wakayin was initially reported to exhibit topoisomerase II 
inhibition (250 µM) by Copp et al.53 In contrast, a later report by Kokoshka et al. showed wakayin 
to exhibit topoisomerase I activity.91 
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An investigation of another Fijian marine invertebrate, Zyzzya fuliginosa, yielded the novel, 
related, pyrroloiminoquinone metabolite, veiutamine (1.74).54 In common with wakayin (1.73), 
veiutamine, which also contains the para-phenol substituent characteristic of the 
tsitsikammamines, exhibited potent cytotoxicity and interestingly, was shown to be more active 
than its related analogue makaluvamine D (1.34).54 
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b) Tsitsikammamine B (1.72) 
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OH3C H
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Tsitsikammamine B (1.72) (36.8 mg, 0.008 % yield) gave an M+1 ion at m/z 319.1321 upon 
analysis by HRFABMS, which is consistent with the molecular formula C19H17N3O2. The NMR 
data of tsitsikammamine B (1.72) i.e. the iminoquinone 13C resonances at δ 166.7 (C-11), 126.3 
(C-12), 118.7 (C-15), 17.5 (C-16), 44.6 (C-17), 156.2 (C-19) and 120.6 (C-21) and the phenolic 
13C signals at δ 116.2 (C-1/C-5), 128.9 (C-2/C-4) and 157.6 (C-3) were all consistent with a para-
phenoxy bis-pyrroloiminoquinone structure. While the proton spectrum revealed the absence of 
the NH-13 signal and the presence of a single methyl singlet (δ 3.96), the 13C spectrum with 
seventeen carbon signals (two overlapped), showed an additional methyl resonance at δ 35.7. 
This, together with the downfield carbon chemical shift of the C-14 resonance to δ 127.9, as well 
as the subsequent collapse of the H-14 resonance (δ 7.12) from a doublet (J13,14 = 1.6 Hz) to a 
singlet in the 1H spectrum, implied methylation at N-13. The NMR data for 1.72 was consistent 
with those of tsitsikammamine B.41,98 
 
c) Tsitsikammamine A N-oxime (4.1) 
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The molecular formula of 4.1 (4.7 mg, 0.001 % yield) ascertained from HRFAB mass spectral 
analysis indicated a molecular ion at m/z 322.1192 (∆ +0.1 mmu), corresponding to a molecular 
formula of C18H16N3O3. The difference between the molecular formula of 4.1 and 1.71 was 
therefore an oxygen atom. 
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Figure 4.5 1H NMR spectrum of tsitsikammamine A N-oxime (4.1) (400 MHz, DMSO-d6) 
with NH-9, NH-13 and OH-3 offset. (Imp = impurity). 
 
The close similarities between the 1H NMR spectra of 4.1 (Figure 4.5) and 1.71 (Figure 4.4) were 
immediately evident. The 13C NMR spectrum (Figure 4.6) of 4.1 showed sixteen distinct carbon 
resonances, with two resonance pairs overlapped once again. The DEPT NMR experiment 
showed two methylene and four methine signals (two of which were overlapped), supporting the 
presence of ten quaternary carbons. The pyrroloiminoquinone substructure was evident from the 
mutually coupled methylene signals at δ 2.97 (2H, m, H2-16) and δ 3.04 (2H, m, H2-17) in addition 
to the small vicinal coupling of the NH-13 proton (1H, br s) at δ 12.47 to δ 7.01 (1H, br s, H-14), 
observed in the COSY NMR spectrum (Figure 4.7). These spin systems, together with the 
pyrroloiminoquinone 13C resonances at δ 168.6 (C-11), 129.4 (C-12), 130.3 (C-14) and 119.8 (C-
15) are characteristic of the tsitsikammamine compounds and accounted for eight of the fourteen 
degrees of unsaturation implied by the molecular formula. A careful evaluation of the differences 
between the 1H NMR spectra of 4.1 and 1.71 revealed that the multiplet attributed to H2-17 was 
shifted upfield (∆ δ 0.8 ppm) suggesting a change in substitution at the neighbouring N-18 atom. 
The significant carbon chemical shifts (Figure 4.6) of C-17 and C-19 to δ 38.7 and 180.4, 
respectively, as well as the less dramatic chemical shifts of C-16 and C-21 to δ 23.5 and 125.3, 
respectively, also suggested substitution at N-18.  
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Figure 4.6 13C NMR spectrum (100 MHz, DMSO-d6) of a) tsitsikammamine A (1.71) and 
b) tsitsikammamine A N-oxime (4.1) with C-16 and C-17 offset. Please note the chemical 
shifts of C-17* and C-19* in particular. (Imp = impurity). 
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Figure 4.7 A section (F1, F2 = δ 2.0 – 8.5 ppm) of the COSY spectrum of compound 4.1 
(400/100 MHz, DMSO-d6) showing the 3J COSY coupling between N-18-OH and H2-17.  
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Supporting evidence for the existence of an N-O band at N-18 was provided by infra red (IR) 
spectroscopy. The interpretation of the IR spectrum of fused ring compounds, such as 4.1, is 
complicated by the greater vibrational coupling experienced compared to compounds with 
isolated ring systems.99,100 Significant shifts in IR absorption bands of the parent structure are 
expected in compounds possessing an N-oxygen band.99-102 Five absorption bands, were 
identified as having undergone significant shifts in the IR spectrum of 4.1 (i.e. 438, 608, 908, 987 
and 1487 cm-1). Classic assignments of N-oxygen bands include the bands present at 
approximately 1250 cm-1 due to vibrational coupled νN-O (e.g. 1252 and 1307 cm–1 for pyridine 
and pyrazine N-oxides respectively)99 and approximately 470 cm-1 due to in plane bending (αN-O) 
(468 and 475 cm-1 for pyridine and pyrazine N-oxides respectively).99  
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Figure 4.8 Overlaid IR spectra (2000 – 400 cm-1) of a) tsitsikammamine A (1.71) and b) 
its N-oxime (4.1). The true N-oxide bands are indicated on the graph by means of an 
arrow while the bands which display the sensitivity typical of N-oxides and N-18 oximes 
are indicated by means of an asterisk (*). 
 
Unfortunately compound 1.71 exhibited a strong band at 1207 cm-1 and it thus assumed that 
compound 4.1’s N-oxygen band is buried underneath this peak (Figure 4.8). A true N-oxygen 
band (medium intensity), characteristic of an in plane bending for the N-oxygen band (αN-O) was, 
however, observed at 438 cm-1 in the IR spectrum of 4.1. The sensitivity of the bands at 608, 908, 
987 and 1487 cm-1 together with the characteristic N-oxygen band at 438 cm-1 thus implies the 
presence of an N-oxygen type functionality. Substituent sensitivity was clearly observed upon 
comparison of napthalene and quinoline N-oxide (Table 4.1), providing additional evidence for the 
existence of the N-oxygen type functionality.100  
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Table 4.1 Substituent sensitivity of the planar ring modes in quinoline N-oxide compared to its 
homocyclic parent (naphthalene).100 
 Band (cm-1) Band (cm-1) Band (cm-1) Band (cm-1) 
Napthalene 1010 936 1458 618 
Quinoline N-oxide 878 928 1447 628 
Difference (shift) -132 -8 -11 +10 
 
The classic assignments for quinoline N-oxide have been given as 1233 (νN-O, vibrational 
coupling) and 318 cm-1 (αN-O).100 This, together with the compounds ability to produce radicals 
upon irradiation, a feature characteristic of N-oxides and N-18 oximes103,104 (please refer to 
Chapter 5), also suggests the presence of an N-oxygen functionality.  
 
It seems likely that 4.1 and 4.2 would exist as oximes instead of N-oxides since they were isolated 
at approximately pH 3.0 (0.05% TFA), which together with the N-18-OH signal at δ 7.76 obtained 
in the 1H NMR spectrum, and the HRFAB MS data, resulted in the assignment of the oxime rather 
than an N-oxide functionality. 
 
The distinctive 13C quaternary signals at δ 126.5 (C-6) and 156.6 (C-3) and the mutually coupled 
two proton pairs at δ 7.55 (d, J = 8.4 Hz, H-2 and H-4) and δ 6.75 (d, J = 8.4 Hz, H-1 and H-5), 
typical of the para-substituted phenol rings of tsitsikammamines were observed. The 13C signals 
at δ 121.2 and 123.9 of C-7 and C-8 of the trisubstituted pyrrole ring system complete the 
skeleton of a bis-pyrroloiminoquinone N-oxime, which is supported by two, three and four bond 
correlations observed in the HMBC NMR experiments (Figure 4.9) of 4.1 (Table 4.2). 
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Figure 4.9 A section (F1 = δ 10 – 50 ppm, F2 = δ 2.0 – 8.0 ppm) of the HMBC spectrum 
of compound 4.1 (400/100 MHz, DMSO-d6).  
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Table 4.2 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 4.1. 
 
Atom no. δC δH (mult, J, Hz) COSY HMBC 
C1 114.5 (d) 6.75 (d), 2H, 8.4 Hz H2 / H4 C2, C3, C4, C5, C8  
C2 129.7 (d) 7.55 (d), 2H, 8.4 Hz H1 / H5 C1, C3, C4, C5, C8  
C3 156.6 (s)    
C4 129.7 (d) 7.55 (d), 2H, 8.4 Hz H1 / H5 C1, C2, C3, C5, C8  
C5 114.5 (d) 6.75 (d), 2H, 8.4 Hz H2 / H4 C1, C2, C3, C4, C8  
C6 126.5 (s)    
C7 121.2 (s)    
C8 123.9 (d) 7.18 (d), 1H, 2.8 Hz NH-9 C6, C7, C10, C11  
NH-9 - 12.67 (s), 1H H-8 C6, C7, C10 
C10 133.2 (s)    
C11 168.6 (s)    
C12 129.4 (s)    
NH-13 - 12.47 (s), 1H H-14 C15 
C14 130.3 (s) 7.01 (d), 1H, 2Hz NH-13 C11, C12 / C21, C15 
C15 119.8 (s)    
C16 23.5 (t) 2.97 (m), 2H H-17 C15, C17 
C17 38.7 (t) 3.04 (m), 3H H-16, N-18-OH C15, C16 
N-18-OH - 7.76 (s), 3H H-17 C16, C17 
C19 180.4 (s)    
C20 123.9 (s)    
C21 125.3 (s)    
C-3-OH  9.45 (br s), 1H   
 
In an effort to confirm the presence of the N-18-oxygen functionality, the conversion of 
tsitsikammamine A into 4.1 was attempted. Pyridine N-oxides, for example, are typically prepared 
by heating pyridine in glacial acetic acid at 80 oC with 30% hydrogen peroxide followed by 
neutralisation of the pyridine N-oxime and isolation of the pyridine N-oxide by distillation.105 The 
preparation of (1S)–10-methylenecamphor, an intermediate in the synthesis of the natural product 
taxol (4.3, Scheme 4.2), by Martínez et al.106 employed the use of meta-chloroperbenzoic acid (m-
CPBA) to convert the amino ketone 4.4 via the N-oxide 4.5 to the taxane intermediate, enone 4.6 
in Scheme 4.2.  
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Chapter 4:T. favus and Strongylodesma sp. 
 
 109
R2
R1
O
NMe2  
 
m-CPBA
95 %  
R2
R1
O
NMe2O  
 
DMSO / heating
Cope elimination
         80 %  
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O
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4.4  4.5  4.6 
Scheme 4.2 Martínez et al.’s synthesis of the taxol intermediate 10-
methylenecamphor.106  
 
Two attempted preparations of an N-oxide analogue of the TFA salt of tsitsikammamine A (1.71), 
using firstly hydrogen peroxide and glacial acetic acid and secondly meta chloroperbenzoic acid 
(m-CPBA), were unsuccessful. In a further effort to oxidise the N-18 of 1.71, the free base of 1.71 
was first prepared by neutralisation with 5 M sodium hydroxide but this neutralisation also proved 
difficult. These results may suggest that the N-oxime is not an artifact arising from the extraction 
and chromatography employed but rather that it might be of enzymatic origin. 
 
d) Tsitsikammamine B N-oxime (4.2) 
 
NN
N+
OH3C H
OH
OH
 
4.2 
 
Compound 4.2 (2.9 mg, 0.0006 % yield) gave a M+1 ion at m/z 336.1348 (∆ +0.1 mmu) by 
HRFABMS analysis, consistent with the molecular formula C19H18N3O3.  
 
The NMR data of tsitsikammamine B N-oxime (4.2) displayed the familiar iminoquinone 13C 
resonances at δ 168.6 (C-11), 129.4 (C-12), 119.8 (C-15) and 125.3 (C-21), all consistent with the 
para-phenoxy bis-pyrroloiminoquinone structure. The proton NMR spectrum (Figure 4.10) 
revealed that the NH-13 signal had disappeared, while the 13C spectrum revealed an additional 
methyl resonance at δ 35.8, which together with the carbon chemical shift of the C-14 resonance 
to δ 130.3, implied the presence of a methylated N-13. The additional oxygen given by the 
molecular formula coupled with the drastic chemical shifts of C-19 and C-17 to δ 180.4 and 38.7, 
respectively, implied that 4.2 was tsitsikammamine B N-oxime. Support for the tsitsikammamine B 
N-oxime structure is provided by the 2D NMR data (Figure 4.11 and Table 4.3). 
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Figure 4.10 1H NMR of 4.2 (400 MHz, DMSO-d6) with NH-9, NH-13 and OH-3 offset. (Imp 
= impurity). 
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Figure 4.11 A section (F1, F2 = δ 2.0 – 8.5 ppm) of the COSY spectrum of compound 4.2 
(400/100 MHz, DMSO-d6). (Imp = impurity). 
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Table 4.3 NMR (DMSO-d6, 400 MHz for 1H and 100 MHz for 13C) data for compound 4.2. 
 
Atom no. δC δH (mult, J, Hz) COSY HMBC 
C1 114.5 (d) 6.75 (d), 2H, 8.4 Hz H2 / H4 C3, C5, C20  
C2 129.7 (d) 7.57 (d), 2H, 8.4 Hz H1 / H5 C1, C3, C4, C5, C6  
C3 156.6 (s)    
C4 129.7 (d) 7.57 (d), 2H, 8.4 Hz H1 / H5 C1, C2, C3, C5, C6  
C5 114.5 (d) 6.75 (d), 2H, 8.4 Hz H2 / H4 C1, C3, C20  
C6 126.5 (s)    
C7 121.2 (s)    
C8 123.9 (d) 7.1 (d) 1H, 2.4 Hz NH-9 C6, C7, C10  
NH-9 - 12.63 (s), 1H H-8 C6, C7, C10, C20 
C10 133.2 (s)    
C11 168.6 (s)    
C12 129.4 (s)    
N-13 - -   
C14 130.3 (s) 7.05 (s), 1H N-13-Me  C12, N-13-Me, C15, C16, C11, 
C19, C21 
C15 119.8 (s)    
C16 23.5 (t) 2.95 (m), 2H H-17 C14, C15, C17, C21 
C17 38.7 (t) 3.02 (m), 2H H-16, N-18-OH C16 
N-18-OH - 7.76 (s), 3H H-17  
C19 180.4 (s)    
C20 123.9 (s)    
C21 125.3 (s)    
N-13-Me 35.8 (q) 3.19 (s), 3H H-14 C14 
 
The isolation of N-oxides from a terrestrial source is fairly common e.g. pyrrolizidine alkaloid N-
oxides from Symphytum officinale (comfrey), a plant from the Boraginaceae family. (To simplify 
interpretation of the spectroscopic data of these compounds, the N-oxides are usually reduced 
using zinc dust). The pyrrolizidine N-oxides are concentrated mainly in the fresh or dried root 
section of S. officinale. Long term administration of the roots of S. officinale to laboratory animals 
was observed to cause hepatotoxicity which led to the eventual development of tumours in 
laboratory animals.107 Another investigation revealed the concentration of the N-oxides of indicine 
(4.7) and 12-acetylindicine (4.8) in the leaves and roots of the medicinal plant Heliotropium 
arborescens.108 
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4.7 R1  =  OH, R2  =  OH 
4.8 R1  =  OAc, R2  =  OH 
 
 
Although the isolation of N-oxides from a marine source is still fairly uncommon, two antifungal 3-
alkyl pyridine alkaloids Cribrochalinamines A (4.9) and B (4.10) have been isolated previously by 
Matsunaga et al.109 from a Japanese sponge Cribrochalina sp. The aqueous methanol fraction 
was separated through a combination of chromatographies such as ODS flash (water : methanol), 
silica gel (chloroform : methanol) and reversed phase HPLC. Interestingly, at no point do the 
authors mention any use of TFA, or any other acid for that matter, to aid the separation of the two 
β-alkyl pyridine derivatives, which may be significant in defining the isolation of an N-oxide or an 
oxime metabolite.109 
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The bioactive bromotyrosine alkaloids purealidins A (4.11) and E (4.12), which have been shown 
to be useful in studying the regulatory mechanisms of myosin K+, EDTA-ATPase or Na+, K+ -
ATPase, were isolated from an Okinawan sponge Psammaplysilla purea Carter (family 
Verongidae). The n-butanol partition fraction was subjected to a combination of silica gel and 
molecular exclusion (LH-20) chromatography. The crude extract was then further purified using 
reversed phase HPLC with aqueous acetonitrile and trifluoroacetic acid.110  
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     4.11 R = NMe3+ CF3COO- 
     4.12 R = NH3+ CF3COO- 
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Similarly, the bromotyrosine alkaloid lipopurealidin D (4.13), was also isolated from an Okinawan 
sponge Psammaplysilla purea Carter111 and the ethyl acetate extract subjected to a combination 
of Si gel and LH-20 chromatography, where the eluent for the former chromatography contained 
either acetic acid or trifluoroacetic acid. Lipopurealidin D shows no cytotoxicity, however (> 10 
µg/mL).111 
 
N O
Br
Br
N
O
N
N
N
H
H
OH
HR
H
NH2
 
4.13  R = 
O  
 
It thus appears that N-18 oximes are possibly formed during the purification procedures and are 
likely to exist in nature as N-oxides. 
 
e) 14-bromo-3-dihydro-discorhabdin C (1.52) 
 
Compound 1.52 (9.6 mg, 0.002 % yield) gave a M+1 ion at m/z 542.8792 by HRFABMS analysis, 
consistent with the molecular formula C18H16N3O2Br3. 1H NMR data were consistent with those 
obtained for the compound isolated from T. pedunculata. 
 
f) 7,8-dehydro-3-dihydro-discorhabdin C (2.1) 
 
HRFABMS analysis gave a M+1 ion at m/z 462.9532 (∆ +0.1 mmu) for compound 2.1 (2.1 mg, 
0.0004 % yield), consistent with the molecular formula C18H15N3O2Br2. The 1H NMR spectra 
obtained were also consistent with those obtained for 2.1 isolated from T. pedunculata. 
 
g) 14-bromo-1-hydroxy-discorhabdin S (2.4) 
 
The 1H NMR spectrum obtained for 2.4 isolated from T. favus was identical to the 1H NMR 
spectrum obtained for the compound isolated from T. pedunculata. The molecular formula 
C18H17N3O3Br2 was established for compound 2.4 (4.3 mg, 0.001 % yield) by HRFABMS analysis 
(M+1, m/z 480.9636, ∆ -0.1 mmu).  
 
h) 2,4-debromo-3-dihydro-discorhabdin C (2.6) 
 
Matching 1H NMR spectra were obtained for compound 2.6 isolated from both T. favus and T. 
pedunculata. Compound 2.6 was also obtained in very low yields (2.0 mg, 0.0004 % yield). 
Chapter 4:T. favus and Strongylodesma sp. 
 
 114
4.3.1 The taxonomy of the sponge Strongylodesma sp.. 
 
 
 
Figure 4.12 An underwater photograph of Strongylodesma sp.. 
 
UPE-96-Philip’s green sponge was collected in Algoa Bay, South Africa, in an intertidal rock pool 
at a depth of 2 m in 1996. “In life the sponge is semispherical, up to 5 cm high and 10 cm wide. 
The surface is smooth with volcano-shaped oscules and smooth mushroom-like areolate 
structures. The texture hard, compressible and the colour greenish-brown. The choanosomal 
skeleton consists of a dense irregular square to polygonal-meshed reticulation of strongyles (~ 
80-100 µm), with no distinction between the primary and secondary tracts. The ectosome is made 
up of a dense irregular interlocking layer of strongyles approximately 220 µm deep above which is 
a layer of perpendicular strongyles, which pierce the surface. No microscleres are present. The 
sponge is most closely comparable to Strongylodesma areolata Lévi, 1969 (Family 
Latrunculiidae), but is here considered another specimen within a new species of 
Strongylodesma.” 58  
 
4.3.2 Extraction and isolation of pyrroloiminoquinone metabolites from Strongylodesma sp.. 
 
The frozen sponge (UPE-96-Philip’s Green sponge) was steeped in methanol and once again 
partitioned according to a modified Kupchan procedure (Scheme 4.3). The known compounds 
discorhabdins A (1.57),36 D (1.61)48 as well as 3-dihydro-discorhabdin C (1.53),42 together with 
one new compound, namely 1-amino-discorhabdin D (3.3) were isolated from Strongylodesma 
sp.. Compounds 1.53 and 3.3 have already been isolated from T. pedunculata and L. lorii 
respectively and are described in Chapters 2 and 3.  
 
Discorhabdin A (1.57) and 3-dihydro-discorhabdin C (1.53) were isolated from the chloroform 
partition, while 1.57, 1.61 as well as the new compound (3.3) were obtained from the n-butanol 
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partition. The structures of the known compounds reported here, are based on spectral 
comparisons with known discorhabdins.  
 
024
Frozen Strongylodesma sp. (dry mass after extraction: 143.1 g)
Solvent extraction
Aqueous MeOH Extract 
Solvent partitioning
Hexane n-Butanol Aq. MeOH
C18 SepPak
Gradient Elution
026
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(MeOH)
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Scheme 4.3 Extraction and pyrroloiminoquinone isolation scheme for Strongylodesma 
sp.. The masses and yields (calculated relative to the dry mass of sponge) of the 
Strongylodesma sp. pyrroloiminoquinone metabolites are summarized below: 
 
022B, 022C 029D, 029E, 
030A, 034G, 041A, 043F 
1.57 208.8 mg 0.15 % 
 
043D  1.61  6.7 mg 0.005 % 
030E 1.53  6.9 mg  0.005 % 
043B 042E 034E 3.3  19.2 mg 0.01 % 
 
4.3.3 Structure elucidation of pyrroloiminoquinone metabolites from Strongylodesma sp.. 
 
i) Discorhabdin A (1.57) 
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Discorhabdin A (1.57, 208.8 mg, 0.15 % yield) showed an M+ ion peak at m/z 416.2 in the low 
resolution LC-MS analyses corresponding to a molecular formula of C18H15N3O2S79Br. The 1H 
(Figure 4.13) and 13C NMR spectra indicated a basic discorhabdin C type skeleton with the proton 
NMR spectra showing seven non-exchangeable and three exchangeable sets of protons. The 1H 
NMR spectrum (Figure 4.13) was rather simple showing two deshielded sp2 methine signals 
corresponding to H-1 (δ 7.47) and H-14 (δ 7.38), together with two sp3 methine signals at δ 5.33 
and 4.58 corresponding to H-8 and H-5. The 13C NMR spectrum showed well resolved signals 
corresponding to all eighteen carbons, while a DEPT experiment confirmed that the twelve non-
exchangeable protons were attached to carbons which included four methylene carbons, four 
methine carbons and ten quaternary carbons. A deshielded carbon signal at δ 187.8 suggested 
an α,β-unsaturated ketone, while typical signals for the iminoquinone moiety were evident from 
the carbons resonating at δ 166.8 and 154.6. The NMR data obtained for this compound is 
consistent with the literature values.36 The LC-MS spectrum of 1.57, presented in Figure 4.14, 
shows the typical M + 1 1:1 doublet isotope ion cluster indicative of a compound containing one 
bromine atom. 
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Figure 4.13 1H NMR spectrum of discorhabdin A (1.57) (400 MHz, DMSO-d6) with NH-9 
and NH-13 offset. (Imp = impurity). 
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Figure 4.14 The LC-MS spectrum of 1.57 showing the typical M + 1 1:1 doublet isotope 
ion cluster of a compound containing one bromine atom. 
 
j) Discorhabdin D (1.61) 
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Discorhabdin D (6.7 mg, 0.005 % yield), isolated as a minor metabolite, showed an M+ ion at m/z 
336.4 in the low resolution LC-MS spectrum corresponding to a molecular formula of 
C18H14N3O2S. The 1H NMR spectra (Figure 4.15) showed eleven non-exchangeable and two 
exchangeable sets of protons. The 13C NMR and DEPT 135 spectra revealed the presence of 
eighteen carbon resonances, including four methylene, two sp2 and two sp3 methine signals, 
together with ten quaternary carbon resonances. Two α,β-unsaturated carbons was evident from 
a carbon chemical shifts at δ 182.9 (C-3) and 166.4 (C-11). The 1H NMR spectrum, significantly 
different to that of discorhabdin A (1.57), lacked the proton chemical shifts of 1.57 at 
approximately δ 7.5 (H-1) and δ 8.1 (NH-18) suggesting substitution in the latter position. 
Methylene and methine signals at δ 2.44 (dd, H2-1), 2.91 (dd, H-1b) and 4.37 (s, H-2) were 
observed instead. The lack of an NH-18 proton signal together with the proton and carbon 
chemical shifts of C-2 (δC 62.1) suggested the presence of a bond between N-18 and C-2. Upon 
comparison of previously isolated discorhabdins (e.g. 3.2 – 3.5), the carbon chemical shifts 
corresponding to C-5 (δ 172.9) and C-8 (δ 62.6) suggested the presence of a thioether 
functionality. The spectroscopic data were therefore consistent with those of discorhabdin D 
published by Perry et al..48 
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Figure 4.15 1H NMR spectrum of discorhabdin D (1.61) (400 MHz, DMSO-d6) with NH-9 
and NH-13 offset. (Imp = impurity). 
 
k) 3-dihydro-discorhabdin C (1.53) 
 
The 1H NMR spectra obtained for compound 1.53 (6.9 mg, 0.005 % yield) were also consistent 
with those obtained for 1.53 isolated from T. pedunculata. 
 
l) 1-amino discorhabdin D (3.3) 
 
Compound 3.3 (19.2 mg, 0.01 % yield), also isolated from L. lorii, gave 1H NMR data which were 
consistent with those obtained for compound 3.3. 
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Chapter 5: Photochemistry 
 
5.1 Introduction 
 
The pyrroloamino-ortho-quinone, pyrroloiminoquinone and bis-pyrroloiminoquinone metabolites 
described in previous chapters have a dual purpose in the sponges that produce them. These 
metabolites potentially act as both cytotoxic chemical defence agents against predation and 
microbial infection and as pigments providing the characteristic brown, green and pink colours of 
the sponges from the family Latrunculiidae and Acarnidae. It is the role of pyrroloamino-ortho-
quinone and pyrroloiminoquinone metabolites as pigments that we explore in this Chapter in 
particular the possible relationship between the interaction of these compounds with light and 
their resultant mechanism of action as cytotoxic agents. The potential of these compounds as 
photosensitive anti-cancer drugs suitable for use in photodynamic therapy is discussed. 
 
Cancer is the uninhibited production of diseased cells that eventually develop into tumours. 
Therapy or management of cancer is dependent on the eradication of these diseased cells either 
through surgery; through chemical treatments that rely on the differences between cancerous and 
normal cells (with certain chemicals found to concentrate in cancerous cells rather than the 
unaffected cells); or through the effects of ionising radiation such as radiotherapy (a form of free 
radical therapy) or photodynamic therapy (the photosensitised production of singlet oxygen).104,112  
 
Free radicals are atoms, molecules or fragments of molecules with an unpaired electron, and are 
produced by a) a variety of metabolic processes in the body, such as the oxidants produced as 
byproducts of mitochondrial electron transport, various enzyme systems, and lipid peroxidation; b) 
as intermediates in the breakdown of drugs through metabolism; or c) through a variety of 
photosensitisation processes.104 Superoxide (O2-) and the highly reactive hydroxyl (OH• ) radicals 
are constantly produced in living organisms.  Several non-radical oxygen derived species 
(hydrogen peroxide and hypochlorous acid) are also generated.  The term reactive oxygen 
species (ROS) describes the oxygen radicals [(O2• -, OH•, peroxyl (RO2• ) and alkoxyl (RO• )] 
radicals) and other non-radical derivatives [(H2O2, HOCl, singlet oxygen (1O2), ozone)]. As they 
are usually highly reactive and short-lived, any oxidants that escape the numerous antioxidant 
defences damage macromolecules such as DNA and proteins, leading ultimately to mutations 
and cancer. In the last decade a surge of interest in free radical chemistry and biology has led to 
great advances in understanding the role of reactive oxygen species (ROS) in DNA damage, 
ageing and the many diseases have been associated with ROS, among them cancer.104,113 But 
although free radicals are usually considered to be damaging to the body – some, such as nitric 
oxide and superoxide – are important in blood pressure control and destroying harmful bacteria. It 
is the damage inducing properties, however, that has led to the interest in exploiting ROS for 
cancer therapy e.g. radiotherapy and photodynamic therapy (PDT).   
 
Chapter 5: Photochemistry 
 
 120
Radiotherapy involves the production of radicals through radiation. The radicals interact with DNA 
and adjacent molecules to cause breaks in the DNA strands, cell death and tumour necrosis. The 
necessity to produce compounds that have the potential to deliver damaging radicals to tumours 
is thus underlined. Similarly, the basis of PDT is a sensitised photooxidation process that destroys 
the fundamental components of the diseased cell. PDT involves the administration of a 
photosensitiser (which accumulates preferentially in the tumour cells) and its subsequent 
activation by laser light.  In its activated form, the photosensitiser reacts with oxygen to produce 
highly toxic singlet oxygen which can itself damage DNA or lead to a variety of oxidation reactions 
involving important macromolecules in the cells, leading to cellular damage of the tumour 
tissue.104,112 The photosensitisers used in PDT are usually good oxidising agents in their excited 
state. Ironically, the cancer that is initiated mainly by mutations due to oxidative damage may be 
cured through oxidative free radical, or through the photosensitised production of singlet oxygen, 
damage to DNA in the cancer cells during radio- or photodynamic therapy.  
 
During the past ten years, however, it has become evident that solid human tumours very often 
contain regions that are deficient in oxygen (hypoxic). The presence of hypoxia has been 
demonstrated in cervical cancer, squamous cell carcinoma of the head and neck, melanoma, 
breast, sarcoma and more recently prostate cancer.113  
 
Because photochemical DNA damage mediated by organic molecules has important toxic and 
therapeutic consequences, the photochemical characterisation of potential antitumour agents 
should be undertaken. The aim of this study was thus to determine the singlet oxygen 
(photochemical processes) and fluorescence (photophysical processes) quantum yields of a suite 
of pyrroloamino-ortho-quinone and pyrroloiminoquinones isolated from four South African 
Latrunculid sponges (Chapters 2 - 4) and, since these metabolites have been shown to have 
significant cytotoxicity, perhaps propose a mechanism of cytotoxicity. 
 
5.2 Photochemistry  
 
Photosensitisation is the absorption of visible light by a coloured substance which initiates 
physical or chemical changes in a substrate.114 The chemical reaction, in which a photoexcited 
molecule M* takes part, is termed photochemistry, and it may lead directly to the final products 
(e.g. isomerisation), or more frequently to an unstable or reactive chemical species (e.g. free 
radicals or radical ions). The reactive chemical species generated in this primary photochemical 
process may react further in secondary processes through a series of dark reactions that lead 
ultimately to the final photoproducts.112 
 
The sequence of a photochemical reaction may be followed through a succession of steps (also 
Figure 5.1): 
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i) Absorption of light M  +  hν  →  M* (5.1 a) 
ii) Fluorescence M*  →  M  +  hνF (5.1 b) 
iii) Non-radiative deactivation M*    M (+ heat) (5.1 c) 
iv) Intersystem crossing M*    3M* (5.1 d) 
v) Primary reaction: 
unimolecular 
 
bimolecular 
 
M* P
Light reaction
 
M* P
Light reaction
 
 
(5.1 e) 
 
(5.1 f) 
P is the primary photochemical product(s), these can then react further in a variety of 
dark reactions. 
vi) Secondary processes P F  (final products)
Dark reaction
 
(5.1 g) 
In organic molecules, M* can either be an excited singlet or triplet state and may react 
on its own in unimolecular reactions (dissociations, isomerisations) or with another 
ground state molecule N, in bimolecular processes (additions, substitutions, etc.). 
ii a) Phosphorescence 3M*  →  M  +  hνP (5.1 h) 
Iii a) Non-radiative deactivation 3M*    M  (+ heat) (5.1 I) 
 
1S1
3T1
1S0
(5.1 a)
(5.1 b)
(5.1 d)
(5.1 h)
Excited State
Photochemistry
Absorption
Internal 
conversion
Fluorescence
 10-7  -  10-9 s
Intersystem 
crossing
Metastable state
Photochemistry
Phosphorescence
          1 - 10 -3 s
Internal 
conversion
 
 
Figure 5.1 Jablonski diagram.117 
 
Upon the absorption of light (5.1a) one electron is excited without a change in spin direction from 
the ground singlet state (1S0) to an excited level, 1S1, i.e. an excited singlet state.114 For the sake 
of simplicity, only the first excited state is shown. Depending on the molecular structure and 
environment, the excitation energy of the 1S1 state may be released by one of several processes: 
a) The unexcited sensitiser may be restored by emission of a photon as fluorescence (5.1b) and 
by radiationless energy transfer to the medium as heat (5.1c); b) alternatively, the transfer of the 
1S1 excitation energy to an unexcited molecule may result in relaxation (efficient energy transfer 
from a donor to an acceptor requires that the acceptor be a lower energy ‘state’ or system; c) 
intersystem crossing (ISC, 5.1d) to the lowest energy triplet state (3T1) requires a spin flip (this 
conversion from the triplet to the singlet ground state would require another spin flip - a ‘forbidden’ 
transition, accounting for the long lifetimes inherent in triplet states; and d) the radiative decay of a 
triplet state leads to phosphorescence (5.1h). Molecules with heavy atoms or a medium with 
heavy atoms promote ISC.114  
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Due to their long decay lifetimes and the presence of unpaired valence electrons, dye (as 
sensitisers) triplet states are chemically reactive. Type I photosensitisation, where fast electron 
transfer reactions between an unstable complex of an excited singlet state and other substrates 
have been identified. Whereas Type I photosensitisation initiated by excited singlet states are 
uncommon, initiation by a metastable triplet state is favoured because of long decay lifetimes and 
the separated, unpaired electrons in different molecular orbitals. In a Type II pathway, energy 
transfer from the sensitiser triplet state to molecular oxygen generates 1O2 in the following 
manner:114 
3T1 (↑↑) +  3O2 (↓↓) →  1S0 (↑↓)+  1O2 (↑↓) 5.2
 
The energy of the sensitiser in the triplet state relative to the energy in the 1S0 ground state must 
greater than the 0.98 eV (22.5 kcal/mol) needed to excite the triplet O2 to the singlet O2 (1∆g+). 
Triplet states of many organic molecules are capable of generating 1O2. Quenching of a sensitiser 
triplet state by molecular oxygen is a competing process, given by: 
 
3T1 (↑↑) +  3O2 (↓↓) →  1S0 (↑↓)+  3O2 (↑↑) 5.3
 
where 3O2 denotes ground state O2 (3Σg-). Competition between electron transfer and 1O2 
production by energy transfer occurs as shown by: 
 
3T1  +  3O2  →  S+  +  O2• - 5.4
 
where S+ is the oxidised photosensitiser free radical and O2• - is the anion radical superoxide. This 
is also classified as a Type I reaction process. Superoxide is the anion of the hydroperoxy 
(perhydroxyl) radical HO2• with pKa = 4.4, an important form of active oxygen. Its function and 
reactions differ from those of 1O2. The enzyme superoxide dismutase catalyses the conversion of 
superoxide to hydrogen peroxide in many cells. Some photosensitisers are capable of generating 
both 1O2 (by energy transfer from the triplet state) and superoxide (by electron transfer). When 
sensitiser triplet states react with substrates other than oxygen, the process may either return the 
sensitiser to its ground state (which is known as physical quenching) or initiate a chemical 
reaction (known as chemical quenching):114 
 
3T1  +  R  →  1S0  +  R 5.5
3T1  +  R  →  S+  +  Rred 5.6
3T1  +  R  →  S-  +  Rox 5.7
 
where Rred and Rox are quencher free radicals and S- is the reduced sensitiser free radical. In 
quinoid sensitisers S- is usually a semiquinone. Reduced sensitisers are another source of 
superoxide as indicated by the following reactions: 
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S-  +  O2  →  S  +  O2
• - 5.8
Q-  +  O2  →  S+  +  O2
• - 5.9
 
The Fenton reaction, in which a metal ion is oxidised by hydrogen peroxide, has also been found 
to generate hydroxyl radicals (OH• ) upon photosensitisation: 
 
Fe2+  +  H2O2  →  Fe3+  +  OH
•  +  OH- 5.10
 
5.2.1 Singlet Oxygen 
 
Because many photochemical reactions involve the attack of excited singlet oxygen 1O2 on a 
ground state reactant molecule, the photophysical properties of the oxygen molecule are 
important.112 
 
a) Electronic structure and lifetime of singlet oxygen 
 
Molecular oxygen has two unpaired electrons in its lowest energy state. The existence of 
unpaired valence electrons in a stable molecule is very rare in nature resulting in a highly reactive 
chemical system.114 The electronic structure of singlet oxygen is ably described by the molecular 
orbital theory. The oxygen molecule is unique in that its lowest electronic state is the triplet ground 
state (3Σg-) and, with two unpaired electrons distributed in the highest orbitals (Figure 5.2), two 
possible singlet excited states result upon the rearrangement of the electron spins within the 
degenerate orbitals. Oxygen is thus capable of having both triplet and singlet excited states. The 
first excited state (1∆g+), i.e. both electrons paired in the same orbital (Figure 5.2), has the lowest 
energy and is expected to undergo two electron reactions. The excitation energy of this form is 
0.98 eV or 22.5 kcal/mol (Figure 5.3). Alternatively, the higher energy singlet state (1Σg+) is 
expected to undergo one electron free radical reactions due to its spin-paired electrons occurring 
in different molecular orbitals (Figure 5.3). The more reactive 1Σg+, with an excitation energy of 
1.63 eV (35.7 kcal/mol-1), has a much shorter lifetime than the 1∆g+ state and decays to the lower 
energy state before any chemical reactions can occur. Neither form (1∆g nor 1Σg) is a radical, 
given that there are no unpaired electrons, nor are there any spin restrictions. The lifetime of the 
singlet oxygen has been found to be dependent on the solvent. 114,115 
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Figure 5.2 Bonding in the diatomic oxygen molecule.116  
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Figure 5.3 Jablonski diagram for an oxygen molecule. (Energy in kcal/mol).112 
 
Figure 5.3 shows the Jablonski diagram for the oxygen molecule. Only the first few states relevant 
to photooxidation processes are shown.  
 
b) Production of singlet oxygen 
 
Singlet oxygen may be generated by either a) chemical methods, e.g., the biologically important 
reaction of hydrogen peroxide with sodium hypochlorite to produce singlet oxygen b) enzymatic 
reactions e.g. by the myeloperoxidase enzyme during phagocytosis; c) gaseous discharge 
(produced by passing an electric current through a gas or vapour) or d) by physical methods such 
photosensitisation (used in PDT).   
 
The pathway in which a photosensitiser triplet state reacts first with a substrate other than 
molecular oxygen is termed Type I, and reactions involving O2- also occur. The alternative Type II 
pathway involves the photosensitiser triplet state reacting first with molecular oxygen (Figure 5.4). 
Type II photosensitisation of a biological system is known as photodynamic action. 
   1Σg+ 
  3Σg-
   1∆g
+ 
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Type I reactions are characterised by the excitation of a sensitiser (S) followed by electron 
transfer between the sensitiser and the substrate (RH) or solvent to give radicals or radical ions. 
These radicals then react with surrounding oxygen molecules (3O2) to form the superoxide radical 
anion that may be protonated at low pH to form the reactive HO2• radical. The mechanism for a 
Type II reaction involves the transfer of energy from the excited sensitiser (S• ) (as a result of the 
absorption of light) to adjacent 3O2 molecules to form singlet oxygen (1O2). Singlet oxygen and 
superoxide thus formed can cause the oxidative destruction of tissue, forming the basis for 
photodynamic therapy (please see Section f) for more detail). 
 
Excited State
S
1S 1S 1S
S
3S   3O2
Fluorescence
 (hvF)
Absorption
  of light
(hv)
S
Energy transfer
1O2 Tissue necrosis
Intersystem 
crossing
Ground State
*
*
*
*
*
 
 
Figure 5.4 A modified Jablonski diagram showing the relevant reactions for a Type II 
mechanism, emphasising the basis of PDT. (S = sensitiser). 
 
c) Detection and measurement of singlet oxygen 
 
Several methods may be used to detect singlet oxygen including the use of: 
i. the protective effects of additives such as scavengers which inhibit the rate of a 1O2 or 
photochemical reaction e.g. histidine, tryptophan, melatonin, 1,4-diazobicyclo-[2,2,2]octane 
(DABCO), thiols, azides, ascorbates (e.g. vitamin C), cholesterol and the carotenes; 
ii. deuterated solvents, an unambiguous test for 1O2, which prolong the lifetime of the 1O2 e.g. 
D2O, DMSO-d6, etc.; and 
iii. luminescence, termed the ‘gold standard of singlet oxygen identification’, which is the result 
of the energy given off during the transition from the excited 1O2 back to the ground state, 
and corresponds to an absorption in the near infra-red (NIR) region at 1268 nm; 
iv. electron paramagnetic resonance (EPR), a non optical technique in which the energy 
transfer between the magnetism of unpaired electrons and an external magnetic field is 
measured with a sensitive microwave detection system.  The magnetic interaction between 
an electron and the magnetic field corresponds to the energy difference between the spin 
up and spin down states.  Singlet oxygen, however, is a non magnetic molecule (Figure 5.2) 
and cannot be detected directly by EPR. The reaction of singlet oxygen with a spin label 
whose structure, as determined by EPR, provides an unambiguous identification e.g. 
2,2,6,6-tetramethyl-4-piperidone (TEMP) is often used.114 
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d) Reactions involving singlet oxygen 
 
Singlet oxygen reacts with many compounds including: olefins, dienes, sulfides, aromatics, 
hetero-aromatics, terpenes, steroids, fatty acids, flavones, tetracyclines, vitamins, amino acids, 
proteins nucleic acids, blood and bile pigments and synthetic polymers.114,115   
 
Reactions fall into three general classes: 
i. the ‘ene' reaction, which involves hydrogen abstraction and oxygen addition 
ii. cycloaddition, which includes the formation of a typical product 1,2-dioxetane and 
endoperoxides of e.g. anthracene, and  
iii. oxygenation as illustrated by: 
 
R-S-R  +  1O2  → R2SO 5.11
 
e) Quenching of singlet oxygen  
 
Deactivation of the 1O2 back to its ground state is known as quenching and may be accomplished 
by either physical or chemical methods (please see Section 5.3.1). Physical deactivation is simply 
the reversion of the singlet oxygen to its ground state without any product formation or oxygen 
consumption. Chemical quenching, consisting of energy transfer and electron transfer 
mechanisms, incorporates the use of a quencher (Q) that reacts with the singlet oxygen to 
produce RO2. Energy transfer involves the generation of a triplet state quencher together with the 
subsequent formation of ground state oxygen, while electron transfer quenching entails the 
interaction between the electron deficient 1O2 molecule and the electron donors to form a charge 
transfer complex.  
  
f) Photodynamic therapy   
 
A number of factors are important in PDT and a good photosensitiser should have:  
i. sufficient triplet energy (more than 94 kJ/mol), for adequate interaction with ground state 
oxygen; 
ii. a high triplet yield; 
iii. a long triplet lifetime; 
iv. a high singlet oxygen quantum yield; and 
v. a strong absorption in the red region of the spectrum (owing to the light absorption and 
scattering properties of human tissue).118 
 
The singlet oxygen quantum yield is a key property of a photosensitising agent since the ability of 
a compound to produce singlet oxygen determines its potency in photodynamic therapy (PDT). 
The production of singlet oxygen is measured as the singlet oxygen quantum yield (Φ∆).117 The 
Chapter 5: Photochemistry 
 
 127
quantum yield gives an indication of the overall efficiency of a photochemical process and may be 
described as the number of molecules of 1O2 generated for every photon absorbed by the 
photosensitiser. The production of 1O2 by photosensitisation involves 4 steps (Figure 5.4): 1) the 
absorption of light by the sensitiser, 2) the formation of the sensitiser triplet state, the quantum 
yield of this process is the ISC efficiency or triplet yield (ΦT), 3) trapping of the triplet state by 
molecular oxygen within its lifetime (the fraction of trapped triplet state is given by fT), 4) Energy 
transfer from the triplet state to molecular oxygen. Virtually all measurements of the quantum yield 
(Φ∆) are scaled to a reference substance, e.g. rose bengal (Φ∆ 0.79) in aqueous media. 
 
5.3 Photochemical techniques 
 
5.3.1 Singlet oxygen quantum yield determinations 
 
The efficiency of a photochemical process is recognised as the quantum yield, defined as the 
number of reactive species formed for every photon of light absorbed.112 The effectiveness or 
ability of a molecule or sensitiser in the excited (triplet) state to react with ground state oxygen 
thus forms the basis of singlet oxygen quantum yield determinations. 
 
The foundation for the analysis was based on the production of singlet oxygen upon irradiation by 
a sensitiser and a quencher, and the quencher subsequently allowed to react with the singlet 
oxygen accordingly produced.117 1,3-Dipenylisobenzofuran (DPBF), with its absorption maximum 
at 417 nm, was used as the quencher and its disappearance was easily monitored. Only the first 
20% decrease is applicable in order to obtain reliable or accurate first order kinetics data. The 
disappearance of the DPBF quencher is related to the production of singlet oxygen and the 
following processes may take place: 
 
S  +  hν  →  1S* Excitation of sensitiser 5.12
1S•  →  3S* Intersystem crossing 5.13
3S*  +  O2  →  S  +  1O2* Chemical quenching 5.14
S  +  1O2* → 3S*  +  3O2 Physical quenching 5.15
1O2* → O2 Natural decay 5.16
  Kq 
DPBF  +  1O2* → DPBF  +  O2  +  Oxidation products 
 
Chemical quenching 5.17
  Kq 
DPBF  +  1O2* → DPBF  +  O2 
 
Physical quenching 5.18
 
The physical quenching processes (Eqn. 5.15 and 5.18) noted above may be ignored because 
the quantum yield of singlet oxygen is not dependent on the concentration of the sensitiser 
present and the DPBF is known to act as a chemical quencher only in organic solvents, 
respectively. Also, compared to the potential sensitiser, DPBF is highly reactive to singlet oxygen, 
making equation 5.14 invalid.117 Thus, the only equations of relevance are 5.16 and 5.17 (while 
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equations 5.12 and 5.13 are mentioned only for the sake of clarity). The rate of disappearance of 
DPBF as a result of singlet oxygen is given by:117 
 
-[DPBF]  =  Kq[DPBF][1O2] 
     dt 
5.19
 
Following rearrangement and substitution the following equation is derived:117 
   
Φ∆
S   = Φ∆Std x (C  o – C t)S x (αt)Std x [DPBF]Std 5.20
   (Co – Ct)Std  (αt)S  [DPBF]S 
 
where: 
S  = sample 
Std  = standard 
(Co – Ct) = change in DPBF concentration (Co = initial and Ct = final) 
α  = 1 (for the monochromatic laser light, previously determined by Maree117) 
t  = photolysis time-span in seconds 
 
It is important, though, to clarify the use of low concentrations of DPBF since first order kinetics 
are observed, while at high concentrations the reaction rate would become independent of the 
DPBF concentration and a zero order rate law would be observed. 
 
5.3.2 Fluorescence quantum yield determinations 
 
The number of photons emitted relative to the number of photons absorbed is known as the 
fluorescence quantum yield. The quantum yield is determined by using a suitable reference 
material (of a known quantum yield) in a specific solvent such as benzene in cyclohexane (ΦF). 
Absorption spectra are recorded prior to plotting emission spectra, while quenching necessitates 
the use of low concentrations. Fluorescence quantum yields are determined using the following 
equation:117 
ΦF  =  ΦF(std) X Area  (S)  x  A  (Std)  x  η2  (S)    
   Area(Std)  x  A(S)  x  η2(Std) 
5.21
 
where: 
S = sample 
Std = standard 
Area = area of the relative emission and absorbance bands together 
A = absorbance 
η = refractive indices of the solvents used 
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5.4 Experimental 
 
5.4.1 Instrumentation and techniques for singlet oxygen determination 
 
The excitation pulse source for the singlet oxygen studies was provided by an Nd-Yag laser 
(providing 47 mW, 9 ns pulses of laser light at 532 nm) and the basic setup is shown in Figure 
5.5. An energy meter was used to measure the pulse energy of the laser light.  
 
Nd-Yag Laser
Sample
Power
Source
 
 
Figure 5.5 Set-up for singlet oxygen quantum yield determinations. 
 
Absorbance spectra were recorded on a Varian UV-Vis-NIR spectrophotometer. The 
photochemical experiments were carried out in a 4 mL UV cell with an optical pathlength of 1 cm. 
The absorbances of the quencher (DPBF) and the sample sensitiser solutions were set to 
approximately 1 by dilution. Care was taken to ensure that the absorbance peak of the DPBF (at 
417 nm) was observed, thus the volume of DPBF used was dependent on the UV bands 
observed for a particular sample. Both the DPBF and pyrroloiminoquinone solutions were made 
up in DMSO. Air saturated solutions were used for all experiments except where stated and the 
measurements carried out at room temperature. The decrease in the DPBF band was monitored 
while ensuring that the bands belonging to the pyrroloiminoquinone samples remained 
unchanged (the light intensity was kept low enough to avoid this decrease, as any change would 
indicate photobleaching or photodegradation of the sample). The absorbance of a reference 
solution (porphine in benzene, Φ∆ = 0.66),118 was used to calculate the Φ∆ of porphine in DMSO, 
which was found to be 0.658, i.e. ~ 0.66. 
 
5.4.2 Instrumentation and techniques for fluorescence quantum yield determinations 
 
Absorbance and fluorescence spectra were recorded in MeOH on a Cary Varian 500 UV-Vis-NIR 
spectrophotometer and a Varian Eclipse spectrofluorimeter. Slit widths for the spectrofluorimeter 
were kept at 10 nm and the excitation wavelengths used were between 260 and 483 nm. 
Fluorescence of the MeOH solvent occurs at excitation wavelengths lower than 240 nm. The 
experiments were carried out in a cell with an optical pathlength of 1 cm at room temperature. The 
absorbance spectra of the sample solutions were recorded and set to between 0.2 and 0.4 by 
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dilution (in order to minimise quenching), and the fluorescence emission spectra subsequently 
run. The reference material used was benzene in cyclohexane (ΦF = 0.05 ± 0.02).119 
 
5.5 Results and Discussion 
 
5.5.1 Singlet oxygen quantum yield determinations 
 
Upon irradiation of the DPBF quencher, in the presence of a select group of 
pyrroloiminoquinones, the absorbance of DPBF was observed to decrease. The UV absorption 
bands of the samples remained unchanged (Figure 5.6), indicating the suitability of the light 
intensity chosen. The singlet oxygen quantum yields (Φ∆), calculated using Eqn. 5.20, is 
presented graphically in Figure 5.7 and listed in Table 5.1.  
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Figure 5.6 A typical UV / Visible absorbance spectrum obtained during singlet oxygen 
production of compound 4.1 in the presence of the DPBF quencher. 
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Figure 5.7 Comparison of the singlet oxygen quantum yields and rate constants obtained 
for the pyrroloamino-ortho-quinone, pyrroloiminoquinones and bis-pyrroloiminoquinones. 
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Moderate values (0.36 ≤ Φ∆ < 0.43) were obtained for 3.1, 1.52, 1.51 and 1.51 FB. Upon 
comparison of the results, the brominated compounds were shown to have slightly higher values. 
These observations may be due to a combination of effects including the heavy atom effect114,117 
and the fact that these compounds are slightly more electron donating. The free base of 1.51 
showed only a marginal increase in singlet oxygen production, though the rate of production was 
slightly slower. Conversely, compounds with stronger electron withdrawing groups (such as 3.3, 
2.4, 1.33 and 1.20) were found to have particularly low quantum yields (0.01 ≤ Φ∆ ≤ 0.1). It is 
possible that these low values may in part be due to the quenching abilities of the amino groups 
(3.3, 1.33), or due to the extra hydroxyl and carbonyl group (2.4, 1.20) functionalities, which are 
also able to act as quenchers. 
 
The bis-pyrroloiminoquinones also demonstrated moderate, though lower, Φ∆ values than the 
discorhabdin type compounds, with the methylated 1.72 compound exhibiting a slightly higher 
value than its counterpart 1.71. A possible explanation, here again, could be the presence of the 
extra inductively electron donating group (a methyl group). Following excitation of these 
pyrroloiminoquinones (PIQ), the following mechanism may have been observed: 
 
3PIQ1  +  O2   →   1PIQ0  +  1O2 5.22
DPBF  +  1O2  →  DPBF  +  O2  +  oxidised products 5.23
 
Surprisingly, three compounds, 1.57 and the N-18 oximes (4.1 and 4.2), consistently produced 
singlet oxygen quantum yields above 1. The free base of 1.57 showed a marked increase in its 
singlet oxygen quantum yield. A quantum yield value greater than 1 is often observed when 
photolysed compounds generate radicals. Bearing in mind that a quantum yield of a primary 
process is a value between 0 and 1 (since it represents the probability that an excited state will 
undergo a reaction), the quantum yield of an overall reaction (primary and secondary processes) 
can, however, be greater than 1, depending on the secondary processes taking place (please see 
Eqn. 5.1 g, Section 5.2.1). These yields can be quite large when chain reactions occur.112   
 
Some photosensitisers have been shown to generate both 1O2 and superoxide (by electron 
transfer), which may also explain our observations. As discussed previously, quinoid-type 
sensitisers can form semiquinone radicals and these reduced sensitisers may then produce 
superoxide by electron transfer as shown in Section 5.2. Although a great deal of work still needs 
to be done, the following is a tentative proposal for the production singlet oxygen by 
pyrroloiminoquinone metabolites: 
 
3PIQ1  +  DPBF  →  PIQ-  +  DPBFox 5.24
PIQ-  +  O2  →  PIQ  +  O2• - 5.25
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Table 5.1 Singlet oxygen quantum yields (Φ∆), rate constants and R2 data obtained for the 
various pyrroloamino-ortho-quinone, pyrroloiminoquinones and bis-pyrroloiminoquinones in 
DMSO.  
 
Compound Φ∆ Rate constant (/s) R2 
1.20 0.14 -1.56  x  10-5 0.997 
1.33 0.03 -1.56  x  10-4 0.997 
1.51 0.38 -6.20  x  10-4 0.992 
1.51 FB 0.41 -3.10  x  10-4 0.991 
1.52 0.43 -7.70  x  10-4 0.992 
1.57 1.39 -2.18  x  10-3 0.996 
1.57 FB 2.50 -2.90  x  10-3 0.995 
1.57 (N2) 0.31 -2.92  x  10-4 0.990 
1.57 DMSO-d6 4.23 -2.74  x  10-3 0.993 
1.71 0.25 -3.75  x  10-4 0.997 
1.72 0.41 -6.26  x  10-4 0.992 
2.4 0.07 -6.06  x  10-4 0.995 
3.1 0.36 -3.26  x  10-4 0.993 
3.3 0.01 -2.75  x  10-5 0.981 
4.1 3.68 -5.05  x  10-3 0.999 
4.2 1.51 -1.79  x  10-3 0.998 
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Figure 5.8 The effects of deuterated, air saturated and ‘nitrogen saturated’ DMSO on the 
singlet oxygen (Φ∆) production of discorhabdin A (1.57). The difference between 1.57 
(TFA salt) and its free base (marked base on the graph) on Φ∆ production is also shown.   
 
As discussed in Section 5.2 c), evidence for the presence or involvement of singlet oxygen in the 
study may be confirmed by performing the photolysis in deuterated solvents (in this instance 
DMSO-d6) or by bubbling an inert gas such as argon or nitrogen to de-aerate the system. The 
former was found to increase the rate of disappearance of DPBF (Figure 5.8), which is typical 
since singlet oxygen has a much longer lifetime in deuterated solvents and the singlet oxygen is 
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thus able to interact with the photo excited molecule to a larger degree. On removal of oxygen 
from the system, on the other hand, the expected substantial decrease in the rate of reaction was 
observed (Table 5.1 and Figure 5.8). Both experiments thus provided the evidence for the 
presence of singlet oxygen. It may therefore be concluded that the pyrroloiminoquinones tested 
produced singlet oxygen. 
 
5.5.2 Fluorescence quantum yield determinations 
 
For the most part, the fluorescence quantum yields (ΦF) obtained for the select group of 
pyrroloiminoquinones were found to be low (Figure 5.9). Amino groups are known to quench 
singlet excited states, which may account for the low values obtained for 3.3 and 3.2, but not 
1.33. Comparison of the values obtained for 3.3 and 3.2 with the moderately high ΦF value 
obtained for the desulfurated 2.4, which has an additional hydroxyl group, may indicate that a 
thioether, i.e. heavy atom effect,117 may account for a decrease in the quantum yield, as seen with 
1.57. Compound 1.33 (Figure 5.9) had a relatively high ΦF, whereas compound 1.20 had one of 
the lowest ΦF values, along with 1.57, and so perhaps the complexity of the ring system is 
unimportant. Comparison of 1.57 with 1.51, 1.52 and 1.53 which have slightly higher quantum 
yields, also indicated that a thioether led to a decrease in ΦF, while an additional hydroxyl group 
led to a slightly higher value (1.51 and 1.52). On the other hand, the effect of an additional 
bromine on the quantum yields of 1.52 and 1.53 was found to lead to a slightly lower quantum 
yield, since molecules with heavy atoms promote ISC (Section 5.2). The N-13-methylated bis-
pyrroloiminoquinone 1.72, had a slightly higher quantum yield than 1.71. On the contrary, a higher 
quantum yield was observed for 1.71’s N-oxime (i.e. 4.1). In retrospect, taking into consideration 
the satisfactory results obtained for the singlet oxygen quantum yield study, the low values arrived 
at for the fluorescence studies are not unusual (please refer to Figures 5.1 and 5.4). As a rule of 
thumb, a low value obtained for the fluorescence may imply a higher value for phosphorescence. 
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Figure 5.9 Fluorescence quantum yield (ΦF) data obtained for selected pyrroloimino-
quinones (values given in the graph). 
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Figure 5.10 Fluorescence and absorbance spectra of 1.33. 
 
Figure 5.10 shows the absorbance and fluorescence spectra obtained for a representative sample 
1.33. The spectra are distinctly different, perhaps indicating that the nuclear configurations of the 
ground and excited states are not the same and that the system may have undergone 
geometrical and structural alterations upon excitation.117 
  
5.6 Conclusion 
 
Most of the pyrroloiminoquinones were shown to produce singlet oxygen which could be effective 
in cell destruction. In general, those compounds with stronger electron withdrawing groups, such 
as amino, or extra carbonyl or hydroxyl group functionalities, were found to have low singlet 
oxygen quantum yields. These functional groups are, however, known to quench singlet oxygen 
production thus explaining the low singlet oxygen quantum yields observed. Alternatively, those 
compounds with thioethers and additional bromines, or inductively electron donating groups such 
as a methyl group, were found to have higher quantum yields. These compounds may follow a 
Type II reaction mechanism. The quantum yields obtained for the N-18 oximes (4.1and 4.2) and 
1.57 are likely to indicate the production of radicals, perhaps with some contribution from singlet 
oxygen, suggesting that a Type I, or a Type I and II, reaction mechanism is involved.  
 
PDT relies on the presence of oxygen to destroy cancerous cells. Hypoxic tumours, however, 
present a drawback for such an aerobic process. The N-18 oximes, having been shown to 
produce radicals, may still find use in cancer therapy since they could have the dual purpose of 
acting as an oxygen surrogate (thus enabling the production of singlet oxygen) in oxygen poor 
tumours (hypoxic) as well as being responsible for the generation of DNA damaging radicals. 
Quinoxaline di-N-oxide103 has been found to be highly selective in killing hypoxic cells found in 
tumours. Upon irradiation, the lesions under both aerobic and anaerobic conditions were believed 
to occur via electron transfer from the nucleobase to the photoexcited quinoxaline di-N-oxide, 
although under aerobic conditions, some contribution from 1O2 was thought to have taken place. 
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In the past, pyrroloiminoquinones have demonstrated significant anticancer activity and were 
originally considered as potential candidates for development as antitumour drugs. These 
compounds interact with DNA in the following manner: 
y by intercalation,   
y through DNA strand breakage, 
y by topoisomerase I / II inhibition, and  
y through semiquinone radical intermediates (which would lead to DNA single strand 
breaks) 
 
Ireland and Barrows30 proposed the in vivo activation of the iminoquinone moiety to the 
semiquinone intermediates and these photochemical investigations conducted have confirmed 
that pyrroloiminoquinones (1.57 and the N-18 oximes) are indeed capable of producing radicals 
that could lead to single strand breakages the study has therefore shown that the 
pyrroloiminoquinones are capable of mediating DNA damage through the production of singlet 
oxygen upon photosensitisation.  
 
The fluorescence quantum yields were found to be low for all compounds except 1.33 and 4.1.  
These two compounds may still find use in PDT in terms of imaging where the compounds ability 
to fluoresce is used to image the tumour by fluorescence detection and its biodistribution is 
therefore followed. Since the basis of PDT is the fact that the sensitiser is harmless until activated 
by light, light may thus be selectively shone on the tumour (the sensitiser located through its 
ability to fluoresce) through an optical fibre. The molecule will therefore be activated and cell 
death will only occur in the predetermined area. In view of the singlet oxygen quantum yield 
production for these compounds the low ΦF yields could be expected (Figure 5.1).   
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Chapter 6: Electrochemistry 
 
6.1 Introduction 
 
Electrochemistry has often been used to describe and understand certain biological processes 
which are known to have an electrochemical foundation. Electron transfer is well known in the 
biological realm, and, ironically, in addition to being responsible for the progressive replication of 
cancerous cells, molecular electron transfer has been proposed to be crucial in an organism’s 
biological defence.120 Common physiological and biochemical processes associated with 
electrochemical reactions include photosynthesis, nerve excitation, blood coagulation, vision, 
smell and many enzymatic reactions, as well as the bioreductive activation of pro-drugs to a more 
toxic constituent.120,121 A biological cell has a rich source of transferable electrons in its 
compounds containing nitrogen, sulfur and oxygen atoms, all of which have non-bonding pairs of 
electrons, i.e. electrons which are available for transfer. However, the cell is poor in electron 
acceptors, with only carbonyls and keto-aldehydes, for example, readily available. A large amount 
of research has thus been carried out over the years in evaluating the electrochemical properties 
of proteins, enzymes and various cellular components,120 and with particular relevance to the 
work described in this thesis in investigating the interaction of various molecules with DNA.122  
 
The concept of bioreductive activation of pro-drugs in hypoxic tumour cells, first observed in vitro 
with metronidazole, to produce the more toxic active compound, has been extensively reviewed121 
and three general classes of such agents are now known. The first class comprises the quinone 
antibiotics of which mitomycin C (6.1) was the prototype drug. The second class of bioreductive 
cytotoxins are benzotriazine di-N-oxides of which tirapazamine (6.2) is the prototype compound. 
Tirapazamine is the first drug to be introduced into clinical trials as a bioreductive cytotoxic agent. 
The nitroimidazoles which were initially developed as radiation sensitisers but also show 
preferential toxicity to hypoxic cells as dual function agents, e.g. RSU 1069 (6.3) form part of the 
third class.121 
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The first two classes contain compounds which exhibit some structural homology with the 
pyrroloiminoquinones discussed in previous Chapters and a brief overview of their 
electrochemical properties is therefore deemed necessary. 
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As mentioned previously, mitomycin C is an example of a pro-drug that is metabolically activated 
by reduction or acidification. Chemical and enzymatic one electron reduction of mitomycin, 
followed by the removal of the C-9a methoxy substituent, with the assistance of the non-bonding 
electrons on the neighbouring aziridine nitrogen atom, a reduced mitosene is obtained.  This 
intermediate is a bifunctional alkylating agent capable of cross-linking DNA. Upon oxidation, the 
activated, reduced form of mitomycin C, which produces adducts with the nucleophiles present, 
covalently linked at C-1 or both C-1 and C-10. Reduced mitosenes are therefore the active 
intermediates in the bioreductive activation process.123,124 Studies on the relationship between 
structural modifications in mitosenes and their antitumour activity have included variations of the 
6- and 7- substituent of the quinone ring, the carbamate function and the aziridine ring and results 
indicate that the reductive activation of mitosenes proceeds via a quinone methide and or iminium 
ion intermediate.123 
 
The 1,2,4-benzotriazine 1,4-di-oxides, after several groups investigated the mechanism for the 
selective toxicity of tirapazamine on hypoxic cells found in solid tumours, are thought to derive 
their antitumour properties from DNA cleavage.123,125 The importance of the N-oxide group for the 
selective activity of 6.2 led to the design of new heterocyclic N,N-dioxides and the exploration of 
their activity in hypoxic cells.123 An enzymatic one electron reduction of the heterocycle was 
proposed to lead to the production of radical species and ultimately to DNA damage. The redox 
activated DNA cleavage by tirapazamine is markedly inhibited by molecular oxygen and, in the 
absence of reducing systems, 6.2 alone does not damage DNA. Workers have suggested that the 
more negative the reduction potential displayed by a particular compound, i.e. to the point at 
which enzymes can no longer reduce the compound, the greater the hypoxia selectivity.121 Monge 
et al. included electrochemical data in their research paper to demonstrate whether the reduction 
potentials can be related to oxic or hypoxic selectivity.121 
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Scheme 6.1 The two possible mechanisms for DNA Cleavage by tirapazamine (6.2).124 
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Two possible mechanisms for DNA cleavage in mammalian cells by tirapazamine are shown in 
Scheme 6.1. The highly cytotoxic 6.4 is produced on reduction of 6.2 and the rates of reduction 
parallel cytotoxicity in several different cell lines. The specific toxicity of 6.2 toward hypoxic cells is 
thought to occur via the activated form of the drug radical (6.4) being destroyed by molecular 
oxygen (i.e. 6.4 is oxidised back to the parent drug in the presence of oxygen). Such back 
oxygenation regenerates the drug and leads to the production of a superoxide radical, a species 
whose in vivo toxicity is diminished by the cellular enzymes superoxide dismutase and catalase. 
Daniels and Gates125 provide evidence in support of the notion that a hydroxyl radical species, 
rather than the radical form of 6.2, is involved in the cleavage of DNA by the reductively activated 
6.2. This supposition, realised through the use of radical scavengers that react specifically with 
oxygen radicals versus other radical species and through monitoring of the low sequence 
selectivity observed in the DNA cleavage by the tirapazamine, is consistent with the involvement 
of a highly reactive, nonselective cleaving agent such as a hydroxyl radical. The ability of 6.2 to 
cleave DNA was also found to depend on the enzymatic reduction.125 The drug radical 6.4 when 
produced in vivo could, however, perhaps react with non-nucleic acid cellular components, 
resulting in DNA cleavage. A weak reduction dependent DNA cleavage was observed with the 
two electron reduced form of tirapazamine (6.5) upon incubation with an enzyme system, which 
alone is not a DNA-cleaving agent. Reducing agents such as sodium dithionite, sodium ascorbate 
and thiols were found to be incapable of effecting the reductive activation of 6.2. It thus appeared 
that 6.2, together with reductive cellular enzymes, may serve as an agent to provide hydroxyl 
radicals, which are known DNA cleaving agents in radiotherapy, specifically to hypoxic tumour 
cells in vivo.125 Hecht and co-workers obtained similar results upon describing the redox-activated 
DNA cleavage by phenazine N-oxides 6.6.125,126 
 
N
N
O
O
R
 
6.6 
 
Radisky et al.30 showed that the DNA reductive cleavage activity of certain pyrroloiminoquinones 
is mediated by redox chemistry. The results demonstrated that makaluvamine-mediated reductive 
cleavage of DNA (determined using a supercoiled pBR322 DNA assay) is dependent on the 
capacity of the compound to intercalate into DNA as well as on its ability to produce a (semi-
quinone) radical. In addition, the makaluvamines (as well as discorhabdin A) were also shown to 
cause significant DNA single-stranded scission, i.e. no double-stranded cleavage was observed in 
the reductive cleavage assay.  
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The photochemistry study (Chapter 5) showed that a suite of fourteen pyrroloiminoquinones 
isolated from South African Latrunculid sponges are proficient singlet oxygen producers, three of 
which were shown to be capable of producing radicals upon irradiation. Electrochemistry may 
therefore a) give insight as to whether these pyrroloiminoquinones undergo one or two electron 
reductions (one electron reductions have been shown to initiate radical-mediated DNA strand 
damage103 and this information may therefore be important in understanding the compound’s 
mechanism of action in vitro), b) give an indication of the compounds’ stability and susceptibility to 
reduction (and thereby characterise these compounds electrochemically), and c) confirm or 
resolve the results obtained using other techniques such as photochemistry. With the expectation 
that a more detailed understanding of the redox chemistry of selected compounds may ultimately 
help facilitate the design of new improved antitumour agents, and since many drugs have been 
shown to be activated in vivo through enzymatic reduction processes, the ability of the 
pyrroloiminoquinone compounds to undergo redox reactions has therefore been investigated. It is 
thus anticipated that the photophysical and electrochemical studies carried out may ultimately 
lead to a deeper understanding of the mechanism of DNA damage induced by these compounds. 
The literature available on the electrochemistry of pyrroloiminoquinones in particular is limited30 
and the properties of sixteen structurally related pyrroloiminoquinones, in pH-varied experiments, 
were characterised using cyclic and square wave voltammetry.  
 
6.2 Electrochemical techniques 
 
6.2.1 Cyclic voltammetry 
 
One of the techniques used to obtain mechanistic information in redox systems is cyclic 
voltammetry (CV). CV enables the electrode potential to be scanned rapidly in search of redox 
couples.  Once located, a couple can then be characterised from the potentials of peaks on the 
cyclic voltammogram and from changes caused by variation of scan rate.127 CV is an enormously 
popular technique and the acquisition of a cyclic voltammogram of a new electrochemical system 
is often the predecessor to other less- straightforward techniques that furnish more detailed 
information.128   
 
In CV, a potential is applied and swept back and forth (where the sweep direction is inverted at a 
chosen potential) linearly with time.  By measuring the resultant current, which is monitored 
continuously, the subsequent oxidation or reduction of the surface species may then be 
examined.  Invaluable, necessary, information as to the presence of an electroactive species (i.e. 
the species absorbed onto the surface of the electrode) in solution or at the electrode surface is 
easily obtained with CV. Cyclic voltammograms are, however, often ambiguous and thus great 
care is taken in the interpretation.128 
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Figure 6.1 Schematic representation of a) the basic setup for a cyclic and square wave 
voltammetric system and b) enlarged schematic of the reference electrode (Ag|AgCl). 
(WFG = waveform generator, P = potentiostat, WE = working electrode, CE = counter 
electrode, RE = reference electrode).128 
 
The equipment used to carry out CV is illustrated in Figure 6.1. The electrochemical cell consists 
of a vessel with an inlet port to allow the saturation of a solution with an inert gas, such as N2 or 
Ar. The removal of O2 is a necessary step to prevent interfering currents that are due to the 
reduction of O2. A standard cell consists of three electrodes immersed in the electrolyte solution: 
a) a working electrode (WE), b) a reference electrode (RE) and c) a counter electrode (CE).  A 
potentiostat monitors and controls the WE potential with respect to the RE. The current flowing 
between the WE and CE (also connected in series) is measured as the potential drop V across a 
resistor R (I = V / R).  The I / V data thus obtained is stored, allowing for further manipulation.128 
 
Figure 6.2 shows a typical cyclic voltammogram that would be obtained from an electroactive 
adsorbed species provided that:  
a) the electrode has the maximum coverage of an oxidised form (O);  
b) the electrochemical reaction can be represented by: Oads  +  ne  ↔  Rads and is kinetically 
fast enough to maintain Nernstian (i.e. reversible) behaviour at each point in the CV scan 
such that the concentrations of O and R near the electrode obey the Nernst equation; 
c) the oxidised and reduced species are both strongly adsorbed and have the same 
enthalpy of adsorption. 128 
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Figure 6.2 The current / potential (I / V) curves expected from an electroactive adsorbed 
species in a reversible redox reaction: Oads  +  ne  ⇆  Rads. E is the potential at which the 
maxima (Ea) and minima (Ec) in the current are observed.128 
 
a) Reversible processes 
 
In reversible systems, the species formed in the forward direction is regenerated in the reverse 
sweep (Figure 6.2), i.e.  
Oads  +  ne  ⇆  Rads 6.1
 
Information obtained from a reversible system includes:129 
i. the E1/2, the half-wave potential, which is characteristic of a particular species, i.e. where  
Eo’  =  E1/2  =  (Ea  +  Ec) / 2   6.2
 
Eo’ is the formal potential, which is corrected to the reference electrode used. 
 
ii. the number of moles of electrons involved in a particular process where:  
 
∆E  =  Ea  -  Ec 6.3
∆E  =  2.3 RT / nF 6.4
 
 where: 
R = Gas constant 
T = Temperature 
F = Faraday’s constant 
n = moles of electrons  
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which at 25 oC becomes 
 
∆E  =  0.0592 / n 6.5
 
where n = moles of electrons involved 
 
iii. stability of a compound (starting compound remains unchanged) and true reversibility of a 
particular species i.e. where 
 
ia / ic  =  1 6.6
 
ip is described by the Randles – Sevcik equation: 
 
ip  =  2.69 x 105n3/2AD1/2CV1/2 6.7
 
where: 
ip  =  peak current (amperes) 
A  =  area of electrode (cm2) 
n  =  moles of electrons 
D  =  diffusion coefficient (cm2/s) 
C  =  concentration (mol/cm3) 
V  =  scan rate (V/s) 
 
According to the Randles-Sevcik equation, an increase in ip is directly proportional to an increase 
in V1/2, which is related to concentration. A linear plot of V1/2 versus ic or ia indicates a diffusion-
controlled mass transfer and is therefore of importance in analytical applications or during 
determinations concerning electrode mechanisms.  
 
CV may thus be used to a) characterise the electroactive system by E1/2; b) to determine whether 
oxidation is occurring; and c) to verify the stability of a complex once oxidation or reduction has 
taken place.   
 
b) Irreversible processes 
 
In an irreversible reaction of the type Oads  +  ne  →  Rads, the voltammogram (Figure 6.3) shows 
no inverse peak on reversing the scan direction, i.e. the compound is unstable. With respect to 
reversible systems the waves are broader and lower, i.e. they are less intense.120 Irreversible 
systems are capable of producing both anodic and cathodic waves but the peaks exhibit very 
large separations i.e. > 200 mV. 
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Figure 6.3 The current / potential (I / V) curves expected from an electroactive adsorbed 
species in an irreversible reaction.  
 
Ep/2 (where Ep/2 = peak at ½ current) is related to E1/2 and may be used in the identification of 
a compound.129 
 
c) Quasi-reversible processes129 
 
In a quasi-reversible system, the peaks appear to be reversible but  
i. at 25 oC    
∆E  ≠  0.0592 / n 6.8
and  
 
ii. if 
∆E  >  60 Mv 6.9
 
the system is characterised as a quasi-reversible process. In essence, molecules 
undergo an appreciable but not a severe change, e.g. 
 
Fe2+(CN)2  →  Fe3+(CN)  +  CN  +  e 6.10
 
6.2.2 Osteryoung square wave voltammetry 
 
Square wave voltammetry (SWV), in this case Osteryoung Square Wave Voltammetry (OSWV), is 
a pulse technique that compliments CV. A predetermined pulse, e.g. 100 mV, is applied for a 
certain time period e.g. 2.5 ms (Figure 6.4). The current (i) obtained before (i1) and after (i2) the 
application of a pulse is recorded simultaneously. The base potential increases by a certain 
amount (dE) for each full cycle of the square wave (e.g. E1 or E2 etc.). All i1 are recorded, as are 
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i2, and subtracted at the end of a run, rather than at the end of each cycle.129 Since only the 
difference in current is recorded, any current recorded due to impurities or the electrolyte solution 
is eliminated. The charging current, i.e. the surplus current which is used to neutralise the 
electrode in CV, is also removed.129  
 
Overall, these factors lead to an increase in sensitivity observed in pulse techniques. SWV is thus 
a rapid method which may be used to monitor transient processes, it is extremely sensitive to the 
electrochemical reversibility of a couple as well as the chemical stability of a product in a forward 
step (Figure 6.5).130 OSWV, which is more sensitive than CV, provides greater resolution of any 
overlapped peaks obtained previously in CV and the E1/2 is thus accurately determined. The 
number of moles of electrons involved may also be determined from the width of a peak at half 
height.129   
 
E (mV)
Time
10 - 100 mV
i1
i2
i1
E1
E2
E3
E4
E5
2.5 ms
i1
i1
i1
i2
i2
i2
 
Figure 6.4 Excitation signals observed in square wave voltammetry.129,130 
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Figure 6.5 The current versus potential (I / V) curves from a) an oxidised and b) a 
reduced electroactive adsorbed species in OSWV, which is often dependent on the scan 
direction.  
 
The current versus potential (I / V) curves expected from a) an oxidised and b) a reduced 
electroactive adsorbed species using OSWV, shown in Figure 6.5, where E1/2  =  (Ea  +  Ec) / 2 as 
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determined in CV. The peak at half height, W1/2 is related to the electron stoichiometry by the 
equation 6.9: 
W1/2  =  3.52 RT  
  nF 
6.9
 
where: 
R = Gas constant 
T = Temperature 
F = Faraday’s constant 
n = moles of electrons  
 
Thus for:  
n  =  1, W1/2 is 90.4 mV and  
n  =  2, W1/2 is 45.2 mV at 25oC. 
 
Sensitivity and resolution involved is dependent on pulse amplitude, frequency and scan rates, 
with larger pulse amplitudes resulting in larger and broader peaks. Because sensitivity and 
resolution is compromised in irreversible processes, these systems show lower and broader 
peaks. Like CV, peak currents are proportional to concentration. 
 
6.3 Results and Discussion 
 
6.3.1 Voltammetric characterisation of pyrroloiminoquinones 
 
For most of the pyrroloiminoquinone metabolites, cyclic voltammetry revealed one clear reduction 
process. Occasionally, only the anodic peak potentials are listed when only the anodic component 
of the reduction process was observed. The main reduction process was assigned as Couple I 
and any additional reduction couples as Couple II, Couple III, etc. Only the main reduction 
process, i.e. Couple I, was studied as a function of voltage sweep rate and switching potential, 
and the tabulated data (Tables 6.2 - 6.5) summarises the main reduction process (Couple I) for 
each of the pyrroloiminoquinones studied. The E1/2 potentials were generally observed to be 
independent of voltage sweep rate and the anodic to cathodic peak separation (∆E), i.e. the ∆E 
values increased with an increase in sweep rates but the E1/2 values remained roughly the same. 
Where there was some uncertainty as to the presence of additional peaks in the data obtained 
from CV, OSWV was used. The buffer solutions (pH 5.5 and 7.5), made up as described in the 
experimental section (Section 8.6), were used as the solvent and the potential swept between      
-800 and 0 mV for all experiments. For the sake of simplicity, the data has been arranged into 
structural classes i.e. a) tricyclic pyrroloiminoquinones, b) discorhabdin C type skeleton, c) the 
discorhabdin D / S type skeleton and d) the bis-pyrroloiminoquinones (Table 6.1). 
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Table 6.1 The grouping of the sixteen pyrroloiminoquinone metabolites into four structural 
classes. 
 
Structural Class Pyrroloiminoquinone metabolites 
a)  
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In general, the pH was observed to influence the number of moles of electrons transferred and, as 
expected, the ease of reduction decreased with an increase in pH for all compounds (Figure 6.6). 
The discorhabdin D type compounds, i.e. those with sulfur, were found to be the easiest to 
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reduce, while the most difficult were the bis-pyrroloiminoquinones. ∆E values were found to be 
closer to 60 mV implying a one electron reduction process for the pH 7.5 buffered solutions, 
except for 1.52, 1.53 and 1.72. These three compounds were, however, found to have ia / ic (i.e. 
unity, equation 6.6) values indicating reversible electron transfer processes. No relationship 
between ∆E and ia / ic was found. The calculations performed to demonstrate unity for ia/ic 
indicated greater deviation from unity for experiments conducted at pH 7.5 (36 % within the range 
of 0.9 and 1.1) which may be due to the lower solubility of these compounds at a higher pH. 
Except for the bis-pyrroloiminoquinones (and their N-18 oximes), the compounds were shown to 
maintain a greater stability at a lower pH (64 % within the same range).  
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Figure 6.6 Comparison of the E1/2 values obtained for the pyrroloiminoquinone 
metabolites. 
 
The mode of transport (i.e. the affinity of a particular species for the electrode surface rather than 
the bulk solution) in an electrochemical cell may take place in one of three ways a) migration, 
where the movement is due to charge; b) diffusion, where the movement is due to the difference 
in concentration of the electroactive species near the electrode and that of the bulk solution; and 
c) stir-convection processes where the electroactive species is forced to move to the desired site. 
Only one mode is operational at any one time provided that the solution is not stirred and that a 
large amount of inert electrolyte is added. Diffusion controlled processes make up the largest 
proportion of all electrochemical analyses.129 In order to verify whether a diffusion-controlled 
process dominated the reactions taking place, a plot of the current (ia) versus the square root of 
the scan rate was evaluated. A diffusion controlled mechanism was found to be the dominant 
process for the pyrroloiminoquinones except for 1.52 and 2.2. From the results obtained, the rate 
constants showed a decrease with an increase in pH, except for the N-18 oximes. The lower 
solubility of these compounds at pH 7.5 may account for the slower rate of electron transfer (the 
observed decrease in the rate constants). No relationship between unity and rate was found e.g. 
upon comparing 1.33, which has a high rate constant and greater deviation from unity (ia / ic) and 
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1.71, which exhibits greater deviation from unity for ia / ic as well as a low rate constant. On the 
whole, the rates and ease of reduction increased with a decrease in pH. 
 
a) Makaluvamine C (1.33) and Damirone B (1.20) 
 
Figure 6.7 shows a typical voltammogram obtained for 1.33. From the ∆E and ia / ic data 
presented in Table 6.2, it is clear that these compounds exhibit mainly reversible, stable 
behaviour, with the exception of 1.33 at pH 7.5 which could be classified as quasi-reversible.  
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Figure 6.7 Cyclic voltammogram of 1.33 (pH 5.5). Scan rate: 25 mV/s. 
 
The ∆E calculations inferred a two electron reduction process (except for 1.33 at pH 7.5) 
according to equation 6.5, while the E1/2 values (Table 6.2 and Figure 6.6) showed that both 1.33 
and 1.20 were quite difficult to reduce, with the more highly oxygenated compound (1.20) 
exhibiting the higher E1/2 value. Both damirone B and makaluvamine C have a methylated, 
charged N-18, though damirone B also has an acidic proton on N-18, which may therefore reflect 
the relative ease of reduction of iminoquinone versus amino-ortho-quinone functionalities.  
 
Table 6.2 Electrochemical CV data for the tricyclic pyrroloiminoquinones versus pH Scan rate: 25 
mV/s. 
 
Compound Ea (mV) E1/2 (mV) ∆E (mV) ia / ic 
1.33 
pH 5.5: 
pH 7.5: 
1.20 
pH 5.5: 
pH 7.5: 
 
-326 
-384 
 
-327 
-428 
 
-350 
-422 
 
-353 
-458 
 
47 
75 
 
51 
59 
 
1.00 
0.97 
 
0.94 
0.92 
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Figure 6.8 Proposed mechanism for the redox reaction of damirone B (1.20). 
 
Proposed mechanisms for the reduction-oxidation processes taking place in damirone B and 
makaluvamine C are given in Figures 6.8 and 6.9, respectively. The initial product of oxidation in 
damirone B is an electron deficient species, giving rise to a semiquinone radical (6.7, Figure 6.8), 
which can therefore react with H2O and OH- to give rise to the product (6.8, Figure 6.8). 
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Figure 6.9 Proposed mechanism for the redox reaction of makaluvamine C (1.33). 
 
b) Discorhabdin C type compounds 
 
Table 6.3 presents the data obtained for the discorhabdin C type pyrroloiminoquinones. The 
compounds are listed according to the ease of reduction of these compounds at pH 5.5 (i.e. from 
lower to higher reduction potentials). One redox couple was typically observed, with the exception 
of 1.52 and 1.53. The ∆E and ia / ic data indicate that these compounds exhibit mainly reversible 
behaviour at pH 5.5, while at pH 7.5 the processes may be classified as quasi-reversible (in that ia 
/ ic deviated slightly from unity), with the exception of 1.53. At a higher pH, these compounds 
experience a lower solubility, which may account for the decrease in stability of the compound 
reactions at the electrode surface. The ∆E values also show that a two electron reduction process 
(with the exception of 2.2 at pH 7.5) predominates at pH 5.5 and 7.5. The ease of reduction at 
both pH 5.5 and 7.5 was observed as follows: 2.2 > 3.1 > 1.57 > 1.51 > 1.52 > 1.53 (Figure 6.6, 
Table 6.3). 
 
On comparison of 1.52 with 2.2, where only a ∆7 olefin distinguishes the two, the ease of 
reduction is observed to increase with increased conjugation. Both compounds have three 
bromine atoms and 2.2 was found to be the easiest of the discorhabdin C type compounds to 
reduce. The oxidised form of 1.52 (i.e. compound 1.51) leads only to a slight decrease in the E1/2 
value, suggesting perhaps that the reduction process is not centred around C-3. In order to 
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investigate the effect of removing a bromine atom on the E1/2 value, 1.52 and 1.53 were compared 
and an increase (from 1.52 to 1.53) in reduction potential observed, i.e. removal of the C-14-Br 
led to an increase in E1/2 and the compound (1.53) was therefore more difficult to reduce. Bromine 
has a high electronegativity and could draw electrons away from the ring, which should make the 
compound easier to reduce (1.52 with three bromine atoms is easier to reduce than 1.53 which 
has only two). However, upon comparison of 1.53 and 3.1, which has only a thioether moiety (no 
bromine groups), a large decrease in the reduction potential is observed with 3.1. The lower 
electronegativity of the sulfur, or perhaps the formation of the extra ring through the sulfur, may 
account for the decrease. A decrease in conjugation (removal of the ∆4 olefin) as well as 
bromination at position 2 led to the expected increase in the reduction potential of discorhabdin A 
on comparison with 3.1. Interestingly, a plot of the 13C NMR shifts for the C-19 carbon of the 
pyrroloiminoquinone skeleton, shown in Figure 6.10, certainly gives an indication of the 
relationship between lack of electron density at C-19 and the ease of reduction i.e. the more 
deshielded the carbon (e.g. 2.2) the easier it is to reduce. The graph also shows a better 
correlation at a lower pH, most likely due to improved solubility. 
 
Table 6.3 Electrochemical CV data for discorhabdin C type pyrroloiminoquinones versus pH. 
Scan Rate: 25 mV/s. 
 
Ea (mV) E1/2 (mV) ∆E (mV) ia / ic  
Compound Couple I Couple II Couple I Couple II Couple I Couple II Couple I Couple II 
2.2 
pH 5.5: 
pH 7.5: 
 
-223 
-297 
 
-450† 
-469† 
 
-251 
-334 
 
-* 
-* 
 
56 
73 
 
-* 
-* 
 
0.95 
0.89 
 
-* 
-* 
3.1 
pH 5.5: 
pH 7.5: 
 
-263 
-315 
 
- 
- 
 
-282 
-337 
 
- 
- 
 
38 
44 
 
- 
- 
 
0.95 
0.89 
 
- 
- 
1.57 
pH 5.5: 
pH 7.5: 
 
-289 
-340 
 
- 
- 
 
-307 
-358 
 
- 
- 
 
36 
35 
 
- 
- 
 
0.95 
1.67 
 
- 
- 
1.51 
pH 5.5: 
pH 7.5: 
 
-311 
-401 
 
-261† 
-233 
 
-333 
-424 
 
-* 
-266.5 
 
43 
46 
 
-* 
67 
 
0.94 
0.44 
 
-* 
0.09 
1.52 
pH 5.5: 
pH 7.5: 
 
-326 
-417 
 
-204 
-594† 
 
-346 
-435 
 
-222.2 
-* 
 
39 
36 
 
36 
-* 
 
1.12 
0.84 
 
0.05 
-* 
1.53 
pH 5.5: 
pH 7.5: 
 
-356 
-423 
 
-295 
- 
 
-384 
-445 
 
-* 
- 
 
56 
43 
 
-* 
- 
 
0.96 
0.99 
 
-* 
- 
* Note:  
-*: No return wave 
†:  Reduced peak potential (i.e. Ea) 
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Figure 6.10 A plot of the C-19 13C NMR shifts for the discorhabdin C type 
pyrroloiminoquinones. 
 
A proposed mechanism for the reduction process of 1.52 is given below in Figure 6.11. Once 
again the electron deficient species formed upon oxidation gives rise to a semiquinone radical, 
which may react with H2O and OH-. 
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Figure 6.11 Proposed mechanism for the redox reaction of 1.52 at pH 5.5 and 7.5. 
 
c) Discorhabdin D / S type compounds 
 
Table 6.4 lists the electrochemical data obtained for the discorhabdin D type 
pyrroloiminoquinones. Generally, only one redox couple was observed, with the exception of 2.4. 
Once again the ∆E and ia / ic data indicate that these compounds exhibit mainly reversible 
behaviour at pH 5.5, while at pH 7.5 the processes may be classified as quasi-reversible (due to 
the larger deviation in the ia / ic values. The ∆E values show that two electron reduction processes 
predominate at both pH 5.5 and 7.5. A proposed mechanism for 3.3 (similarly for the other 
discorhabdin C type compounds) at pH 5.5 is given in Figure 6.12. 
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Figure 6.12 Proposed mechanism for the redox reaction of 3.3 at both pH 5.5 and 7.5. 
 
The order in the ease of reduction of the discorhabdin D type compounds at pH 5.5 and 7.5 is as 
follows: 3.3 > 3.5 > 3.2 > 2.4 (Figure 6.6). 
 
Table 6.4 Electrochemical CV data for discorhabdin D type pyrroloiminoquinones versus pH. 
Scan Rate: 25 mV/s. 
 
Ea E1/2 ∆E ia / ic  
Compound Couple I Couple II Couple I Couple II Couple I Couple II Couple I Couple II 
3.3 
pH 5.5: 
pH 7.5: 
 
-236 
-284 
 
-† 
- 
 
-253 
-309 
 
 
- 
 
-33 
-49 
 
 
- 
 
-0.91 
-0.90 
 
 
- 
3.5 
pH 5.5: 
pH 7.5: 
 
-236 
-294 
 
- 
- 
 
-257 
-316 
 
- 
- 
 
-41 
-44 
 
- 
- 
 
-0.99 
-0.78 
 
- 
- 
3.2 
pH 5.5: 
pH 7.5: 
 
-238 
-297 
 
 
 
-259 
-320 
  
-41 
-46 
  
-0.91 
-0.79 
 
2.4 
pH 5.5: 
pH 7.5: 
 
-380 
-449 
 
-267† 
-650† 
 
-398 
-471 
 
-* 
-* 
 
-36 
-44 
 
-* 
-* 
 
-1.19 
-0.62 
 
-* 
-* 
*Note: 
-*: No return wave 
†:  Reduced peak potential (i.e. Ea) 
 
Compound 2.4 (with bromines at C-4 and C-14 and no thioether functionality) was found to be the 
most difficult to reduce of the discorhabdin D type compounds. Drawing on earlier observations 
this may be expected since the remaining discorhabdin D type compounds have a thioether and 
no halogenated groups, which should make them easier to reduce. Compound 1.51 which also 
has no thioether functionality, has three bromine groups and the increase in the E1/2 value is 
therefore expected when compared to the sulfur containing discorhabdin D type compounds. 
Upon comparison of compound 2.4 and 1.53, E1/2 is less negative for the latter compound (i.e. 2.4 
is more difficult to reduce), which may be due to the lack of a ∆1 olefin or because of the presence 
of a strong electron withdrawing group at C-1, since electron donating groups are generally 
considered to make the reduction of a particular compound easier. Neither have a thioether 
functionality and both compounds have two bromine atoms albeit in different positions. In order to 
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assess the effect of a substituent at C-1 on the discorhabdin D types, the E1/2 values of 3.2, 3.3 
and 3.5 were compared. Those compounds with primary amines (3.3 and 3.5) were recognised 
as being easier to reduce than those with secondary amines, regardless of the complexity of the 
substituent at C-1. Compound 3.5 with its carboxylic acid side-chain led to a slight increase in the 
E1/2 value and was consequently found to be slightly harder to reduce. The extra ring formed 
through the formation of a N-18 to C-2 bond, does not seem to have an unfavourable influence on 
the E1/2 values especially if an additional ring is also formed through a thioether functionality. 
Comparison of 1.57 with 3.2, 3.3, and 3.5 showed that the more complex systems were easier to 
reduce. Discorhabdin A has a ∆1 olefin and a thioether which should increase the ease of 
reduction, but the presence of a single bromine group on position 2 may lead to an increase in 
E1/2 and discorhabdin A is therefore more difficult to reduce. Finally, in order to evaluate the 
influence of the extra ring of discorhabdin D types on E1/2, 3.3 was compared to 3.1. These 
compounds have no bromine atoms, both have a ketone at position 3 and both contain sulfur. 
Compound 3.1 has a ∆1 olefin while 3.3 has N-18 to C-2 bond and a substituent at position 1. 
Even though 3.3 lacks the ∆1 olefin, it underwent reduction at the lowest potential in this group, 
which may be due to the extra ring or the strong electron withdrawing substituent at position 1.  
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Figure 6.13 A plot of the C-19 13C NMR shifts for the discorhabdin D type pyrrolo-
iminoquinones. Although the data points are few, this graph is intended to show the 
general trend for the tricyclic pyrroloiminoquinones (a), the discorhabdin D / S types (c) 
and the bis-pyrroloiminoquinone (d) classes in contrast to that obtained for the 
discorhabdin C types (b) (Figure 6.10).  
 
At a higher pH, protons are generally more easily stripped from primary amines than secondary 
amines. However, the same ∆E values are observed for the secondary amine substituent (3.2) 
and 2.4, indicating perhaps that the reduction processes observed are not taking place at the 
spiro ring. The discorhabdin D type compounds were therefore acknowledged as being far easier 
to reduce than most of the discorhabdin C type compounds e.g. 1.51. 
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Figure 6.13 shows a plot of the 13C NMR shifts for the C-19 carbon of the (c) class 
pyrroloiminoquinone skeleton. The opposite was found to be true for the discorhabdin D type 
compounds and a negative slope obtained was in this instance i.e. the relationship between the 
lower electron density at carbon 19 and an increase in reduction potential was observed i.e. the 
more deshielded the carbon (e.g. 2.4) the harder it was to reduce. Once again, the plot shows 
better correlations at a lower pH, most likely due to solubility. 
 
d) Bis-pyrroloiminoquinones 
 
The data obtained for the bis-pyrroloiminoquinone compounds is presented in Table 6.5.  
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Figure 6.14 Cyclic voltammogram of 1.72. Scan rate: 25 mV/s. 
 
The potentials of the redox couples for the bis-pyrroloiminoquinones range from -349 to -567 mV 
for Couple I, from -310 to -414 mV for Couple II and –224 mV for Couple III at pH 5.5. The peak 
potentials become increasingly negative with an increase in pH. The ∆E values were found to be 
too large for a reversible system and the ia / ic data was generally found to deviate from unity. The 
results indicate that these compounds exhibit mainly quasi-reversible to irreversible behaviour at 
both pHs. Slow electron transfer, or irreversible structural change, between the compound of 
interest and the working electrode is often to blame for an observation deemed irreversible. 
Hydrogen bonding may also be responsible for inefficient or slow electron transfer.117 The cyclic 
voltammogram obtained for 1.72, shown in Figure 6.14, is the most complex of the 
pyrroloiminoquinones. The cyclic voltammogram shows two reversible systems of approximately 
the same height, and therefore the same number of electrons are transferred, while the 
demethylated compound 1.71 shows only two reduction couples, implicating the involvement of 
the N-13 methyl group. The increasingly negative peak potentials of the N-18 oximes (4.1 and 
4.2) make these pyrroloiminoquinones the most difficult to reduce and perhaps the ionic character 
of the N+–OH bond could be responsible for the additional increase in peak reduction potential 
and stability. A plot of the C-19 13C NMR shifts revealed that the electron density at C-19 is far 
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less relevant for the bis-pyrroloiminoquinone compounds than for the discorhabdin type 
compounds. 
  
The ease of reduction at pH 5.5 was observed as follows: 1.72 > 1.71 > 4.1 > 4.2, while at pH 7.5 
the sequence obtained was: 1.71 > 1.72 > 4.1 > 4.2 (Figure 6.6, Table 6.5). 
 
Table 6.5 Potential assignments (CV) of the bis-pyrroloiminoquinones versus pH. Scan Rate: 25 
mV/s. 
 
Ea 
Couple 
E1/2 
Couple 
∆E 
Couple 
ia / ic 
Couple 
 
Compound 
I II III I II III I II III I II III 
1.72 
pH 5.5: 
pH 7.5: 
 
-349 
-505 
 
-310 
-414 
 
-224 
-297 
 
-395 
-531 
 
-396 
-425 
 
-248 
-318 
 
92 
52 
 
172 
22 
 
48 
43 
 
1.25 
0.85 
 
0.69 
0.58 
 
1.25 
0.06 
1.71 
pH 5.5: 
pH 7.5: 
 
-417 
-425 
 
-310 
- 
 
- 
- 
 
-438 
-478 
 
-333 
- 
 
- 
- 
 
41 
105 
 
46 
- 
 
- 
- 
 
1.33 
0.001 
 
0.75 
- 
 
- 
- 
4.1 
pH 5.5: 
pH 7.5: 
 
-508 
-620 
 
- 
- 
 
- 
- 
 
-525 
-637 
 
- 
- 
 
- 
- 
 
33 
33 
 
- 
- 
 
- 
- 
 
0.48 
0.38 
 
- 
- 
 
- 
- 
4.2 
pH 5.5: 
pH 7.5: 
 
-567† 
-690 
 
- 
- 
 
- 
- 
 
-* 
-669 
 
- 
- 
 
- 
- 
 
-* 
42 
 
- 
- 
 
- 
- 
 
-* 
0.65 
 
- 
- 
 
- 
- 
*Note: 
-*: No return wave 
†:  Reduced peak potential (i.e. Ea) 
 
The electron donating group of 1.72 led to a decrease in E1/2 at pH 5.5, while the opposite is true 
for pH 7.5. The presence of an N-oxime at N-18 signified a large increase in the reduction 
potential for these compounds, implicating the iminoquinone moiety in the reduction processes. 
The strong electron withdrawing group or the ionic character of the bond present on N-18, may be 
responsible for the E1/2 observed.  
 
A large difference in the E1/2 values was also realised upon comparison of 1.71 and 3.1. The 
compounds possess the same number of carbons and both are not halogenated. Compound 3.1 
differs in that it has sulfur, a spiro ring and is comparatively less conjugated. 1.71, on the other 
hand, has a hydroxyl group at position 3. Compound 1.71 was found to be far harder to reduce 
and this may be due to the absence of the sulfur group or the lack of a spiro ring. This is 
unexpected since sulfur, with its electron rich nature, is expected to lead to a decrease in ease of 
reduction. Comparison of compounds 1.71 and 1.53, both of which lack a thioether and have a 
hydroxyl group at position 3 and where the latter is brominated at positions 2 and 4 and is less 
conjugated, showed that 1.71 is far more difficult to reduce than 1.53. Again, the lack of a spiro 
ring and electron withdrawing groups on positions 2 and 4 (where bromine is, in fact, expected to 
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lead to an ease in reduction due to its electron withdrawing nature) may account for the variation. 
These observations may therefore indicate that the site of the reduction process is not likely to be 
taking place at the spiro ring, but rather on the ‘left hand side’ of the molecule, i.e. the 
iminoquinone portion. 
 
A proposed mechanism for the observed reduction-oxidation process is given below in Figure 
6.15. 
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Figure 6.15 Proposed mechanism for the redox reaction of 4.1. 
 
6.3.2 Stability study 
 
Upon variation of the sweep rates, electroactive intermediates of widely varying stabilities may be 
observed and, in order to determine whether a diffusion-controlled process is the dominant 
mechanism at the electrode surface, the peak current (ia) versus the square root of the scan rate 
is monitored (Table 6.6 and Figure 6.16).  
 
Figure 6.16 shows a sample plot of the variation of the catalytic currents with an increase in 
square root of the scan rate, for scan rates ranging from 25 to 800 mV/s, confirming the diffusion-
controlled movement of the species to the electrode at these scan rates during the reduction of 
the pyrroloiminoquinones. The linear plots obtained for most of the pyrroloiminoquinones (Table 
6.6) indicate that a diffusion-controlled process prevails with the exception of, as shown by the R2 
values, 1.52 and 2.2, both at pH 7.5. The dynamics involved could include the lower solubility of 
the compounds at the higher pH, adsorption onto the electrode surface between scans, or slow 
electron transfer between the compound and the electrode surface. The ia / ic values obtained 
(Table 6.3) were also observed to be quite low for these two compounds at pH 7.5. 
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Figure 6.16 Plot of ia versus the square root of the scan rate for 3.2. 
 
Table 6.6 Data (rate constants and R2 values) obtained for the plot of peak current (ia) versus 
square root of the scan rate at pH 5.5 and 7.5. 
 
pH 5.5 pH 7.5  
Compound Rate constant / (mV/s)1/2 R2 Rate constant / (mV/s)1/2 R2 
1.52 -1.986 x 10-7 0.994 -1.086 x 10-7 0.875 
2.2 -1.647 x 10-7 0.987 -7.588 x 10-8 0.868 
1.51 -1.947 x 10-7 0.995 -6.482 x 10-8 0.987 
1.53 -2.779 x 10-7 0.946 -1.970 x 10-7 0.995 
1.33 -5.600 x 10-7 0.999 -4.736 x 10-7 0.974 
3.2 -1.055 x 10-7 0.997 -7.544 x 10-8 0.994 
3.3 -1.341 x 10-7 0.998 -1.102 x 10-7 0.999 
1.20 -2.907 x 10-7 0.986 -2.695 x 10-7 0.989 
3.5 -1.656 x 10-7 0.991 -1.013 x 10-7 0.991 
3.1 -1.667 x 10-7 0.999 -8.177 x 10-8 0.999 
1.71 -1.448 x 10-7 0.993 -1.444 x 10-7 0.991 
1.72 -6.991 x 10-8 0.998 -9.261 x 10-8 0.982 
4.1 -9.745 x 10-8 0.997 -1.276 x 10-7 0.988 
4.2 1.657 x 10-8 0.967 8.224 x 10-8 0.996 
2.4 -9.287 x 10-8 0.918 -8.271 x 10-8 0.999 
1.57 -3.543 x 10-7 0.905 -5.902 x 10-8 0.930 
 
Comparison of the simpler pyrroloiminoquinones indicated that the oxidised compound (1.20) 
showed a decrease in rate (Figure 6.17 and Table 6.6) when compared to 1.33 which has a 
primary amine. On the whole, the more complex systems showed lower rate constants, while 1.33 
underwent the fastest process. 
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Figure 6.17 Comparison of the rate constants obtained for the pyrroloamino-ortho-quinones, 
pyrroloiminoquinones and bis-pyrroloiminoquinones. 
 
An increase in conjugation was found to lead to a decrease in the rate constants obtained. This 
was observed upon comparison of 1.52 and 2.2. Oxidation of 1.52 at C-3 (1.51) was found to lead 
to a slight decrease in rate, which may indicate that perhaps reduction is not taking place at C-3 
(drawn from the comparisons between 1.51 and 1.52 as well as 1.53 and 1.57). An increase in 
rate, upon sulfurisation and reduction or elimination in the number bromine groups present (upon 
comparison of 1.53 and 3.1, 1.52 and 1.53, as well as 1.53 and 1.57) was observed. Discorhabdin 
A, with its bromine at C-2 and the lack of a ∆4 olefin, has a higher rate constant than 3.1, perhaps 
due to a decrease in conjugation.  
 
Compound 2.4 was found to have the slowest rate among the discorhabdin D types. A substantial 
decrease in rate, due either to the formation of N-18 to C-2 bond (extra ring), substitution at C-1 
or the lack of ∆1,2, is observed upon comparison of 1.53 and 2.4. An increase in conjugation has, 
however, previously been found to lead to a decrease in rate. Upon comparison of 3.3 with 3.1 
substitution at C-1, the lack of a ∆1 olefin, or the presence of an extra ring were found to decrease 
the rate constants. Of the discorhabdin D type compounds, all of which have a substituent at 
position 1, those with primary amines at C-1 were faster than 3.2 (which has a secondary amine). 
The presence of the more complex side-chain (as found in 3.5) led to a slight increase in rate 
when compared to a simple amino group (3.3). A thioether functionality was found to lead to an 
increase in rate upon comparison of 2.4 with 3.2, 3.3 as well as 3.5. Compounds 3.2 and 2.4 with 
their less acidic substituents, may account for the slower rates. 
 
The occurrence of an electron donating group on N-13 of the bis-pyrroloiminoquinone skeleton, 
led to a decrease in rate, while the presence of an electron withdrawing group on N-18 also led to 
a decrease. A decrease in rate, perhaps due to the lack of a spiro ring or a thioether was also 
observed upon comparison of 1.71 with 3.1. Overall, lower rate constants were observed at pH 
7.5 except for the N-18 oximes. 
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6.4 Conclusion 
 
The electrochemical behaviour of sixteen pyrroloiminoquinones was studied using cyclic 
voltammetry and square wave voltammetry. All compounds had negative reduction potentials 
within biologically relevant ranges and the pH-varied experiments demonstrated that the reduction 
potentials are pH dependent. Generally, it was found that the reduction potentials increased with 
an increase in pH for all compounds, that the moles of electrons transferred were dependent on 
the pH, and that the rates increased with a decrease in pH, except for the N-18 oximes. The 
following list is drawn from observation:  
 
Lower reduction potentials were observed with: 
a) increased conjugation, 
b) oxidation at C-3 (slight increase in the ease of reduction) 
c) the introduction of a primary amine at C-10 
d) the introduction of a sulfur group, which should in fact lead to a higher reduction 
potential 
e) the introduction of an extra rings through the formation of the N-18 to C-2 bond or 
through a thioether 
f) the introduction of electron withdrawing groups at position 1 
 
Higher reduction potentials were observed upon: 
a) oxidation at C-10 
b) removal of bromine at C-14 
c) the introduction of bromines at position 2 and 4, which is unexpected 
d) substitution at N-18 with a strong electron withdrawing group 
e) removal or replacement of the spiro ring, which may or may not be associated with 
the reduction process 
 
A discorhabdin D type skeleton was found to render the compounds more susceptible to reductive 
activation. The number of bromine atoms was unexpectedly observed to lead to increasingly 
negative reduction potentials for some compounds (discorhabdin C types) and, since most of the 
bromines are located on the spiro ring (with only one bromine ever present on the pyrrole ring), it 
is likely therefore that the reduction is taking place at the iminoquinone moiety. The pyrrole 
bromine atoms may, however, affect the ease of reduction. The bis-pyrroloiminoquinones and the 
N-18 oximes in particular, were found to have largely negative reduction peak potentials. In a 
study of the quinoxaline di-N-oxides, it was found that as the electron withdrawing nature of the 
substituents increased, the potential for the first reduction became less negative and the 
compound more easily reduced.121 This is in contrast to what has been observed with some of the 
pyrroloiminoquinones. Bromine is known to be strongly electron withdrawing and should therefore 
be expected to lead to an increase in the ease of reduction. This was observed and expected with 
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compounds 1.53 and 1.52 (where 1.52 has three bromine atoms while 1.53 has two), but upon 
comparison of 3.1 and 1.57 (where 1.57 has a bromine group), the opposite was true. This may, 
however be accounted for if the site of the reduction process is far removed from the spiro ring, 
i.e. if the reduction process is taking place rather at the iminoquinone moiety. A plot of the E1/2 
values versus C-19 13C NMR shifts showed negative slopes for all of the pyrroloiminoquinone 
classes except for the discorhabdin C type pyrroloiminoquinones. Thus the more deshielded the 
carbon at position 19, the easier the compound was to reduce, except for the discorhabdin C 
types. This may, however, suggest that either an alternate mechanism is in operation for the C 
type pyrroloiminoquinones or that the reduction process is taking place only at the iminoquinone 
moiety. Further evidence could be provided by the fact that a sulfur group is expected to lead to a 
decrease in the ease of reduction of these compounds, where more often than not, the opposite 
was true, e.g. the discorhabdin D / S type compounds, discorhabdin A, etc.  
 
A decrease in the rate was recognised upon oxidation, an increase in conjugation and the 
elimination of all bromines from the pyrroloiminoquinone skeleton. An increase in rate constant 
was observed upon removal of the C-14-Br and sulfurisation. Thus, with a decrease in pH, the 
rates and ease of reduction of the pyrroloiminoquinones were therefore increased. 
 
As expected, greater deviation from ia / ic = 1 (36 % within the range of 0.9 and 1.1) was found for 
experiments conducted at pH 7.5 which may be due to the lower solubility of these compounds at 
the higher pH. The pyrroloiminoquinones were found to have greater stability at pH 5.5 (64 % 
within the same range) except for the bis-pyrroloiminoquinones and their N-18 oximes. No 
relationship was found between ia / ic and rate e.g. compound 1.33 has a high rate and ia / ic, while 
the opposite is true for 1.71 (which has low unity, and therefore stability, and a low rate constant. 
∆E and ia / ic values indicated that most of the reactions taking place, with a few exceptions (i.e. 
the bis-pyrroloiminoquinone types), were reversible at pH 5.5 and quasi-reversible at pH 7.5 and 
that no relationship existed between ia / ic and ∆E. 
 
In conclusion, in addition to the possibility of 1O2 and radical-mediated DNA strand damage, these 
observations may provide an additional mechanism for cell destruction i.e. electron transfer 
mechanisms, especially the one electron reduction mechanisms, may also be at play. The data 
obtained by Monge et al.121 for anthraquinone (∆E = 80 mV, ipa / ipc ≈ 1), was found to be 
consistent with a reversible one electron reduction to its semiquinone (in DMF, using a platinum 
working electrode and measured against a standard calomel electrode (SCE)).121 Examples of the 
types of compounds containing an anthraquinone nucleus includes the anthracyclines, where the 
nucleus is attached to an amino sugar, which are used as broad-spectrum antineoplastic drugs. 
Because these drugs contain a quinone-hydroquinone functionality, they participate in biological 
oxidation-reduction reactions and are able to chelate divalent cations such as Ca2+ and Fe2+ and 
this leads to a lower cardiac toxicity. More importantly, just like the pyrroloiminoquinones, they are 
able to intercalate between the base pairs in a DNA double helix. Anthracyclines such as 
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doxorubicin are also known to cause single stranded DNA breaks and impair DNA repair. Results 
of in vitro studies have confirmed that doxorubicin radicals participate in oxygen mediated single 
strand breakage, which is, unfortunately also the cause of their high cardiac toxicity.124  
 
Since quinones have been observed to produce semiquinones30, 116, 121, 124 it may be assumed, for 
those pyrroloiminoquinones that undergo a one electron reduction at least, that they are, in fact, 
also producing semiquinone radicals. The compounds that were observed to produce radicals 
upon photosensitisation (discorhabdin A and the tsitsikammamine N-18 oximes) were resolved to 
undergo two electron reduction processes. These compounds are, however, still likely to produce 
a semiquinone radical, since they also possess the quinone moiety. In the case of the N-18 
oximes, this may be accounted for by the simultaneous production of a radical on N-18 and as 
well as the semiquinone. Because of the inherent highly negative peak potentials displayed by 4.1 
and 4.2 at pH 5.5 and, especially, biological pH, and because these N-18 oximes have been 
shown to produce radicals (Chapter 5), these compounds could show some, perhaps even 
selective, toxicity towards hypoxia tumour cells, albeit at perhaps a slightly lower toxicity level; 
since the two electron reduced mono-N-oxide (6.5) has been shown by Daniels and Gates125 
(Scheme 6.1) to have a weaker reduction-dependent DNA cleavage activity. The authors125 did, 
however, state that the poor cleavage by the mono-N-oxide (6.5) could be due to the fact that the 
enzyme system employed in the study was not effectively reducing the compound and that the 
compound is likely to produce hydroxyl radicals in a similar approach to that outlined in Scheme 
6.1. An investigation of the type of radicals produced and the mechanism of toxicity of the highly 
cytotoxic discorhabdin A, however, remains an intriguing experimental opportunity. 
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7.1 Human colon tumour (HCT-116), Oesophageal (WHC01) and ovarian (ME180) 
cytotoxicity assays 
 
HCT-116 has often been used as an initial screen for evaluating the cytotoxicity of pyrroloamino-
ortho-quinone and pyrroloiminoquinone natural products, e.g. the makaluvamines.30,70 It was 
therefore an ideal cell line model for studying our suite of compounds since it provided a basis 
from which to compare the cytotoxicity of pyrroloamino-ortho-quinone and the 
pyrroloiminoquinone metabolites. 
 
In addition to the HCT-116 cell line model used to test twenty four of our compounds, the 
cytotoxicity of two pyrroloiminoquinones, i.e. discorhabdin A and tsitsikammamine B, towards 
oesophageal (WHC01) and cervical (ME180) cancer cell lines was also studied. Black 
populations in certain regions of Southern Africa and the central and eastern seaboard of Africa 
experience an abnormally high incidence of oesophageal cancer.131 The high incidence of this 
disease is associated with a range of environmental factors including smoking, woodsmoke, 
alcohol, the inadvertent consumption of carcinogenic mycotoxins produced by the Fusarium 
fungus that thrives on grain stored under damp conditions and a diet poor in fresh fruit and 
vegetables.131 The identification of novel agents with significant cytotoxic activity against 
oesophageal cancer cells would substantially enhance our ability to treat this debilitating disease 
in Africa.  
 
The HCT-116 cytotoxicity assays were performed by Catherine Sincich (Scripps Institution of 
Oceanography) and the oesophageal and cervical cancer screens by Catherine Arendse 
(Department of Medical Biochemistry, University of Cape Town). Details of the protocols used are 
provided in Chapter 8 (Section 8.7). 
 
The results of the HCT-116 cytotoxicity screening of twenty four pyrroloamino-ortho-quinones and 
the pyrroloiminoquinones isolated from four species of Latrunculid sponge are presented in Table 
7.1. Discorhabdin A (1.57) displayed the highest toxicity at 0.007 µM, followed by the free base of 
discorhabdin A (1.57 FB), 1.51, 3.3, 2.1, 2.2, 3.4, 1.53, 3.5. Curiously, three discorhabdin D type 
compounds (3.3, 3.4 and 3.5) displayed relatively high toxicities, which is unexpected based on 
Blunt et al.’s observation that discorhabdin D (1.61) had a much lower in vitro cytotoxicity than it’s 
in vivo toxicity.36 It would therefore be interesting to obtain the in vivo activity of these three 
compounds. The presence of a ∆7 olefin also appeared to improve the cytotoxicity of the 
discorhabdins as observed with 2.1 and 2.2 compared to 1.52 and 1.53 respectively. The 
presence of a tetrahydrothiophene bridge also appeared to be important (e.g. 3.1). In accordance 
with the literature available,30,70 the importance of a pyrroloiminoquinone core as a prerequisite for 
cytotoxicity was also demonstrated upon comparison of the IC50 values obtained for 
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makaluvamine C (1.33) with those of damirone B (1.20) and makaluvic acid A (1.47). The fact that 
discorhabdin A is present in vast quantities in the shallow water Strongylodesma sp. sponge and 
that it has such potent activity together with it’s ability to produce free radicals in the presence of 
light (Chapter 5) may be significant in terms of the organism’s defence mechanisms. The inactivity 
of the tsitsikammamine A and B N-18 oximes in the HCT-116 assay was also of interest.  
 
Table 7.1 Human colon tumour (HCT-116) cytotoxicity data for the pyrroloamino-ortho-quinone, 
pyrroloiminoquinone and bis-pyrroloiminoquinone metabolites. 
 
Compound HCT-116 (IC50 µM) Compound HCT-116 (IC50 µM) 
1.20 3.102 2.2 0.222 
1.33 1.089 2.3 1.266 
1.47 28.399 2.4 12.496 
1.51 0.077 2.5 0.298 
1.52 0.645 2.6 1.655 
1.53 0.323 3.1 0.327 
1.57 0.007 3.2 2.249 
1.57 FB* 0.058 3.3 0.119 
1.61 0.595 3.4 0.232 
1.71 1.414  3.5 0.355 
1.72 2.382  4.1 128.213 
2.1 0.197 4.2 16.541 
* FB = free base  
 
The ‘cut-off’ established by Bristol-Myers for determining if a compound is worth pursuing as a 
clinical drug are those with IC50 values below 3 µM.132 With three quarters of the compounds 
tested exhibiting possibly exploitable cytotoxic activity, the question of selectivity still remains 
(See Table 7.2). 
 
Tsitsikammamine B (1.72) and discorhabdin A (1.57) both showed strong activity133 (Table 7.2) 
against oesophageal (WHC01) and cervical (ME180) cancer cell lines. The non-selectivity of 
discorhabdin A and tsitsikammamine B for cancer cells is clearly shown by the toxicity of these 
compounds to normal cells viz breast epithelial (MCF12F) and fibroblasts (DMB). 
 
Table 7.2 Oesophageal (WHC01) and ovarian (ME180) cancer inhibition of discorhabdin A and 
tsitsikammamine B. 
 
Compound WHCO1 (IC50 µM) ME180 (IC50 µM) MCF12F (IC50 µM) DMB (IC50 µM) 
1.57 0.0168 0.0205 0.0216 0.0284 
1.72 2.8918 - - 5.0786 
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7.2 Topoisomerase I activity 
 
Prior to DNA replication, the supercoiled DNA must be relaxed (untwisted). The topoisomerase I 
enzyme relieves the torsional strain in supercoiled DNA by binding to the DNA molecule, cleaving 
one strand and at the same time inducing a covalent bond between the released phosphodiester 
bond and a tyrosine residue in the enzyme to form a phosphotyrosine bond. The unbroken DNA 
strand then passes through this single strand break and the single strand break is subsequently 
resealed. Type I topoisomerase enzymes are therefore important in the transcription and repair of 
damaged DNA and are thought to be positioned just ahead of the DNA replication fork (Figure 
7.1).134  
 
During the initial stage of replication, the two DNA strands are prepared for this process and a 
number of proteins are also involved. As illustrated in Figure 7.1, a helicase is required for the 
unwinding of the DNA at the replication fork. DNA binding protein molecules, which fix themselves 
to the two DNA strands, stabilise the unwound DNA. The function of these proteins is to open a 
region on the DNA strand that will allow an enzyme to begin the synthesis of an RNA primer. This 
is followed by chain elongation, a process catalysed by a DNA polymerase III holoenzyme. The 
completion of the transcription of a DNA strand follows the removal of the RNA primers by the 
DNA polymerase I enzyme and the establishment of a phosphodiester bond between the two 
strands which is catalysed by the DNA ligase enzyme.135 
 
 
Figure 7.1 DNA topoisomerase I – a unique target for anti-tumour drugs (reproduced with 
permission from Dr. Brad Carte). 
 
Camptothecin (7.1), one of the few natural products displaying significant topoisomerase I 
inhibition, was isolated from the Chinese ornamental tree Camptotheca acuminata.136 
Camptothecin is thought to stabilise the crucial step of the topoisomerase I catalysis when the 
enzyme induces a a single strand break in the DNA and is covalently bound to the DNA molecule 
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(Figure 7.1).91 The camptothecin – topoisomerase I – DNA complex is therefore stabilised, 
preventing the passage of the helicases and other replication enzymes down the DNA strand. 
Although 7.1 was in clinical trials in the 1970’s, the severe bladder toxicity exhibited by 
camptothecin precluded its use as an anticancer agent, and this in turn led to the development of 
camptothecin analogues topotecan (7.2, Hycamptin®), irinotecan (7.3 Camptosar®), 9-amino- (7.4) 
and 9-nitro-camptothecin (7.5). The latter two compounds are awaiting approval, while the former 
two agents have been approved for use in the USA.2 
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Like camptothecin (7.1), wakayin (1.73) was found by Kokoshka et al.91 to inhibit topoisomerase I 
catalysed relaxation of DNA, and both camptothecin and wakayin were found to enhance the 
cleavage at DNA sites normally attributed to topoisomerase I attack. However, unlike 
camptothecin, wakayin was also found to be a strong intercalator (Ks 20 µM, for the displacement 
of 50 % EtBr (5 µM) from DNA (25 µg/mL)), suggesting a different cleavage complex nature.91  
 
Topoisomerase II enzymes are ATP dependent and are able to cleave both strands of a DNA 
molecule, subsequently allowing another portion of the DNA molecule to pass through this cut. 
These enzymes thus catalyse the linking (catenation) and unlinking (decatenation) of two different 
DNA molecules. The conformational changes induced by these processes causes topological 
changes which are vital to the cellular functions such as replication, transcription and 
chromosomal segregation.134,137 The importance of the topoisomerase II enzyme thus becomes 
an obvious target for a wide variety of anticancer drugs in which the interruption of the enzyme’s 
function would inevitably lead to cell death. Examples of such anticancer agents include the 
epipodophyllotoxins, such as etoposide (7.6) and teniposide. These drugs are thought to block 
Chapter 7: Bioactivity 
 
 166
the catalytic activity of DNA topoisomerase II by stabilising an enzyme-DNA complex in which the 
DNA is subsequently cleaved and covalently linked to the enzyme.134,137  
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In a paper describing the cytotoxicity of the pyrroloiminoquinones, the makaluvamines, Barrows et 
al.70 demonstrated the ability of makaluvamines to act through inhibition of topoisomerase II, in 
contrast to the topoisomerase I inhibitory properties of the apparently structurally related wakayin. 
The makaluvamines showed enhanced activity towards topoisomerase II cleavable complex-
sensitive cell lines (Chinese hamster ovarian (CHO) cell line, xrs-6, where positive control drugs 
include bleomycin and etoposide (7.6) and negative controls such as camptothecin (7.1) and 
melphalan) were used). Makaluvamine C (1.33) was shown to produce protein linked DNA double 
strand breaks while makaluvamine A (1.31) induced double strand breaks in a neutral filter elution 
assay in a manner similar to the standard amsacrine (m-AMSA). Makaluvone and damirone B 
displayed insignificant toxicity and, interestingly, while discorhabdin A did show some toxicity in 
the CHO cell line model, 1.57 did not show enhanced activity toward the DNA mutant repair cell 
line xrs-6.70 The details of the topoisomerase I inhibition assays performed by Katherine Marshall 
at the University of Utah are presented in Chapter 8 (Section 8.7). 
 
An example of the type of data obtained from a topoisomerase inhibition assay is given in Figure 
7.2. The activities of tsitsikammamines A and B and their respective N-18 oximes were compared 
with 9-amino-camptothecin (7.1) in the topoisomerase I inhibition assay. Neither the 
tsitsikammamines nor their N-18 oxime analogues showed any activity in the topoisomerase II 
inhibition assays.138 
 
Figure 7.2 shows an agarose containing gel and topoisomerase I – cleaved DNA. DNA can be 
seen to migrate from top to bottom of the gel in three bands. The top band is nicked (n) circular 
DNA. The next band down is supercoiled (sc) DNA and the fastest migrating band is relaxed but 
intact circular DNA (at the bottom of the lanes except for lanes 4 and 5 in a)). In the assay, the 
percent of DNA cleavage varied greatly amongst the bis-pyrroloiminoquinones from a high of 59 
% for tsitsikammamine A at 500 µM to rather low levels for tsitsikammamine B N-18 oxime. 
Although the bis-pyrroloiminoquinones did display some topoisomerase I inhibition from 
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comparison with the activity displayed by 9-amino-camptothecin (7.4, 87 % cleavage at a 
concentration of 9 µM), the activity of the tsitsikammamines is lower by a factor of approximately 
100. 
 
 
 
 
 
Figure 7.2 DNA cleavage assayed by agarose gel electrophoresis. Electrophoresis was 
carried out in the presence of 9-amino-camptothecin (7.4). (Reproduced with permission 
from Katherine Marshall, University of Utah, USA.).138 (r = relaxed, sc = supercoiled, n = 
nicked, top1 = topoisomerase I, 9AC = 9-amino-camptothecin, TA = tsitsikammamine A, 
TA-NO = tsitsikammamine A N-18 oxime, TB = tsitsikammamine B, TB-NO = 
tsitsikammamine B N-18 oxime).  
Lane 1, substrate DNA only. Lane 2, a reaction of substrate and DNA topoisomerase I. Lanes 3 and 
4, reaction of DNA substrate and 9-AC without (lane 3) and with (lane 4) topoisomerase I. Lanes 6, 
8, 9 and 11 reaction of DNA substrate with 500 µM TA and TA-NO without (lanes 6 and 9) and with 
(lanes 8 and 11) topoisomerase I. Lanes 7 and 10 DNA substrate with topoisomerase I and 100 µM 
TA and TA-NO respectively. Similarly, lanes 12, 14, 15 and 17 reaction of DNA substrate with 500 
µM TB and TB-NO without (lanes 12 and 15) and with (lanes 14 and 17 respectively) 
topoisomerase I. Lanes 13 and 16 reaction of DNA substrate with 100 µM TA and TA-NO, 
respectively, with topoisomerase I. 
 
7.3 Intercalation studies 
 
Intercalation is the process whereby compounds which possess a planar aromatic ring system 
may be inserted between base pairs of DNA. This interaction leads to inhibition of DNA and or 
RNA polymerase reactions, causing metabolic changes and cell death.124,139 There is evidence 
that many of the known intercalating compounds, such as quinacrine (7.7) and ethidium (7.8), 
which also have activity against microbial organisms and neoplastic cells, exert their effect 
through a binding process of this type with DNA.139  
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1   2   3   4        6   7   8   9  10 11     12 13 14 15 16 17 
n
 
sc 
r 
1) DNA only    (0 %) 
2) DNA + top1    (0 %) 
3) DNA + 9 µM 9AC    (6 %) 
4) DNA + top1 + 9 µM 9AC   (87 %) 
5) DNA + top1 + 9 µM 9AC (not on second gel)   
6) DNA + 500 µM TA   (10 %) 
7) DNA + top1 + 100 µM TA   (36 %) 
8) DNA + top1 + 500 µM TA   (59 %) 
9) DNA + 500 µM TA-NO     (9 %) 
10) DNA + top1 + 100 µM TA-NO  (37 %) 
11) DNA + top1 + 500 µM TA-NO  (45 %) 
12) DNA + 500 µM TB   (23 %) 
13) DNA + top1 + 100 µM TB   (29 %) 
14) DNA + top1 + 500 µM TB   (27 %) 
15) DNA + 500 µM TB-NO   (12 %) 
16) DNA + top1 + 100 µM TB-NO  (?) 
17) DNA + top1 + 500 µM TB-NO  (26 %) 
a) 
b) 
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Factors not related to intercalation, such as transport through membranes and the metabolic 
transformation of drugs, also influence the activity of a potential drug. Intercalation and medicinal 
activity are influenced by factors such as binding constants, kinetics, and structural effects and 
activity. Specific drugs that have been found to bind to DNA by intercalation include the 
antimalarial drugs and antitumour drugs.139 
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DNA intercalators typically cause viscosity increases in low-molecular weight sonicated DNA, 
unwinding of superhelical DNA, i.e. a characteristic 3.4 Ǻ length increase for sonicated DNA, as 
well as an unwinding angle similar to that of the standard intercalator example ethidium (7.8), 
which has an arbitrarily assigned unwinding angle of 26o.139 NMR spectroscopy as well as X-ray 
crystallographic data can also be used to confirm the binding mode of potential intercalators. 
When compounds intercalate into DNA, the planar ring structure is inserted approximately 
perpendicularly to the long axis of the DNA double helix.124,139 
 
The ability of a compound to displace ethidium bromide (EtBr) from DNA is generally used as a 
measure of DNA intercalation. The flat planar pyrroloiminoquinone core of the tsitsikammamines 
implied that these compounds could be capable of intercalating into DNA. An EtBr displacement 
assay confirmed this activity. Figure 7.3 presents the results of the ethidium bromide 
displacement assay for the tsitsikammamines and their respective N-18 oximes. The 
tsitsikammamines together with their N-18 oximes were thus found to intercalate DNA.138 
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Figure 7.3 Results obtained for the ethidium bromide displacement assay for the 
tsitsikammamines and their respective oximes (reproduced with permission from 
Katherine Marshall, University of Utah).138 EtBr displacement was determined by 
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subtracting the amount of background EtBr fluorescence from all samples and 
then dividing by the amount of fluorescence in the DNA and EtBr control. 0 is 
complete displacement,  >1 no displacement. 
 
Wakayin was found to be a strong intercalator with a Ks value of 20 µM for displacement of 50 % 
EtBr (5 µM) from DNA (25 µg/mL).91 It appears that the tsitsikammamines and their respective N-
18 oximes were found to be strong intercalators with 1.71 and its N-18 oxime 4.1 having the 
stronger activity (Ks ~ 10 µM for both 1.71 and 4.1). Interestingly discorhabdin A is regarded as a 
poor intercalator (Ks 89 µM).70 
 
7.4 Bioreductive activation as a basis for selective cytotoxicity? 
 
Since the existence of certain processes in biological systems are known to have an 
electrochemical foundation, electrochemistry has often been used to describe and understand 
these processes.120 Lin et al.140 suggested in 1972 that the reductive reactions of hypoxic cells 
(oxygen deficient) outside of the vascular supply of a tumour mass could be more likely than that 
for the normal well-oxygenated equivalent.140 Experiments conducted previously on anaerobic 
cultures of microbes had demonstrated the possibility that certain biological systems may be 
conducive to reductive processes and this property could therefore, similarly, be exploited in 
oxygen deficient tumours to develop chemotherapeutic agents which became cytotoxic after 
reductive activation.103,125,126,141 Hypoxic cells are resistant to radiation therapy and a number of 
common chemotherapeutic agents, and therefore tumour cell hypoxia is often a problem rather 
than an advantage in cancer treatment. However, several promising or clinically useful antitumour 
agents are thought to obtain some therapeutic advantage by causing DNA damage more 
efficiently in hypoxic tumour cells as compared to normally oxygenated cancer cells.125,141 The 
activation of certain pro-drugs such as nitroimidazole, mitomycin C and other quinones, and 
benzotriazine di-N-oxides in hypoxic cells to a more toxic compound upon reduction has been 
shown by a number of workers.126,141-143 
 
As discussed previously in Chapter 6, the natural product mitomycin C (6.1), a pro-drug, that is an 
alkylating agent and is activated in vivo to a bifunctional or trifunctional DNA-acting agent.124,141,144 
After activation 6.1 binds preferentially to the guanine and cytosine moieties of DNA, leading to 
cross linking of DNA, thus inhibiting DNA synthesis and function. Mitomycin C contains three 
groups that can damage cells, the quinone moiety that can participate in free radical reactions 
generating superoxides,123,124,144 and aziridinyl and urethane functions that can take part in DNA 
alkylation. Studies have shown that the carbamate and aziridinyl moieties are not essential for 
activation and that the anticancer activity was linked to the low redox potential displayed by 
mitomycin molecules.141 Activation of mitomycin is known to proceed by means of a one electron 
reduction of the quinone and loss of a methoxy group (Scheme 7.1). This is followed by alkylation 
of DNA with the formation of interstrand cross links, resulting in inhibition of DNA synthesis, DNA 
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fragmentation and cell death.123,124,141,144 Reduced mitosenes are therefore the active 
intermediates in the bioreductive activation process. 
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 Scheme 7.1 Bioreductive alkylation pathway for mitomycin C (6.1).124 
 
The nitroimidazoles, initially developed as radiation sensitisers, also show preferential toxicity to 
hypoxic cells, e.g. RSU 1069 (6.3).142 Benzotriazine di-N-oxides e.g. tirapazamine are also 
examples of bioreductive cytotoxic agents. It has been suggested that the more negative the 
reduction potential, the greater the hypoxia selectivity, i.e. to the point at which enzymes can no 
longer reduce the compound.121 The antitumour properties of these compounds are thought to 
stem from their selective toxicity toward hypoxic cells found in solid tumours, and are thought to 
derive their biological activity from the cleavage of DNA. It is believed that an enzymatic one-
electron reduction of the antitumour heterocycle leads to the production of radical species 
(thought to be a hydroxyl radical species). The redox activated DNA cleavage of e.g. tirapazamine 
is found to be markedly inhibited by molecular oxygen. In the absence of reducing systems, 
tirapazamine alone does not damage DNA. It thus appears that tirapazamine, together with 
reductive cellular enzymes, may serve as a vehicle to deliver the known DNA cleaving agent of 
radiotherapy, the hydroxyl radical, specifically to hypoxic tumour cells in vivo.125 Evidence 
obtained from these studies suggested that a hydroxyl radical rather than a radical form of the 
potential drug was responsible for the DNA cleavage activity, which had no sequence specificity, 
and this is typical of the involvement of hydroxyl radicals. In addition, workers103,125,126 suggested 
that the hydroxyl radical was formed in a reaction triggered by a one electron enzymatic reduction 
of the potential drug. 
 
DNA sequencing and conformation studies have been assisted by the availability of molecules 
that mediate strand scission. New DNA cleaving agents are also of substantial practical interest in 
the development of potential anti tumour agents, especially those that may be able to damage a 
target sequence selectively. However, the DNA cleavage induced by potential drugs must occur 
proficiently under physiological conditions.126 Relatively few molecules meet this requirement and 
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interestingly most are natural products, such as the antibiotic CC-1065 (7.7),145 (-)-epicatechin 
(7.8),146 5-alkylresorcinol (7.9)147 and calichemicin γ1I (7.10).148   
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Since many drugs are activated in vivo through enzymatic reduction processes and then become 
active, the electrochemical data was included to demonstrate whether the reduction potentials 
can be related to selectivity. Figure 7.4 which shows graphs of the E1/2 reduction potentials versus 
HCT-116 appears to demonstrate generally the lower the reduction potential (i.e. the easier a 
compound is to reduce), the greater the cytotoxicity (at both pH 5.5 and 7.5). 
 
The discorhabdin C type compounds i.e. 1.51 - 1.53 and discorhabdin A, were found to deviate 
the most from the trends emerging from the graphs displayed in Figure 7.4, which may indicate 
that the cytotoxicity displayed by these compounds is unlikely to be related to their reduction 
potentials. Interestingly, the more elaborate the discorhabdin skeleton (heptacyclic versus 
pentacyclic), the lower the reduction potentials observed. 
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Figure 7.4 Plot of the E1/2 (mV) reductive potentials at both pH 5.5 (a) and (c); and 7.5 (b) 
and (d) versus IC50 HCT-116 values obtained for a select group of nine 
pyrroloiminoquinone compounds. Plots a) and b) investigated the correlation between 
HCT-116 cytotoxicity and reduction potential of all nine compounds tested (R2 = 0.17). 
Selective removal of discorhabdin A and three compounds with a discorhabdin C skeleton 
(1.51 - 1.53) suggested a possible correlation (R2 = 0.93) between HCT-116 cytotoxicity 
and reduction potentials for the remaining six compounds.  
 
While the makaluvamines have been shown to possess topoisomerase inhibition in several 
papers, discorhabdin A was shown by Radisky et al.30 and Barrows et al.70 to be a poor inhibitor of 
topoisomerase II. In the same paper, the makaluvamines were shown to be DNA-active 
compounds which under some conditions could react chemically to cleave DNA (e.g. reductive 
conditions).30 Their potential as anticancer agents was suggested from their cytotoxicity to HCT-
116 and their ability to inhibit topoisomerase II. In addition the makaluvamines were observed to 
intercalate into DNA and were shown to cause DNA strand breakage like the mitosenes (e.g. 
mitomycin C) but only under reductive conditions. In euoxic conditions, the makaluvamines did 
not damage DNA in vitro unless a topoisomerase II enzyme extract was added. Consistent with 
this, the makaluvamines did not show enhanced toxicity in other repair deficient lines. These lines 
were the DNA excision repair deficient and mitomycin C-sensitive UV-20 line and the single 
strand break repair deficient and X-ray sensitive EM9 line. Barrows et al.70 showed that the most 
active (toxic) makaluvamines were those that intercalate well into DNA and also those that 
displayed the highest reductive potentials. Makaluvone and damirone B, which were shown to be 
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poor intercalators, and makaluvamine B, which showed no reductive potential versus –180 to –
250 mV for the other makaluvamines, were neither cytotoxic nor inhibitors of topoisomerase II. 
Discorhabdin A was found to be one of the poorer intercalators (Ks value of 85 µM) and had the 
second smallest reduction potential (after makaluvamine B), which was consistent with its 
inactivity against topoisomerase II.30,70  
 
7.5 Singlet oxygen production as a basis for selective cytotoxicity? 
 
No correlation between singlet oxygen production and HCT-116 cytotoxicity (Figure 7.5) was 
observed, which was expected since the two experiments are unlikely to be related. The 
compounds were observed to produce radicals only upon activation with laser light at a 
wavelength of 532 nm and, since the cell cytotoxicity assays are not done specifically at these 
light conditions, a correlation between the two sets of data is not expected. 
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Figure 7.5 Comparison of the singlet oxygen quantum yields (Φ∆) performed at λ = 532 
nm versus IC50 HCT-116 values obtained for a select group of thirteen pyrroloamino-
ortho-quinone, pyrroloiminoquinones and bis-pyrroloiminoquinones. (SOQY = singlet 
oxygen quantum yield). 
 
Interestingly, the most cytotoxic compound (for all three cancer cell line models), discorhabdin A 
(1.57), exhibited a singlet oxygen quantum yield value greater than 1, which implies the 
production of radicals (Chapter 5). Similarly, the N-18 oximes (4.1 and 4.2) were also observed to 
produce radicals, though the IC50 values obtained in the cytotoxicity assays resulted in the 
cytotoxicity of these compounds being regarded as insignificant, which could in fact turn out to be 
an advantage (since the general toxicity of discorhabdin A would preclude its use as a drug, 
please see Table 7.2). The low cytotoxicity of the N-18 oximes may therefore be advantageous 
since they could only be induced to produce radicals upon irradiation and may therefore be 
competent beneficial PDT candidates. 
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7.6 Conclusion 
 
Discorhabdin A (1.57) showed extremely strong cytotoxic activity and our results were in 
agreement with the available literature. Interestingly, discorhabdin D and its analogues (3.2, 3.3, 
3.4 and 3.5) all displayed significant cytotoxicity in the HCT-116 cell line model. Our results also 
agreed with available literature in that the pyrroloiminoquinone core structure is essential to the 
cytotoxic activity displayed by the pyrroloiminoquinones and pyrroloamino-ortho-quinones.  
  
In addition to the strong activity displayed by discorhabdin A, the compound also demonstrated 
the ability to produce radicals upon photo activation. The tsitsikammamine N-18 oximes, which 
were also found to produce radicals and singlet oxygen, did not display any significant bioactivity. 
This relative non-toxicity of the tsitsikammamine oximes, unless activated by light, may prove to 
make them suitable for PDT. In addition, compound 4.1 displayed the ability to fluoresce upon 
excitation at longer wavelengths, which means that tsitsikammamine A N-18 oxime could also be 
used in imaging, another requirement of PDT.117 All four tsitsikammamines were also shown to 
intercalate into DNA and to inhibit topoisomerase activity to some extent. Interestingly, 
discorhabdin A, unlike the makaluvamines,70 does not inhibit topoisomerase II activity, while the 
tsitsikammamines138 and the related alkaloid wakayin91 inhibit topoisomerase I. Comparison of 
these apparently related structures may therefore give some idea as to the structural 
requirements for specific inhibition of topoisomerase I and II. Since most antimalarials are known 
DNA intercalators, it would be interesting to see whether the pyrroloiminoquinones would also 
show some antimalarial activity, but their general cytotoxicity would probably preclude their use as 
antimalarials (Table 7.1). 
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Chapter 8: Experimental Section 
 
8.1  General experimental section 
 
Unless otherwise stated, the experimental procedures followed were carried out as follows. The 
1H (400 MHz), 13C (100 MHz), Dept 135, COSY, HMQC, HMBC, NOESY and HSQC-TOCSY 
NMR spectra were recorded on an Avance Bruker 400 MHz spectrometer using standard pulse 
sequences. Chemical shifts are reported in ppm and referenced to the residual undeuterated 
solvent resonances (DMSO δH 2.50, δC 39.43; CH3OH δH 3.30, δC 49.05) and coupling constants 
are reported in Hz. Infra-red spectra were recorded as KBr discs on a Perkin-Elmer Spectrum 
2000 FT-IR spectrometer. Since the discorhabdins isolated display such close structural 
similarities, IR spectra were obtained for only a select few compounds. The low resolution mass 
spectra were obtained using a Finnigan Mat LCQ mass spectrometer, while the high resolution 
spectra were obtained by Prof. L. Fourie of the Mass Spectrometry Unit at the Universiteit vir Hoër 
Christelike Onderwys in Potchefstroom on a Micromass 70-70E spectrometer. Separation of the 
pyrroloiminoquinones was achieved on a reverse phase high performance liquid chromatographic 
system using a Phenomenex C18 column (10 mm i.d., 15 cm, flow rate 3 mL/min) using a Spectra-
Physics liquid chromatography pump, Waters R401 differential refractometer and a Rheodyne 
injector. Analysis of pyrroloiminoquinones by LC-MS (ESI) conditions employed: positive ion 
mode, capillary temperature 200 oC, capillary voltage 7.0 V, discharge voltage 4.5 kV, tube lens 
offset –60.0 V, discharge current 50 µA, octapole 1 offset –5.8 V, octapole 2 offset –7.5 V, 
interoctapole lens –58.0 V, with the sheath and auxiliary gases set to 30 and 0 arbitrary units. 
 
All solvents were distilled prior to use. Reverse phase TLC was done on Merck RP-18 F254s glass 
plates and viewed under UV light (254 nm). Solid phase extractions of the crude extracts were 
carried out on Waters 10 cm3 C18 Sep-Paks.  
 
8.2 Chapter 2: Experimental information 
 
Collection and extraction of Tsitsikamma pedunculata (OCDN 6451-V): 
Tsitsikamma pedunculata (OCDN 6451-V) was collected in Algoa Bay, South Africa in 1999 at a 
depth of -40 m and frozen immediately after collection (dry mass 105.5 g). The methanol / 
dichloromethane (2 : 1) organic extract was partitioned to give the hexane (2.51 g), chloroform 
(3.20 g), n-butanol (2.41 g) and aqueous methanol (8.90 g) fractions. A sequence of C18 solid 
phase extractions using a step gradient (100 % H2O to 100 % MeOH / TFA) and reversed phase 
HPLC (using 0.05 % TFA in various H2O / MeOH eluents) of the chloroform and n-butanol 
partition fractions afforded compounds 1.51 – 1.53, and 1.52, 1.53 and 2.1 - 2.6 respectively. See 
Scheme 2.1 for chromatographic details. 
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14-bromo-discorhabdin C (1.51): a reddish-brown solid (22.7 mg, 0.02 % yield), was 
characterised as its TFA salt. 1H (DMSO-d6, 400 MHz) δ 2.02 (2H, t, J = 5.6 Hz, H-7); 2.70 (2H, t, 
J = 7.3 Hz, H-16); 3.63 (1H, m, H-8); 3.70 (2H, t, J = 7.1 Hz, H-17); 7.70 (1H, s, H-1); 7.70 (1H, s, 
H-5); 8.20 (1H, br s, NH-18); 10.30 (1H, br s, NH-9); 14.15 (1H, br s, NH-13). 13C (DMSO-d6, 100 
MHz) δ 17.5 (C-16, t); 33.4 (C-7, t); 38.3 (C-8, t); 43.4 (C-17, t); 44.5 (C-6, s); 91.7 (C-20, s); 
112.4 (C-14, s); 119.8 (C-15, s); 122.6 (C-2, s); 122.6 (C-4, s); 124.1 (C-12, s); 124.2 (C-21, s); 
150.9 (C-1, d); 150.9 (C-5, d); 151.5 (C-10, s); 152.0 (C-19, s); 164.3 (C-11, s); 171.2 (C-3, s). 
HRFABMS m/z [M+1] 540.8636 (calcd for C18H14N3O279Br3, 540.8636). 
 
14-bromo-3-dihydro-discorhabdin C (1.52): an olive green solid (18.7 mg, 0.02 % yield), was 
characterised as its TFA salt. 1H (DMSO-d6, 400 MHz) δ  6.37 (1H, s, H-1); 1.89 (2H, t, J = 5.3 Hz, 
H-7); 2.74 (2H, t, J = 7.2 Hz, H-16); 3.53 (1H, m, H-8); 3.81 (2H, t, J = 7.1 Hz, H-17); 4.68 (1H, s, 
H-3); 6.37 (1H, s, H-5); 7.80 (1H, br s, NH-18); 10.10 (1H, br s, NH-9); 14.00 (1H, br s, NH-13). 
13C (DMSO-d6, 100 MHz) δ 17.6 (C-16, t); 34.7 (C-7, t); 38.2 (C-8, t); 41.9 (C-6, s); 43.6 (C-17, t); 
70.8 (C-3, d); 96.1 (C-20, s); 112.1 (C-14, s); 119.7 (C-15, s); 124.1 (C-2, s); 124.1 (C-4, s); 124.1 
(C-12, s); 124.4 (C-21, s); 133.9 (C-1, d); 133.9 (C-5, d); 151.2 (C-10, s); 151.9 (C-19, s); 164.6 
(C-11, s). HRFABMS m/z [M+1] 542.8792 (calcd for C18H16N3O279Br3, 542.8793). 
 
3-dihydro-discorhabdin C (1.53): a red solid (90.4 mg, 0.09 % yield), was characterised as its 
TFA salt. 1H (DMSO-d6, 400 MHz) δ  1.85 (2H, t, J = 7.3 Hz, H-16); 2.80 (2H, t, J = 5.6 Hz, H-7); 
3.60 (1H, t, J = 5.6 Hz, H-8); 3.70 (2H, t, J = 7.6 Hz, H-17); 4.60 (1H, s, H-3); 6.50 (1H, s, H-1); 
6.50 (1H, s, H-5); 7.40 (1H, s, H-14); 7.80 (1H, br s, NH-18); 10.20 (1H, br s, NH-9); 13.20 (1H, br 
s, NH-13). 13C (DMSO-d6, 100 MHz) δ 17.7 (C-16, t); 33.4 (C-7, t); 37.2 (C-8, t); 42.1 (C-6, s); 
42.6 (C-17, t); 69.2 (C-3, d); 92.9 (C-20, s); 119.7 (C-15, s); 122.7 (C-2, s); 122.7 (C-4, s); 122.9 
(C-21, s); 123.1 (C-12, s); 127.4 (C-14, d); 133.5 (C-1, d); 133.5 (C-5, d); 152.4 (C-10, s); 153.1 
(C-19, s); 165.5 (C-11, s). HRFABMS m/z [M+1] 464.9688 (calcd for C18H17N3O279Br2, 464.9688). 
 
7,8-dehydro-3-dihydro-discorhabdin C (2.1): an olive green solid (1.2 mg, 0.001 % yield), was 
characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 2.1. 
HRFABMS m/z [M+1] 462.9532 (calcd. for C18H15N3O279Br2, 462.9531). 
 
14-bromo-7,8-dehydro-3-dihydro-discorhabdin C (2.2): a green solid (7.7 mg, 0.007 % yield), 
was characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 
2.2.  HRFABM m/z [M+1] 540.8635 (calcd for C18H14N3O279Br3, 540.8636). 
 
Discorhabdin S (2.3): a dark green solid (4.4 mg, 0.004 % yield), was characterised as its TFA 
salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 2.3. HRFABMS m/z [M+1] 
387.0582 (calcd for C18H18N3O279Br, 387.0582). 
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14-bromo-1-hydroxy-discorhabdin S (2.4): a brown solid (4.2 mg, 0.004 % yield), was 
characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 2.4. 
HRFABMS m/z [M+1] 480.9638 (calcd for C18H17N3O379Br2, 480.9637). 
 
1-bromo-4-debromo-2-hydroxy-discorhabdin S (2.5): a golden brown solid (2.6 mg, 0.003 % 
yield), was characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see 
Table 2.5. HRFABMS m/z [M+1] 403.0532 (calcd for C18H18N3O379Br, 403.0532). 
 
2,4-debromo-3-dihydro-discorhabdin C (2.6): a reddish-brown solid (1.2 mg, 0.001 % yield), 
was characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 
2.6. HRFABMS m/z [M+] 308.1400 (calcd for C18H18N3O2, 308.1399). 
 
8.3  Chapter 3: Experimental information 
 
Collection and extraction of Latrunculia lorii (OCDN 6428-V): 
Latrunculia lorii (OCDN 6428-V) was collected in Riy Banks, Algoa Bay, South Africa in 1999 at a 
depth of -24 m and frozen immediately after collection (dry mass 138.2 g). The methanol / 
dichloromethane organic extract was partitioned to give the hexane (4.17 g), chloroform (0.99 g), 
n-butanol (6.27 g) and aqueous methanol (9.60 g) fractions. A sequence of C18 solid phase 
extractions using a step gradient (100 % H2O to 100 % MeOH / TFA) and reversed phase HPLC 
(using 0.05 % TFA in various H2O / MeOH eluents) of the chloroform and n-butanol partition 
fractions afforded compounds 1.33, 1.20, 1.47, 3.1 - 3.4, and 1.33, 1.20, 3.1 – 3.3 and 3.5 (in 
larger quantities) respectively. See Scheme 3.1 for chromatographic details. 
 
Makaluvamine C (1.33): a reddish brown solid (22.6 mg, 0.02 % yield), was characterised as its 
TFA salt. 1H (DMSO-d6, 400 MHz) δ 2.91 (2H, t, J3,4 = 7.6 Hz, H-3); 3.31 (3H, s, H-5’); 3.89 (2H, t, 
J3,4 = 7.6 Hz, H-4); 5.73 (1H, s, H-6); 7.26 (2H, s, H-2); 8.61 (1H, br s, H-9a); 9.43 (1H, br s, NH-
9b); 13.07 (1H, br s, NH-1). 13C (DMSO-d6, 100 MHz) δ 18.8 (C-3, t); 38.9 (C-5’, q); 52.5 (C-4, t); 
85.4 (C-6, d); 117.7 (C-8b, s); 123.2 (C-8a, s); 123.3 (C-2a, s); 126.5 (C-2, d); 155.6 (C-5a, s); 
156.5 (C-7, s); 167.3 (C-8, s). HRFABMS m/z [M+] 202.0980 (calcd for C11H12N3O, 202.0980). 
 
Damirone B (1.20): a reddish brown solid (70.2 mg, 0.05 % yield), was characterised as its TFA 
salt. 1H (DMSO-d6, 400 MHz) δ 2.81 (2H, t, J3,4 = 6.6 Hz, H-3); 3.05 (3H, s, H-5’); 3.61 (2H, t, J3,4 
= 6.6 Hz, H-4); 5.20 (1H, s, H-6); 6.66 (1H, br s, NH-5); 7.06 (1H, s, H-2); 12.42 (1H, br s, NH-1). 
13C (DMSO-d6, 100 MHz) δ 19.6 (C-3, t); 37.8 (C-5’, q); 51.3 (C-4, t); 92.6 (C-6, d); 116.4 (C-8b, 
s); 124.0 (C-2, d); 124.2 (C-8a, s); 124.7 (C-2a, s); 153.8 (C-5a, s); 170.2 (C-7, s); 177.5 (C-8, s). 
HRFABMS m/z [M+] 203.0821 (calcd for C11H11N2O2, 203.0821). 
 
Makaluvic Acid (1.47): a brown solid (2.7 mg, 0.002 % yield), was characterised as its TFA salt. 
1H (DMSO-d6, 400 MHz) δ 2.81 (2H, t, J3,4 = 7.1 Hz, H-3); 3.06 (3H, s, H-5’); 3.63 (2H, t, J3,4 = 7.1 
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Hz, H-4); 6.89 (1H, d, JNH1,2 = 2.8 Hz, H-2); 12.29 (1H, br s, NH-1); 16.05 (1H, s, H-8a). 13C 
(DMSO-d6, 100 MHz) δ 19.6 (C-3, t); 34.0 (C-5’, q); 49.9 (C-4, t); 115.1 (C-8b, s); 118.2 (C-2, d); 
122.1 (C-2a, s); 123.2 (C-8a, s); 159.8 (C-8, s); 165.0 (C-5a, s). HRFABMS m/z [M+1] 195.0760 
(calcd for C9H11N2O3, 195.0770). 
 
Discorhabdin G* (3.1): a dark golden brown solid (18.2 mg, 0.01 % yield), was characterised as 
its TFA salt. 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 3.1. HRFABMS m/z [M+] 
336.0807 (calcd for C18H14N3SO2, 336.0807). 
 
Discorhabdin M (3.2): a reddish-brown solid (35.1 mg, 0.03 % yield), was characterised as its 
TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 3.2. HRFABMS m/z [M+] 
409.0971 (calcd for C20H17N4SO4, 409.0971). 
1-amino discorhabdin D (3.3): a dark green solid (56.9 mg, 0.04 % yield), was characterised as 
its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 3.3. HRFABMS m/z 
[M+] 352.0995 (calcd for C18H15N4SO2, 352.0994). 
 
1-methoxy discorhabdin D (3.4): a brown solid (4.1 mg, 0.003 % yield), was characterised as its 
TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 3.4. HRFABMS m/z [M+] 
366.0912 (calcd for C19H16N3SO3, 366.0912). 
 
1-alanyl discorhabdin D (3.5): a dark green solid (16.3 mg, 0.01 % yield), was characterised as 
its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 3.5. HRFABMS m/z 
[M+] 423.1127 (calcd for C21H19N4SO4, 423.1127). 
 
8.4 Chapter 4: Experimental information 
 
Collection and extraction of Tsitsikamma favus (SAF 94-006): 
Tsitsikamma favus was collected in Tsitsikamma Marine Reserve, South Africa in 1994 at a depth 
of –20 m and frozen immediately after collection (dry mass 473.3 g). The methanol organic 
extract was partitioned to give the hexane (17.50 g), chloroform (3.85 g), n-butanol (4.64 g) and 
aqueous methanol (28.65 g) fractions. A sequence of C18 solid phase extractions using a step 
gradient (100% H2O to 100% MeOH/TFA) and reversed phase HPLC (using 0.05% TFA in 
H2O/MeOH) of the chloroform and n-butanol partition fractions afforded compounds 1.71, 1.72, 
1.52 and 4.1, 4.2, 2.1, 2.4, 2.6, respectively. See Scheme 4.1 for chromatographic details. 
 
Tsitsikammamine A (1.71): a reddish brown solid (10.3 mg, 0.002 % yield), was characterised 
as its TFA salt. IR (KBr disk) νmax 3154, 1680, 1626, 1447, 1372, 1324, 1266, 1201, 1131, 836, 
796, 719, 592 cm-1. 1H (DMSO-d6, 400 MHz) δ 2.93 (2H, t, J = 8.0 Hz, H-16); 3.85 (2H, J = 8.0 
Hz, t, H-17); 6.87 (2H, d, J = 8.4 Hz, H-1); 6.87 (2H, d, J = 8.4 Hz, H-5); 7.10 (1H, d, J = 1.6 Hz, 
H-14); 7.15 (1H, m, H-8); 7.37 (2H, d, J = 8.4 Hz, H-2); 7.37 (2H, d, J = 8.4 Hz, H-4); 13.01 (1H, 
Chapter 8: Experimental Section 
 
 179
br s, NH-13); 13.28 (1H, br s, NH-9). 13C (DMSO-d6, 100 MHz) δ 17.6 (C-16, t); 44.9 (C-17, t); 
113.4 (C-20, s); 116.2 (C-1, d); 116.2 (C-5, d); 119.2 (C-15, s); 120.7 (C-21, s); 122.4 (C-7, s); 
123.1 (C-14, d); 125.0 (C-8, d); 127.2 (C-6, s); 127.8 (C-12, s); 128.9 (C-2, d); 128.9 (C-4, d); 
134.6 (C-10, s); 156.8 (C-19, s); 157.5 (C-3, s); 166.3 (C-11, s). HRFABMS m/z [M+] 304.1087 
(calcd for C18H14N3O2, 304.1086). 
  
Tsitsikammamine B (1.72): a dark red solid (36.8 mg, 0.008 % yield), was characterised as its 
TFA salt. 1H (DMSO-d6, 400 MHz) δ 2.91 (2H, t, J = 8.0 Hz, H-16); 3.83 (2H, J = 8.0 Hz, t, H-17); 
3.96 (3H, s, N-Me); 6.87 (2H, d, J = 8.4 Hz, H-1); 6.87 (2H, d, J = 8.4 Hz, H-5); 7.12 (1H, s, H-14); 
7.17 (1H, d, J = 2.4 Hz, H-8); 7.36 (2H, d, J = 8.4 Hz, H-2); 7.36 (2H, d, J = 8.4 Hz, H-4); 13.28 
(1H, br s, NH-9). 13C (DMSO-d6, 100 MHz) δ 17.5 (C-16, t); 35.7 (N-CH3, q); 44.6 (C-17, t); 113.3 
(C-20, s); 116.2 (C-1, d); 116.2 (C-5, d); 118.7 (C-15, s); 120.6 (C-21, s); 122.4 (C-7, s); 125.1 (C-
8, d); 126.3 (C-12, s); 127.1 (C-6, s); 127.9 (C-14, d); 128.9 (C-2, d); 128.9 (C-4, d); 134.5 (C-10, 
s); 156.2 (C-19, s); 157.6 (C-3, s); 166.7 (C-11, s). HRFABMS m/z [M+1] 319.1321 (calcd for 
C19H17N3O2, 319.1321). 
 
Tsitsikammamine A N-oxime (4.1): a bright orange red solid (4.7 mg, 0.001 % yield), was 
characterised as its TFA salt. IR (KBr disk) νmax 3066, 1674, 1646, 1487, 1434, 1405, 1381, 1271, 
1207, 1147, 987, 908, 841, 792, 721, 608, 438 cm-1. For 1H and 13C NMR data (400/100 MHz, 
DMSO-d6) see Table 4.1. HRFABMS m/z [M+2] 322.1192 (calcd for C18H16N3O3, 322.1192). 
 
Tsitsikammamine B N-oxime (4.2): a bright orange red solid (2.9 mg, 0.0006 % yield), was 
characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 4.2. 
HRFABMS m/z [M+1] 336.1348 (calcd for C19H18N3O3, 336.1348). 
14-bromo-3-dihydro-discorhabdin C (1.52): an olive green solid (9.6 mg, 0.002 % yield), was 
characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Section 
9.2 above. HRFABMS m/z [M+1] 542.8792 (calcd for C18H16N3O279Br3, 542.8793). 
 
7,8-dehydro-3-dihydro-7,8-dehydro-discorhabdin C (2.1): an olive green solid (2.1 mg, 0.0004 
% yield), was characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) 
see Table 2.1. HRFABMS m/z [M+1] 462.9532 (calcd. for C18H15N3O279Br2, 462.9531). 
 
14-bromo-1-hydroxy-discorhabdin S (2.4): a brown solid (4.3 mg, 0.001 % yield) was 
characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 2.4. 
HRFABMS m/z [M+1] 480.9636 (calcd for C18H17N3O379Br2, 480.9637). 
 
2,4-debromo-3-dihydro-discorhabdin C (2.6): a reddish-brown solid (2.0 mg, 0.0004 % yield), 
was characterised as its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 
2.6.  
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Attempted oxidation of 1.71: 
 
Compound 1.71 (3.0 mg) was dissolved in glacial acetic acid (0.5 mL) and treated with an excess 
30 % solution of H2O2 (1.0 mL) at 80 oC for 24 hrs with stirring. No colour change was observed 
and only starting material was recovered.  
 
Compound 1.71 (2.5 mg) was dissolved in MeOH (1 mL) and treated with an excess m-CPBA 
(1.5 mg) with stirring for 24 hrs. No colour change was observed and only starting material was 
recovered.  
 
Collection and extraction of Strongylodesma sp.:  
 
The Strongylodesma sp. sponge was collected in Algoa Bay, South Africa in 1996 at a depth of –
2 m and frozen immediately after collection (dry mass 143.1 g). The methanol organic extract was 
partitioned to give the hexane (16.69 g), chloroform (1.17 g), n-butanol (4.65 g) and aqueous 
methanol (5.45 g) fractions. A sequence of C18 solid phase extractions using a step gradient 
(100% H2O to 100% MeOH/TFA) and reversed phase HPLC (using 0.05% TFA in H2O/MeOH) of 
the chloroform and n-butanol partition fractions afforded compounds 1.57, 1.53 and 1.61, and 3.3 
respectively. See Scheme 4.3 for chromatographic details.  
 
Discorhabdin A (1.57): a dark green solid (208.8 mg, 0.15 % yield) was characterised as its TFA 
salt. 1H (DMSO-d6, 400 MHz) δ 2.48 (1H, m, H-7a); 2.67-3.17 (5H, m, H-4, H-7b, H-16); 3.70 (1H, 
m, H-17a); 3.93 (1H, m, H-17b); 4.58 (2H, dd, J = 6.0, 11.6 Hz, H-5); 5.33 (1H, s, H-8); 7.38 (1H, 
d, J = 1.6 Hz, H-14); 7.47 (1H, s, H-1); 9.42 (1H, br s, NH-18); 10.35 (1H, br s, NH-9); 13.18 (1H, 
br s, NH-13). 13C (DMSO-d6, 100 MHz) δ 18.8 (C-16, t); 41.3 (C-7, t); 44.6 (C-17, t); 45.2 (C-4, t); 
50.3 (C-6, s); 54.6 (C-5, d); 59.6 (C-8, d); ~105 (C-20, s); 120.7 (C-15, s); 124.0 (C-21, s); 124.2 
(C-12, s); 128.1 (C-14, s); 148.8 (C-10, s); 154.6 (C-19, s); 166.8 (C-11, s); 187.8 (C-3, s). Low 
resolution MS m/z [M+] 416.2. 
 
Discorhabdin D (1.61): a green solid (6.7 mg, 0.005 % yield) was characterised as its TFA salt. 
1H (DMSO-d6, 400 MHz) δ 2.44 (1H, dd, J = 2.8, 13.4 Hz, H-1a); 2.55 (1H, d, J = 12.1 Hz, H-7a); 
2.70 (1H, dd, J = 3.5, 12.1 Hz, H-7b); 2.91 (1H, dd, J = 2.8, 13.4 Hz, H-1b); 3.03 (1H, m, H-16); 
3.84 (1H, m, H-17a); 4.03 (1H, m, H-17b); 4.37 (1H, s, H-2); 5.68 (1H, m, H-8); 6.13 (1H, s, H-4); 
7.29 (1H, d, J = 2.3 Hz, H-14); 10.70 (1H, br s, NH-9) 13.15 (1H, br s, NH-13). 13C (DMSO-d6, 100 
MHz) δ 19.3 (C-16, t); 30.1 (C-1, t); 38.5 (C-7, t); 41.0 (C-6, s); 51.1 (C-17, t); 62.1 (C-2, d); 62.6 
(C-8, d); 99.5 (C-20, s); 112.3 (C-4, d); 117.6 (C-15, s); 121.4 (C-12, s); 123.6 (C-21, s); 126.8 (C-
14, d); 145.8 (C-10, s); 147.7 (C-19, s); 166.4 (C-11, s); 172.9 (C-5, s); 182.9 (C-3, s). Low 
resolution MS m/z [M+] 436.4. 
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3-dihydro-discorhabdin C (1.53): a red solid (6.9, 0.005 % yield), was characterised as its TFA 
salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Section 8.2.  
 
1-amino discorhabdin D (3.3): a dark green solid (19.2 mg, 0.01 % yield), was characterised as 
its TFA salt. For 1H and 13C NMR data (400/100 MHz, DMSO-d6) see Table 3.3.  
 
8.5 Chapter 5: Experimental information 
 
Materials: 
 
A select group of pyrroloiminoquinones, previously isolated from various latrunculid sponges, 
were used to determine the singlet oxygen quantum yields.  DMSO, 5,10,15,20-tetraphenyl–
21H,23H-porphine (porphine) and 1,3-diphenylisobenzofuran (DPBF) were purchased from 
Sigma-Aldrich.  
 
Preparation of the free base of compounds 1.51 and 1.57: 
 
Compounds 1.51 (2.5 mg) and 1.57 was dissolved in 5 M NaOH. A change of colour (to yellow) 
was observed and the compounds subsequently extracted with chloroform. The chloroform 
fractions containing the compounds were dried and the solvent removed in vacuo. The 
compounds were then subjected to reversed phase fractionation on a rapid sample preparation 
SepPak (Part No. 51910) using a gradient elution and dried.  
 
8.6 Chapter 6: Experimental information 
 
Methods: 
 
Voltammetric measurements were done in a conventional three-electrode system.  Both CV and 
OSWV data were collected using a CV-50W Bio-Analytical System (BAS) voltammetric analyser. 
A gold electrode (0.8 mm in diameter) and a platinum electrode were used as the working and 
auxiliary electrodes, respectively. Before use in the electrochemical experiments, the surface of 
the gold electrode was hand polished on fine chamois leather containing γ−Al2O3 slurry. A 
AgΙAgCl (3 mol/dm3 KCl) reference electrode was used for the aqueous solutions studied. The 
electrolyte buffer solutions were made up prior to data collection and the solutions saturated with 
nitrogen before running the experiment. Nitrogen was supplied by MG Fed gas and purified by 
passing through a Drierite self-indicating mesh 8 (anhydrous CaSO4) from SAAR Chemicals. All 
experiments were carried out at ambient temperature. The buffer solutions were made up as 
follows: 
pH 5.5:  (NaH2PO4.H2O 6.22 mg/mL, Na2HPO4 (anhydrous) 0.232 mg/mL, Na2EDTA 0.375 
mg/mL);  
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pH 7.5:  (NaH2PO4.H2O 0.575 mg/mL, Na2HPO4 (anhydrous) 2.17 mg/mL, Na2EDTA 0.375 
mg/mL).30 
 
8.7  Chapter 7: Experimental information 
 
HCT-116, WHC01 and ME180 cytotoxicity assays: 
 
a) Cell culture 
 
The human colon tumour cell line (HCT-116) was purchased from ATCC. The HCT-116 cells 
were maintained in McCoy’s medium similarly enriched with 2 % foetal bovine serum, 8 % 
newborn serum, 8 % newborn bovine serum with penicillin (100 µg/mL), streptomycin (100 
µg/mL). Cells were grown at 37 oC as monolayers in culture flasks (75 cm2) and detached with 
trypsin before seeding into microtiter culture plates.  
 
The WHC01 (oesophageal) and ME180 (ovarian) cell lines (MTT assay) were similarly maintained 
and prepared by Catherine Arendse, Department of Medical Biochemistry, University of Cape 
Town, South Africa. IC50 determinations were carried out using the MTT kit from Roche (Cat # 
1465007), according to manufacturer’s instructions. Briefly, 1500 cells were seeded per well in 90 
µL in Cellstar 96-well plates. Cells were incubated for 24 hours then the pyrroloiminoquinones 
plated at various concentrations in 10 µL (constant final concentration of DMSO = 0.1 %). After 48 
hours incubation, observations were made, and 10 µL MTT solution added to each well. After a 
further 4 hours incubation, 100 µL of solubilisation solution was added to each well and the plates 
incubated again overnight. The following morning, plates were read at 595 nm on an Anthos 
microplate reader 2001.  
 
b) Cell cytotoxicity  
 
Cytotoxicity was established in a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay as performed by Mossmann149 and modified by others.91,150,151 Drugs were dissolved 
in 100 % DMSO at initial concentrations of 10 mM and serially diluted. The final concentration of 
DMSO in the cell culture wells was 1 % or less. 20000 Cells were seeded in growth media in 200 
µL in 96-well plates. 4 hours after seeding, cells were treated, each dose in quadruplicate, with 
serially diluted drug (1 µL). After 72 hrs, all cultures were re-fed with McCoy’s medium (100 µL) 
and an aliquot of MTT solution (11 µL, 5 mg/mL in PBS, pH 7.4) was added to each well. The 
plates were incubated for 4 hrs at 37 oC. Viable cells reduced MTT to a purple formazan product 
that was solubilised by the addition of DMSO (100 µL) to aspirated culture wells. The absorbance 
at 540 nm was measure for each well using a Bio-Rad MP450 plate reader. Average absorbance 
for each set of drug treated wells was compared to the average absorbance of the control wells to 
determine the fractional survival at any particular drug concentration. The IC50 was defined as the 
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drug concentration that yielded a fraction survival of 50 %. IC50 values reported were the average 
of three to five independent experiments. 
 
Quantitation of DNA catenation and cleavage: 
 
DNA cleavage assays were performed as described by Matsumoto et al..152 Aliquot (20 µL) 
volumes containing Tris-HCl (50 mM, pH 7.5), KCl (85 mM), MgCl2 (10 mM), EDTA (0.5 mM), 
bovine serum albumin (30 µg/mL), DTT (2 mM), radiolabled (500 ng) and supercoiled rf M13 mp 
19 DNA and purified top2 or top1 (80 – 120 ng) were treated with the drug made up in DMSO and 
incubated at 30 oC for 30 min. The reactions were stopped by the addition of 1.5 mg/mL 
proteinase K (2 µL) in 0.5 % SDS and incubated at 37 oC for 60 min. The DNA was fractionated 
by electrophoresis in 0.8 % agarose (containing 50 ng ethidium bromide/mL TAE) to separate 
nicked (n), linear – only on top2 gel and runs just below the nicked band (l), relaxed (r) and 
supercoiled (sc) DNA. DNA was visualised under UV light and sliced out of the gel. Gel slices 
were placed in scintillation vials with water (1 mL), melted in a microwave oven and mixed with 
Opti-Fluor (10 mL, Packer Co.) while molten, and radioactivity determined by standard scintillation 
counting. The percentage of cleaved DNA, represented by radioactivity in the combined nicked 
and linear bands) was determined relative to the total radioactivity in the reactions, following 
subtraction of radioactivity due to endogenously cleaved DNA. The percentage of catenated DNA 
was determined similarly. 
 
Ethidium bromide (EtBr) displacement assays: 
 
The Ks value is defined as the concentration of compound required to decrease DNA bound EtBr 
fluorescence by 50 % and the assay has been described by Kokoshka et al.91 and modified by 
Barrows et al..70 Salmon testes sperm DNA (25 µg/mL) and EtBr (0.5 µg/mL) were put in a 96-well 
plate in TE (100 µL). Controls consisted of EtBr in TE only, DNA in TE only and EtBr + DNA in TE. 
Final concentrations in the wells ranged from 100, 1, 0.1 to 0.01µM for each compound. Each 
plate consisted of an n = 4 for each drug dose tested and n = 8 for the controls. The 96-well 
plates were read by a fluorescent plate reader. EtBr displacement was determined by subtracting 
the amount of background EtBr fluorescence from all samples and then dividing by the amount of 
fluorescence in the DNA and EtBr control. All four compounds were found to intercalate into DNA. 
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